"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Assay Parameters";"Assay Variant Accession";"Assay Variant Mutation";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID";"Properties";"Action Type";"Standard Text Value"
"CHEMBL404811";"DIGITONIN";"None";"1229.32";"None";"None";"DIGITONIN";"C[C@@H]1CC[C@@]2(OC1)O[C@H]1[C@@H](O)[C@H]3[C@@H]4CC[C@H]5C[C@@H](O[C@@H]6O[C@H](CO)[C@H](O[C@@H]7O[C@H](CO)C(O)[C@H](O[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O)[C@H]7O[C@@H]7O[C@H](CO)[C@H](O)[C@H](O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL413034";"";"None";"1015.14";"None";"None";"14";"CNCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N2CCC[C@H]2C(=O)N[C@H](Cc2ccccc2)C(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O";"IC50";"'='";"86.0";"nM";"7.07";"";"";"UO_0000065";"6.96";"None";"None";"None";"0";"CHEMBL647843";"In vitro binding affinity at angiotensin II (type 2) receptor in rabbit uterus.";"B";"BAO_0000357";"single protein format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126724";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL25719";"GERANIOL";"None";"154.25";"0";"2.67";"GERANIOL";"CC(C)=CCC/C(C)=C/CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL975";"MESNA";"4.0";"164.18";"0";"-0.20";"MESNA";"O=S(=O)([O-])CCS.[Na+]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL309367";"";"None";"576.71";"2";"5.14";"12n";"CCCc1nc(CN2CCN(c3ccccc3)C[C@H]2C)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"12.41";"0.23";"2.01";"6.16";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL72721";"";"None";"577.69";"1";"4.54";"12k";"CCCCc1nc(CN2CCN(c3ccccn3)CC2)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"10.65";"0.20";"1.61";"4.77";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL1566249";"AMPIROXICAM";"2.0";"447.47";"0";"2.56";"AMPIROXICAM";"CCOC(=O)OC(C)OC1=C(C(=O)Nc2ccccn2)N(C)S(=O)(=O)c2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL155847";"";"None";"450.47";"0";"4.46";"21";"COc1ccc2c(c1OCc1ccccc1)CC(C(=O)O)N(C(=O)Nc1ccc(F)cc1)C2";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"15.03";"0.28";"2.31";"7.68";"0";"CHEMBL643791";"Inhibitory activity against angiotensin II type 2 (AT2) receptor in rabbit uterine membranes.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127723";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL507053";"";"None";"1496.68";"None";"None";"13";"CO/C(C)=C1/NC(=O)[C@H]([C@@H](C)O)NC(=O)c2csc(n2)-c2cc(O)c(-c3nc(C(=O)NCCNC(=O)CN(C)C)cs3)nc2-c2csc(n2)[C@@H]2COC(=O)c3c4c5c(cccc5n3O)COC(=O)[C@@H](O[C@H]3C[C@](C)(O)[C@H](N(C)C)[C@H](C)O3)[C@@H](OC4)[C@H](NC(=O)c3csc1n3)c1nc(cs1)C(=O)N2";"IC50";"'='";"78.0";"nM";"7.11";"";"";"UO_0000065";"4.75";"None";"None";"None";"0";"CHEMBL996322";"Inhibition of AT2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136943";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL510526";"";"None";"1439.63";"None";"None";"3";"CO/C(C)=C1/NC(=O)[C@H]([C@@H](C)O)NC(=O)c2csc(n2)-c2cc(O)c(-c3nc(C(=O)NCCN(C)C)cs3)nc2-c2csc(n2)[C@@H]2COC(=O)c3c4c5c(cccc5n3O)COC(=O)[C@@H](O[C@H]3C[C@](C)(O)[C@H](N(C)C)[C@H](C)O3)[C@@H](OC4)[C@H](NC(=O)c3csc1n3)c1nc(cs1)C(=O)N2";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"4.67";"None";"None";"None";"0";"CHEMBL996322";"Inhibition of AT2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136943";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL508306";"";"None";"1495.69";"None";"None";"6";"CO/C(C)=C1/NC(=O)[C@H]([C@@H](C)O)NC(=O)c2csc(n2)-c2cc(O)c(-c3nc(C(=O)NCCCN4CCOCC4)cs3)nc2-c2csc(n2)[C@@H]2COC(=O)c3c4c5c(cccc5n3O)COC(=O)[C@@H](O[C@H]3C[C@](C)(O)[C@H](N(C)C)[C@H](C)O3)[C@@H](OC4)[C@H](NC(=O)c3csc1n3)c1nc(cs1)C(=O)N2";"IC50";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"4.40";"None";"None";"None";"0";"CHEMBL996322";"Inhibition of AT2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136943";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL507013";"";"None";"1453.65";"None";"None";"8";"CO/C(C)=C1/NC(=O)[C@H]([C@@H](C)O)NC(=O)c2csc(n2)-c2cc(O)c(-c3nc(C(=O)N(C)CCN(C)C)cs3)nc2-c2csc(n2)[C@@H]2COC(=O)c3c4c5c(cccc5n3O)COC(=O)[C@@H](O[C@H]3C[C@](C)(O)[C@H](N(C)C)[C@H](C)O3)[C@@H](OC4)[C@H](NC(=O)c3csc1n3)c1nc(cs1)C(=O)N2";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL996322";"Inhibition of AT2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136943";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL504492";"";"None";"1509.72";"None";"None";"19";"CO/C(C)=C1/NC(=O)[C@H]([C@@H](C)O)NC(=O)c2csc(n2)-c2cc(OC)c(-c3nc(C(=O)NCCCN4CCOCC4)cs3)nc2-c2csc(n2)[C@@H]2COC(=O)c3c4c5c(cccc5n3O)COC(=O)[C@@H](O[C@H]3C[C@](C)(O)[C@H](N(C)C)[C@H](C)O3)[C@@H](OC4)[C@H](NC(=O)c3csc1n3)c1nc(cs1)C(=O)N2";"IC50";"'='";"5070.0";"nM";"5.29";"";"";"UO_0000065";"3.51";"None";"None";"None";"0";"CHEMBL996322";"Inhibition of AT2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136943";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL307290";"";"None";"665.74";"1";"4.89";"17";"CCCCOC(=O)NS(=O)(=O)c1ccccc1-c1ccc(Cn2c(CC)nc3ccc(NC(=O)N4CCOCC4)cc3c2=O)c(F)c1";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"11.26";"0.22";"2.60";"5.03";"0";"CHEMBL643789";"In vivo inhibitory concentration against AT2 receptor of human adrenal membrane";"B";"BAO_0000218";"organism-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150477";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL315994";"";"None";"608.74";"1";"4.58";"21a";"CCCc1nc(SC)c(C(O)C(=O)O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"12.85";"0.25";"3.24";"5.19";"0";"CHEMBL643790";"In vitro binding affinity at Angiotensin II Type 2 receptor in rabbit uterus membrane by [125I]AII displacement.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"CHEMBL3638197";"Uterus";"None";"Membrane";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128070";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1995";"None";"";"";""
"CHEMBL128416";"";"None";"371.44";"0";"3.86";"10";"O=C(O)C1Cc2ccccc2CN1C(=O)C(c1ccccc1)c1ccccc1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"18.04";"0.33";"2.84";"11.63";"0";"CHEMBL643791";"Inhibitory activity against angiotensin II type 2 (AT2) receptor in rabbit uterine membranes.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127723";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL71953";"";"None";"557.74";"2";"6.61";"11a";"CCCCCN(CCCCC)Cc1nc(CCC)n(Cc2ccc(-c3ccccc3-c3nn[nH]n3)cc2)c1C(=O)O";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"12.01";"0.22";"0.09";"5.94";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL1909055";"COBALTOUS CHLORIDE";"4.0";"129.84";"None";"None";"COBALT (II) CHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL428880";"CROMOLYN";"4.0";"468.37";"0";"2.11";"CROMOLYN";"O=C(O)c1cc(=O)c2c(OCC(O)COc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909056";"COBALT(II) ACETYLACETONATE";"None";"257.15";"None";"None";"COBALT(II) ACETYLACETONATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1947131";"";"None";"547.66";"2";"6.65";"6d";"CCCc1nc2c(C)cc(C(=O)NCc3ccc(OC)cc3)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"IC50";"'='";"3600.0";"nM";"5.44";"";"";"UO_0000065";"9.94";"0.18";"-1.21";"5.83";"0";"CHEMBL1949357";"Displacement of [125I]Sar1 Ile8-Ang 2 from angiotensin 2 AT2 receptor after 180 mins by gamma counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944634";"1";"Scientific Literature";"Eur J Med Chem";"2012";"None";"";"";""
"CHEMBL263191";"";"None";"665.79";"2";"5.21";"6";"CCCc1nc2ccc(NC(=O)NC(C)C)cc2c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)COCC(C)C)cc1F";"IC50";"'='";"3.5";"nM";"8.46";"";"";"UO_0000065";"12.70";"0.25";"3.25";"5.69";"0";"CHEMBL643789";"In vivo inhibitory concentration against AT2 receptor of human adrenal membrane";"B";"BAO_0000218";"organism-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150477";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL98350";"LY-294002";"-1.0";"307.35";"0";"3.30";"LY-294002";"O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL74556";"";"None";"693.84";"2";"6.93";"3";"CCCCc1nc2ccc(NC(=O)N(C)C(C)C)cc2c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"11.67";"0.23";"1.17";"5.80";"0";"CHEMBL643789";"In vivo inhibitory concentration against AT2 receptor of human adrenal membrane";"B";"BAO_0000218";"organism-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150477";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL386630";"TESTOSTERONE";"4.0";"288.43";"0";"3.88";"TESTOSTERONE";"C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2435823";"";"None";"455.56";"1";"6.06";"11b";"CCCc1nc2c(C)cc(NC(=O)CC)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"IC50";"'='";"78.0";"nM";"7.11";"";"";"UO_0000065";"15.60";"0.29";"1.05";"8.44";"0";"CHEMBL2439560";"Displacement of [125I]-Sar1Ile8-angiotensin 2 from angiotensin 2 AT2 receptor (unknown origin) after 180 mins by gamma counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2434924";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";""
"CHEMBL2435827";"";"None";"517.63";"2";"6.89";"11f";"CCCc1nc2c(C)cc(NC(=O)Cc3ccccc3)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"IC50";"'='";"77.0";"nM";"7.11";"";"";"UO_0000065";"13.74";"0.25";"0.22";"8.45";"0";"CHEMBL2439560";"Displacement of [125I]-Sar1Ile8-angiotensin 2 from angiotensin 2 AT2 receptor (unknown origin) after 180 mins by gamma counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2434924";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";""
"CHEMBL74144";"";"None";"671.75";"2";"5.92";"18";"CCc1nc2ccc(NC(=O)c3ccccn3)cc2c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"37.0";"nM";"7.43";"";"";"UO_0000065";"11.06";"0.21";"1.51";"4.98";"0";"CHEMBL643789";"In vivo inhibitory concentration against AT2 receptor of human adrenal membrane";"B";"BAO_0000218";"organism-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150477";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL430997";"";"None";"547.67";"1";"4.26";"15";"CCCc1nc(CN2CCN(c3ccccn3)CC2)c(C=O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"10.96";"0.20";"1.74";"5.52";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL505099";"";"None";"1454.60";"None";"None";"17";"CO/C(C)=C1/NC(=O)[C@H]([C@@H](C)O)NC(=O)c2csc(n2)-c2cc(O)c(-c3nc(C(=O)NCCNC(N)=O)cs3)nc2-c2csc(n2)[C@@H]2COC(=O)c3c4c5c(cccc5n3O)COC(=O)[C@@H](O[C@H]3C[C@](C)(O)[C@H](N(C)C)[C@H](C)O3)[C@@H](OC4)[C@H](NC(=O)c3csc1n3)c1nc(cs1)C(=O)N2";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL996322";"Inhibition of AT2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136943";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL453";"SULFISOXAZOLE";"4.0";"267.31";"0";"1.67";"SULFISOXAZOLE";"Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL7550";"L-158809";"None";"409.50";"0";"4.51";"118, L-158809";"CCc1nc2c(C)cc(C)nc2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"23.68";"0.43";"5.19";"11.39";"0";"CHEMBL1670671";"Binding affinity to angiotensin AT2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1667742";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1458880";"CADMIUM DICHLORIDE";"None";"183.32";"None";"None";"SID102651";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3084803";"ASTROMICIN";"-1.0";"405.50";"1";"-3.59";"ASTROMICIN";"CO[C@H]1[C@@H](O)[C@H](N)[C@@H](O[C@H]2O[C@H]([C@H](C)N)CC[C@H]2N)[C@H](O)[C@@H]1N(C)C(=O)CN";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3092993";"";"None";"378.44";"0";"1.94";"ATPT";"CCCCc1nn(C)c(=O)n1Cc1ccc(-n2cccc2-c2nnn[nH]2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3096389";"Binding affinity to AT2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3091458";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";""
"CHEMBL666";"FOSCARNET";"4.0";"126.00";"0";"-0.16";"FOSCARNET";"O=C(O)P(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL936";"DIPHENIDOL";"4.0";"309.45";"0";"4.19";"DIPHENIDOL";"OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL686";"MEFENAMIC ACID";"4.0";"241.29";"0";"3.75";"MEFENAMIC ACID";"Cc1cccc(Nc2ccccc2C(=O)O)c1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1670";"MITOTANE";"4.0";"320.05";"1";"5.93";"MITOTANE";"Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201117";"METHOCARBAMOL";"4.0";"241.24";"0";"0.53";"METHOCARBAMOL";"COc1ccccc1OCC(O)COC(N)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL339605";"";"None";"686.21";"2";"6.45";"5b";"CCCCc1nn(-c2cc(NC(=O)CC)ccc2Cl)c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OC(C)(C)C)cc1F";"IC50";"'='";"3.7";"nM";"8.43";"";"";"UO_0000065";"12.29";"0.25";"1.98";"5.96";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL306638";"";"None";"735.90";"2";"8.16";"18";"CCCc1nc(CC)c(C(=O)OCc2ccccc2C(=O)c2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"11.85";"0.22";"0.56";"6.52";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL125760";"";"None";"688.18";"2";"5.29";"40";"CCOCC(=O)Nc1ccc(Cl)c(-n2nc(CC)n(Cc3ccc(-c4ccccc4S(=O)(=O)NC(=O)OC(C)(C)C)cc3F)c2=O)c1";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"12.82";"0.26";"3.53";"5.86";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL331632";"";"None";"706.20";"2";"6.57";"41";"CCc1nn(-c2cc(NC(=O)c3ccccc3)ccc2Cl)c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OC(C)(C)C)cc1F";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"11.33";"0.22";"1.43";"5.66";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL122157";"";"None";"702.60";"2";"5.78";"43";"CCC(=O)Nc1ccc(Br)c(-n2nc(CC)n(Cc3ccc(-c4ccccc4S(=O)(=O)NC(=O)OC(C)(C)C)cc3F)c2=O)c1";"IC50";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"12.48";"0.27";"2.99";"6.20";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL338888";"";"None";"686.21";"2";"6.45";"39";"CCCCC(=O)Nc1ccc(Cl)c(-n2nc(CC)n(Cc3ccc(-c4ccccc4S(=O)(=O)NC(=O)OC(C)(C)C)cc3F)c2=O)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"12.68";"0.25";"2.25";"6.15";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL415";"CLOMIPRAMINE";"4.0";"314.86";"0";"4.53";"CLOMIPRAMINE";"CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL157138";"LISURIDE";"4.0";"338.46";"0";"2.84";"LISURIDE";"CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL93";"ZILEUTON";"4.0";"236.30";"0";"2.73";"ZILEUTON";"CC(c1cc2ccccc2s1)N(O)C(N)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL621";"TRAZODONE";"4.0";"371.87";"0";"2.36";"TRAZODONE";"O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL34431";"CILOSTAMIDE";"2.0";"342.44";"0";"3.48";"CILOSTAMIDE";"CN(C(=O)CCCOc1ccc2[nH]c(=O)ccc2c1)C1CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1042";"CHOLECALCIFEROL";"4.0";"384.65";"1";"7.62";"CHOLECALCIFEROL";"C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL34124";"OLODANRIGAN";"2.0";"507.59";"2";"5.44";"PD-126055";"COc1ccc2c(c1OCc1ccccc1)C[C@@H](C(=O)O)N(C(=O)C(c1ccccc1)c1ccccc1)C2";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"18.17";"0.33";"3.78";"12.12";"1";"CHEMBL647844";"Inhibitory activity was evaluated against Angiotensin II receptor, type 2";"B";"BAO_0000357";"single protein format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129469";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL70100";"";"None";"769.92";"2";"8.36";"17";"CCCc1nc(CC)c(C(=O)OCc2ccccc2C(=O)c2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCc2ccccc2)cc1";"IC50";"'='";"2.1";"nM";"8.68";"";"";"UO_0000065";"11.27";"0.21";"0.32";"6.49";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL70353";"";"None";"610.72";"2";"6.88";"11";"CCCc1nc(CC)c(C(=O)OCc2ccccc2C(=O)c2ccccc2)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"10.68";"0.19";"-0.36";"5.64";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL338137";"";"None";"767.80";"2";"7.72";"24";"CCCCc1nn(-c2cc(NC(=O)c3ccccc3)ccc2C(F)(F)F)c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OC(C)(C)C)cc1F";"IC50";"'='";"6.3";"nM";"8.20";"";"";"UO_0000065";"10.68";"0.21";"0.48";"5.80";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL96554";"";"None";"672.77";"2";"7.28";"4d";"CCCCc1nn(-c2ccccc2C(F)(F)F)c(=O)n1Cc1ccc(-c2cc(CCC)ccc2S(=O)(=O)NC(=O)OC(C)(C)C)cc1";"IC50";"'='";"270.0";"nM";"6.57";"";"";"UO_0000065";"9.76";"0.19";"-0.71";"5.85";"0";"CHEMBL649910";"In vitro inhibitory concentration against AT2 receptor from human adrenal tissues.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128028";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL86617";"";"None";"696.81";"2";"6.07";"11d";"CCCCc1nc(SC)c(C(O)(C(=O)O)C(F)(F)F)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)NCC2CCCCC2)cc1";"IC50";"'='";"5.6";"nM";"8.25";"";"";"UO_0000065";"11.84";"0.24";"2.18";"5.48";"0";"CHEMBL643790";"In vitro binding affinity at Angiotensin II Type 2 receptor in rabbit uterus membrane by [125I]AII displacement.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"CHEMBL3638197";"Uterus";"None";"Membrane";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128070";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1995";"None";"";"";""
"CHEMBL177435";"";"None";"448.53";"1";"5.21";"XC331 (3)";"CCCc1nc(-c2ccccc2)c(C=O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"6.7";"nM";"8.17";"";"";"UO_0000065";"18.22";"0.33";"2.96";"9.15";"0";"CHEMBL647512";"In vitro binding affinity against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1121863";"1";"Scientific Literature";"J Med Chem";"1981";"None";"";"";""
"CHEMBL124903";"";"None";"719.76";"2";"6.21";"37";"CCCCNC(=O)c1ccc(C(F)(F)F)c(-n2nc(CC)n(Cc3ccc(-c4ccccc4S(=O)(=O)NC(=O)OC(C)(C)C)cc3F)c2=O)c1";"IC50";"'='";"8.2";"nM";"8.09";"";"";"UO_0000065";"11.23";"0.22";"1.88";"5.72";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL72409";"";"None";"549.68";"1";"3.94";"14";"CCCc1nc(CN2CCN(c3ccccn3)CC2)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL311018";"";"None";"725.84";"2";"7.67";"25";"CCCOC(=O)NS(=O)(=O)c1ccccc1-c1ccc(Cn2c(CCC)nc(CC)c2C(=O)OCc2cccc(C(=O)c3ccccc3)c2)c(F)c1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"11.02";"0.21";"0.33";"5.99";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL306216";"";"None";"580.67";"1";"4.89";"12g";"CCCc1nc(CN2CCN(c3ccc(F)cc3)CC2)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"80.0";"nM";"7.10";"";"";"UO_0000065";"12.22";"0.23";"2.21";"6.11";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL290214";"";"None";"640.81";"2";"7.14";"L-163491";"CCCCOC(=O)NS(=O)(=O)c1ccc(Cc2cccc(OC)c2)cc1-c1ccc(Cn2c(CC)nc3c(C)cc(C)nc32)cc1";"IC50";"'='";"101.0";"nM";"7.00";"";"";"UO_0000065";"10.92";"0.21";"-0.14";"6.22";"1";"CHEMBL648580";"Binding affinity towards Angiotensin II receptor, type 2 was measured through displacement of [125I]-Ang II in pig uterus myometrial membranes";"B";"BAO_0000249";"cell membrane format";"Sus scrofa";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149104";"1";"Scientific Literature";"J Med Chem";"2004";"None";"";"";""
"CHEMBL194608";"";"None";"637.73";"2";"5.55";"19";"Cc1nc2ccc(NC(=O)NC(C)C)cc2c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"12.48";"0.24";"2.41";"5.36";"0";"CHEMBL643789";"In vivo inhibitory concentration against AT2 receptor of human adrenal membrane";"B";"BAO_0000218";"organism-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150477";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL69839";"";"None";"678.83";"2";"6.67";"62";"CCCCOC(=O)NS(=O)(=O)c1ccccc1-c1ccc(Cn2c(CCC)nc(CC)c2C(=O)NCCCOc2ccccc2)c(F)c1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"11.34";"0.22";"1.03";"5.99";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL308703";"";"None";"563.67";"1";"4.15";"XH-148";"CCCc1nc(CN2CCN(c3ccccn3)CC2)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"12.81";"0.23";"3.07";"5.60";"1";"CHEMBL643595";"Inhibition of Angiotensin II receptor, type 2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129469";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL34124";"OLODANRIGAN";"2.0";"507.59";"2";"5.44";"PD-126055";"COc1ccc2c(c1OCc1ccccc1)C[C@@H](C(=O)O)N(C(=O)C(c1ccccc1)c1ccccc1)C2";"IC50";"'='";"0.58";"nM";"9.24";"";"";"UO_0000065";"18.20";"0.33";"3.80";"12.14";"0";"CHEMBL647513";"In vitro binding affinity of compound was measured against angiotensin II (AT2) receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127913";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL508699";"";"None";"1538.71";"None";"None";"14";"CO/C(C)=C1/NC(=O)[C@H]([C@@H](C)O)NC(=O)c2csc(n2)-c2cc(O)c(-c3nc(C(=O)NCCNC(=O)CN4CCOCC4)cs3)nc2-c2csc(n2)[C@@H]2COC(=O)c3c4c5c(cccc5n3O)COC(=O)[C@@H](O[C@H]3C[C@](C)(O)[C@H](N(C)C)[C@H](C)O3)[C@@H](OC4)[C@H](NC(=O)c3csc1n3)c1nc(cs1)C(=O)N2";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"4.29";"None";"None";"None";"0";"CHEMBL996322";"Inhibition of AT2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136943";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL499715";"";"None";"1411.57";"None";"None";"12";"CO/C(C)=C1/NC(=O)[C@H]([C@@H](C)O)NC(=O)c2csc(n2)-c2cc(O)c(-c3nc(C(=O)NCCN)cs3)nc2-c2csc(n2)[C@@H]2COC(=O)c3c4c5c(cccc5n3O)COC(=O)[C@@H](O[C@H]3C[C@](C)(O)[C@H](N(C)C)[C@H](C)O3)[C@@H](OC4)[C@H](NC(=O)c3csc1n3)c1nc(cs1)C(=O)N2";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL996322";"Inhibition of AT2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136943";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL338027";"";"None";"730.66";"2";"6.56";"L-163958";"CCCCC(=O)Nc1ccc(Br)c(-n2nc(CC)n(Cc3ccc(-c4ccccc4S(=O)(=O)NC(=O)OC(C)(C)C)cc3F)c2=O)c1";"IC50";"'='";"0.12";"nM";"9.92";"";"";"UO_0000065";"13.58";"0.29";"3.36";"7.02";"0";"CHEMBL643595";"Inhibition of Angiotensin II receptor, type 2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129469";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL155728";"";"None";"446.50";"0";"4.34";"19";"COc1ccc2c(c1OCc1ccccc1)CC(C(=O)O)N(C(=O)N(C)c1ccccc1)C2";"IC50";"'='";"9.4";"nM";"8.03";"";"";"UO_0000065";"17.98";"0.33";"3.69";"10.12";"0";"CHEMBL643791";"Inhibitory activity against angiotensin II type 2 (AT2) receptor in rabbit uterine membranes.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127723";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL340078";"";"None";"792.64";"2";"8.02";"23";"CCCCc1nn(-c2cc(NC(=O)CC)ccc2C(F)(F)F)c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)c2cc(Cl)ccc2Cl)cc1F";"IC50";"'='";"5.1";"nM";"8.29";"";"";"UO_0000065";"10.46";"0.21";"0.27";"6.27";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL315327";"";"None";"636.80";"2";"5.14";"21c";"CCCc1nc(SC)c(C(O)(CC)C(=O)O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"13.66";"0.27";"3.56";"5.78";"0";"CHEMBL643790";"In vitro binding affinity at Angiotensin II Type 2 receptor in rabbit uterus membrane by [125I]AII displacement.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"CHEMBL3638197";"Uterus";"None";"Membrane";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128070";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1995";"None";"";"";""
"CHEMBL346728";"";"None";"614.77";"2";"6.96";"L-159894";"CCc1nc2c(C)cc(C)nc2n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)C(c2ccccc2)c2ccccc2)cc1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"12.60";"0.24";"0.78";"8.24";"0";"CHEMBL643595";"Inhibition of Angiotensin II receptor, type 2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129469";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL56367";"NIMESULIDE";"4.0";"308.31";"0";"2.76";"NIMESULIDE";"CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1235242";"";"None";"183.18";"0";"0.78";"4-FLUORO-L-PHENYLALANINE";"N[C@@H](Cc1ccc(F)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL39352";"";"None";"503.62";"1";"4.79";"12";"CCCC1=NC(C)(C)C(=O)N1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)c2ccccc2)cc1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"13.30";"0.25";"1.91";"6.98";"0";"CHEMBL643597";"The compound was tested for the ability to displace 50% of totally specifically bound [125I]- Ang II from Angiotensin II receptor, type 2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153253";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL189171";"ACEMETACIN";"4.0";"415.83";"0";"3.47";"ACEMETACIN";"COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL125008";"";"None";"778.70";"2";"7.46";"27";"CCCCc1nn(-c2cc(NC(=O)c3ccccc3)ccc2Br)c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OC(C)(C)C)cc1F";"IC50";"'='";"6.1";"nM";"8.21";"";"";"UO_0000065";"10.55";"0.22";"0.75";"5.81";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL86754";"IODOQUINOL";"2.0";"396.95";"0";"3.15";"IODOQUINOL";"Oc1c(I)cc(I)c2cccnc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL125280";"";"None";"741.74";"2";"6.86";"21";"CCCCc1nn(-c2cc(NC(=O)CC)ccc2C(F)(F)F)c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)c2ccccc2F)cc1F";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"11.73";"0.23";"1.84";"6.58";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL70935";"";"None";"677.80";"2";"6.75";"47";"CCCc1nc(CC)c(C(=O)OCC(=O)c2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"12.83";"0.25";"1.95";"6.51";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL17487";"";"None";"679.77";"2";"5.14";"16";"CCc1nc2ccc(NC(=O)N3CCOCC3)cc2c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"65.0";"nM";"7.19";"";"";"UO_0000065";"10.57";"0.20";"2.05";"4.83";"0";"CHEMBL643789";"In vivo inhibitory concentration against AT2 receptor of human adrenal membrane";"B";"BAO_0000218";"organism-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150477";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL289614";"";"None";"576.76";"2";"6.74";"3; L-162,782";"CCCCOC(=O)NS(=O)(=O)c1ccc(CC(C)C)cc1-c1ccc(Cn2c(CC)nc3c(C)cc(C)nc32)cc1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"15.87";"0.30";"2.41";"8.87";"1";"CHEMBL3768051";"Binding affinity to type-2 angiotensin-2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763155";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL850";"SPARFLOXACIN";"4.0";"392.41";"0";"2.08";"SPARFLOXACIN";"C[C@@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@H](C)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201207";"BETAMETHASONE PHOSPHORIC ACID";"4.0";"472.45";"0";"2.01";"BETAMETHASONE PHOSPHATE";"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL191";"LOSARTAN";"4.0";"422.92";"0";"4.27";"Losartan DuP-753";"CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL832379";"Displacement of [125I]-Ang II from pig uterus membrane angiotensin II type 2 (AT2) receptor";"B";"BAO_0000019";"assay format";"Sus scrofa";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138699";"1";"Scientific Literature";"J Med Chem";"2004";"None";"";"";""
"CHEMBL302579";"";"None";"768.91";"2";"8.32";"55";"CCCc1nc(CC)c(C(=O)OCc2ccccc2NC(=O)c2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"11.70";"0.22";"0.68";"6.18";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL1909064";"LIPOPOLYSACCHARIDE E. COLI O55:B5";"None";"None";"None";"None";"LIPOPOLYSACCHARIDE E. COLI O55:B5";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201220";"DIATRIZOIC ACID";"4.0";"613.91";"1";"3.12";"DIATRIZOIC ACID";"CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL603";"ZAFIRLUKAST";"4.0";"575.69";"2";"5.70";"ZAFIRLUKAST";"COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL413";"SIROLIMUS";"4.0";"914.19";"3";"6.18";"Rapamycin";"CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1390";"";"None";"344.50";"0";"4.08";"MEDROXYPROGESTERONE";"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL895";"NALBUPHINE";"4.0";"357.45";"0";"1.71";"NALBUPHINE";"Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL643";"PROMETHAZINE";"4.0";"284.43";"0";"4.24";"PROMETHAZINE";"CC(CN1c2ccccc2Sc2ccccc21)N(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL458019";"PARAQUAT DICHLORIDE";"None";"257.16";"0";"1.00";"PARAQUAT DICHLORIDE";"C[n+]1ccc(-c2cc[n+](C)cc2)cc1.[Cl-].[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL456807";"PHENYLHYDRAZINE";"None";"108.14";"0";"0.97";"PHENYLHYDRAZINE";"NNc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL983";"SUCCINYLCHOLINE CHLORIDE";"4.0";"361.31";"0";"0.27";"SUXAMETHONIUM CHLORIDE";"C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL262777";"VANCOMYCIN";"4.0";"1449.27";"None";"None";"vancomycin";"CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1219";"RABEPRAZOLE";"4.0";"359.45";"0";"2.99";"RABEPRAZOLE";"COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1148";"TORSEMIDE";"4.0";"348.43";"0";"2.53";"TORSEMIDE";"Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL276674";"";"None";"701.77";"2";"6.67";"3a";"CCCCc1nn(-c2cc(NC(=O)CC)ccc2C(F)(F)F)c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OC(C)(C)C)cc1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"11.04";"0.22";"1.07";"5.48";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL1440";"TETRACYCLINE";"4.0";"444.44";"1";"-0.21";"TETRACYCLINE";"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL91";"MICONAZOLE";"4.0";"416.13";"1";"6.45";"MICONAZOLE";"Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1";"IC50";"'='";"23986.0";"nM";"4.62";"";"";"UO_0000065";"11.10";"0.25";"-1.83";"17.08";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL427526";"(R)-IBUPROPHEN";"1.0";"206.28";"0";"3.07";"R(-)-IBUPROFEN";"CC(C)Cc1ccc([C@@H](C)C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1419";"SIBUTRAMINE";"4.0";"279.86";"0";"4.74";"SIBUTRAMINE";"CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL154111";"SALSALATE";"4.0";"258.23";"0";"2.31";"SALSALATE";"O=C(Oc1ccccc1C(=O)O)c1ccccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL408403";"ANGIOTENSIN II";"4.0";"1046.20";"None";"None";"Angiotensin-II";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O";"IC50";"'='";"0.08";"nM";"10.10";"";"";"UO_0000065";"9.65";"None";"None";"None";"0";"CHEMBL3876344";"Displacement of [125I]CGP 42112A from human recombinant AT2 receptor expressed in HEK293 cells measured after 4 hrs by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3875185";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"CHEMBL3307715";"";"";""
"CHEMBL308361";"";"None";"674.82";"2";"5.18";"18c";"CCCCOC(=O)NS(=O)(=O)c1ccccc1-c1ccc(Cn2c(CCC)nc(CN3CCN(c4ccccn4)CC3)c2C(=O)O)cc1";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"10.44";"0.20";"1.87";"4.79";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL73780";"";"None";"626.72";"2";"6.66";"10g";"CCCc1nc(CN(Cc2ccccc2)C(=O)Nc2ccccc2)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"10.41";"0.19";"-0.14";"4.60";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL304620";"";"None";"624.80";"2";"5.78";"17b";"CCCCN(Cc1nc(CCC)n(Cc2ccc(-c3ccccc3S(=O)(=O)NC(=O)CCC)cc2)c1C(=O)O)C(=O)CCC";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"11.28";"0.22";"1.27";"5.08";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL302485";"";"None";"610.72";"2";"6.88";"13";"CCCc1nc(CC)c(C(=O)OCc2ccc(C(=O)c3ccccc3)cc2)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"9.33";"0.17";"-1.18";"4.93";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL304065";"";"None";"679.80";"2";"6.75";"16";"CCCc1nc(CC)c(C(=O)OCc2ccccc2C(=O)c2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OC)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"11.77";"0.22";"1.25";"5.99";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL309455";"";"None";"643.79";"2";"6.28";"5";"CCCCN(Cc1ccccc1)C(=O)C#CCOC(=O)c1c(CC)nc(CCC)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"9.94";"0.18";"0.12";"5.38";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL307430";"";"None";"649.75";"2";"5.56";"8";"CCc1nc2ccc(NC(=O)NC(C)C)cc2c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC2CC2)cc1F";"IC50";"'='";"6.5";"nM";"8.19";"";"";"UO_0000065";"12.60";"0.24";"2.63";"5.51";"0";"CHEMBL643789";"In vivo inhibitory concentration against AT2 receptor of human adrenal membrane";"B";"BAO_0000218";"organism-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150477";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL31";"GATIFLOXACIN";"4.0";"375.40";"0";"1.98";"gatifloxacin";"COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL710";"FINASTERIDE";"4.0";"372.55";"0";"3.81";"FINASTERIDE";"CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1451";"TRIAMCINOLONE";"4.0";"394.44";"0";"0.62";"TRIAMCINOLONE";"C[C@]12C=CC(=O)C=C1CC[C@H]1[C@@H]3C[C@@H](O)[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@]12F";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1566956";"TROXIPIDE";"2.0";"294.35";"0";"1.19";"TROXIPIDE";"COc1cc(C(=O)NC2CCCNC2)cc(OC)c1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL418971";"BISPHENOL A";"None";"228.29";"0";"3.42";"BISPHENOL A";"CC(C)(c1ccc(O)cc1)c1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL820";"BUSULFAN";"4.0";"246.31";"0";"-0.28";"BUSULFAN";"CS(=O)(=O)OCCCCOS(C)(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL19299";"LOXOPROFEN";"4.0";"246.31";"0";"2.79";"LOXOPROFEN";"CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1618305";"NALOXONAZINE";"None";"650.78";"1";"3.28";"NALOXONAZINE";"C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2/C(=N/N=C2\CC[C@@]4(O)[C@H]6Cc7ccc(O)c8c7[C@@]4(CCN6CC=C)[C@H]2O8)CC[C@@]3(O)[C@H]1C5";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL122273";"";"None";"752.64";"2";"6.60";"48";"CCCCC(=O)Nc1ccc(Br)c(-n2nc(CC)n(Cc3ccc(-c4ccccc4S(=O)(=O)NC(=O)c4ccccc4F)cc3F)c2=O)c1";"IC50";"'='";"0.64";"nM";"9.19";"";"";"UO_0000065";"12.22";"0.26";"2.59";"6.96";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL340632";"";"None";"714.26";"2";"6.63";"8";"CCCCNC(=O)c1ccc(Cl)c(-n2nc(CCCC)n(Cc3ccc(-c4ccccc4S(=O)(=O)NC(=O)OC(C)(C)C)cc3F)c2=O)c1";"IC50";"'='";"3.1";"nM";"8.51";"";"";"UO_0000065";"11.91";"0.24";"1.88";"6.02";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL13378";"(R,S)-AMPA";"None";"186.17";"0";"-0.36";"(RS)-AMPA";"Cc1onc(O)c1CC(N)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL507301";"";"None";"1547.68";"None";"None";"15";"CO/C(C)=C1/NC(=O)[C@H]([C@@H](C)O)NC(=O)c2csc(n2)-c2cc(O)c(-c3nc(C(=O)NCCNC(=O)c4cc(O)cc(O)c4)cs3)nc2-c2csc(n2)[C@@H]2COC(=O)c3c4c5c(cccc5n3O)COC(=O)[C@@H](O[C@H]3C[C@](C)(O)[C@H](N(C)C)[C@H](C)O3)[C@@H](OC4)[C@H](NC(=O)c3csc1n3)c1nc(cs1)C(=O)N2";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL996322";"Inhibition of AT2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136943";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL526364";"";"None";"1485.65";"None";"None";"16";"CO/C(C)=C1/NC(=O)[C@H]([C@@H](C)O)NC(=O)c2csc(n2)-c2cc(O)c(-c3nc(C(=O)NCCNCC(O)CO)cs3)nc2-c2csc(n2)[C@@H]2COC(=O)c3c4c5c(cccc5n3O)COC(=O)[C@@H](O[C@H]3C[C@](C)(O)[C@H](N(C)C)[C@H](C)O3)[C@@H](OC4)[C@H](NC(=O)c3csc1n3)c1nc(cs1)C(=O)N2";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL996322";"Inhibition of AT2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136943";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL1201237";"LEVOBUNOLOL";"4.0";"291.39";"0";"2.33";"LEVOBUNOLOL";"CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1231";"OXYBUTYNIN";"4.0";"357.49";"0";"3.34";"OXYBUTYNIN";"CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL103";"PROGESTERONE";"4.0";"314.47";"0";"4.72";"Progesterone";"CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL9419";"METACETAMOL";"2.0";"151.16";"0";"1.35";"3-ACETAMIDOPHENOL";"CC(=O)Nc1cccc(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL294199";"CAPSAICIN";"4.0";"305.42";"0";"3.79";"CAPSAICIN";"COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL307145";"PYROGALLOL";"4.0";"126.11";"0";"0.80";"PYROGALLOL";"Oc1cccc(O)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL364713";"NOSCAPINE";"4.0";"413.43";"0";"2.88";"NOSCAPINE";"COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200845";"HALCINONIDE";"4.0";"454.97";"0";"3.89";"HALCINONIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1372";"OXIGLUTATIONE";"4.0";"612.64";"3";"-3.88";"GLUTATHIONE, OXIDIZED FORM";"N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)NCC(=O)O)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1365675";"AMITRAZ";"2.0";"293.41";"0";"4.87";"AMITRAZ";"Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL101168";"";"None";"134.14";"0";"0.15";"1-AMINOBENZOTRIAZOLE";"Nn1nnc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1730";"CEFOTAXIME";"4.0";"455.47";"1";"-0.62";"CEFOTAXIME";"CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL659";"GALANTAMINE";"4.0";"287.36";"0";"1.85";"GALANTAMINE";"COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL487894";"DIPYRONE SODIUM";"None";"333.35";"0";"0.77";"DIPYRONE";"Cc1c(N(C)CS(=O)(=O)[O-])c(=O)n(-c2ccccc2)n1C.[Na+]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL280998";"CATECHOL";"None";"110.11";"0";"1.10";"CATECHOL";"Oc1ccccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909075";"";"None";"None";"None";"None";"QUINOLONE, CHEMI-LINZ ; CYANAMID";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1425";"MERCAPTOPURINE ANHYDROUS";"4.0";"152.18";"0";"0.64";"MERCAPTOPURINE";"Sc1ncnc2nc[nH]c12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL521";"IBUPROFEN";"4.0";"206.28";"0";"3.07";"Ibuprofen";"CC(C)Cc1ccc(C(C)C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL460499";"CARMOFUR";"2.0";"257.26";"0";"0.81";"CARMOFUR";"CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL158557";"";"None";"551.60";"2";"5.14";"8";"COc1ccc2c(c1OCc1ccc(C(=O)O)cc1)CC(C(=O)O)N(C(=O)C(c1ccccc1)c1ccccc1)C2";"IC50";"'='";"750.0";"nM";"6.12";"";"";"UO_0000065";"11.10";"0.20";"0.98";"5.40";"0";"CHEMBL643791";"Inhibitory activity against angiotensin II type 2 (AT2) receptor in rabbit uterine membranes.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127723";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL1566";"ACARBOSE";"4.0";"645.61";"3";"-8.56";"ACARBOSE";"C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)O[C@@H]3CO)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL63560";"(R)-BICALUTAMIDE";"None";"430.38";"0";"2.88";"(R)-BICALUTAMIDE";"C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL307318";"";"None";"706.84";"2";"7.04";"54";"CCCCCOC(=O)NS(=O)(=O)c1ccccc1-c1ccc(Cn2c(CCC)nc(CC)c2C(=O)OCCC(=O)Nc2ccccc2)c(F)c1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"12.73";"0.25";"1.96";"6.18";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL155938";"";"None";"500.38";"2";"5.16";"17";"COc1ccc2c(c1OCc1ccccc1)CC(C(=O)O)N(C(=O)Cc1c(Cl)cccc1Cl)C2";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"14.30";"0.29";"1.99";"9.41";"0";"CHEMBL643791";"Inhibitory activity against angiotensin II type 2 (AT2) receptor in rabbit uterine membranes.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127723";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL157946";"";"None";"736.67";"1";"4.48";"PD-123319";"Cc1cc(Cn2cnc3c2C[C@@H](C(=O)O)N(C(=O)C(c2ccccc2)c2ccccc2)C3)ccc1N(C)C.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F";"IC50";"'='";"6.9";"nM";"8.16";"";"";"UO_0000065";"16.05";"0.29";"3.68";"10.37";"0";"CHEMBL643791";"Inhibitory activity against angiotensin II type 2 (AT2) receptor in rabbit uterine membranes.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127723";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL30";"CIMETIDINE";"4.0";"252.35";"0";"0.60";"CIMETIDINE";"CN/C(=N\CCSCc1nc[nH]c1C)NC#N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1477";"CERIVASTATIN";"4.0";"459.56";"0";"4.88";"CERIVASTATIN";"COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL131";"PREDNISOLONE";"4.0";"360.45";"0";"1.56";"Prednisolone";"C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL712";"ANISINDIONE";"4.0";"252.27";"0";"2.86";"ANISINDIONE";"COc1ccc(C2C(=O)c3ccccc3C2=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL267345";"AMPHOTERICIN B";"4.0";"924.09";"3";"0.71";"AMPHOTERICIN B";"C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL423192";"ANISOMYCIN";"None";"265.31";"0";"0.50";"ANISOMYCIN";"COc1ccc(C[C@H]2NC[C@H](O)[C@H]2OC(C)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL283196";"ALPHA-NAPHTHOFLAVONE";"None";"272.30";"0";"4.61";"ALPHA-NAPHTHOFLAVONE";"O=c1cc(-c2ccccc2)oc2c1ccc1ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL177756";"FLUORESCEIN";"None";"332.31";"0";"3.97";"FLUORESCEIN";"O=C(O)c1ccccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL783";"NATEGLINIDE";"4.0";"317.43";"0";"3.26";"NATEGLINIDE";"CC(C)[C@H]1CC[C@H](C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL13209";"NITRAZEPAM";"4.0";"281.27";"0";"2.38";"NITRAZEPAM";"O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL19236";"MOXONIDINE";"4.0";"241.68";"0";"0.82";"MOXONIDINE";"COc1nc(C)nc(Cl)c1NC1=NCCN1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1475";"TRIOXSALEN";"4.0";"228.25";"0";"3.46";"TRIOXSALEN";"Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL338434";"";"None";"747.81";"2";"7.59";"15";"CCCCC(=O)Nc1ccc(C(F)(F)F)c(-n2nc(CCCC)n(Cc3ccc(-c4ccccc4S(=O)(=O)NC(=O)OC(C)(C)C)cc3F)c2=O)c1";"IC50";"'='";"3.8";"nM";"8.42";"";"";"UO_0000065";"11.26";"0.22";"0.83";"5.96";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL29292";"UBENIMEX";"2.0";"308.38";"0";"0.53";"Bestatin";"CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL165";"RESVERATROL";"3.0";"228.25";"0";"2.97";"RESVERATROL";"Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL991";"STAVUDINE";"4.0";"224.22";"0";"-0.71";"STAVUDINE";"Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL74573";"";"None";"753.89";"2";"8.30";"EXP-597";"CCCc1nc(CC)c(C(=O)OCc2ccccc2C(=O)c2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"0.69";"nM";"9.16";"";"";"UO_0000065";"12.15";"0.23";"0.86";"6.85";"1";"CHEMBL643595";"Inhibition of Angiotensin II receptor, type 2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129469";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL339040";"";"None";"700.23";"2";"6.24";"13";"CCCCc1nn(-c2cc(C(=O)NCCC)ccc2Cl)c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OC(C)(C)C)cc1F";"IC50";"'='";"3.4";"nM";"8.47";"";"";"UO_0000065";"12.09";"0.24";"2.23";"5.99";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL193";"NIFEDIPINE";"4.0";"346.34";"0";"2.18";"NIFEDIPINE";"COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL338790";"";"None";"212.21";"0";"1.31";"4-AMINO-1,8-NAPHTHALIMIDE";"Nc1ccc2c3c(cccc13)C(=O)NC2=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL679";"EPINEPHRINE";"4.0";"183.21";"0";"0.35";"EPINEPHRINE";"CNC[C@H](O)c1ccc(O)c(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL191";"LOSARTAN";"4.0";"422.92";"0";"4.27";"LOSARTAN";"CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL34259";"METHOTREXATE";"4.0";"454.45";"0";"0.27";"METHOTREXATE";"CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL41";"FLUOXETINE";"4.0";"309.33";"0";"4.44";"FLUOXETINE";"CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL445206";"ISOEUGENOL";"None";"164.20";"0";"2.43";"ISOEUGENOL";"C/C=C\c1ccc(O)c(OC)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1262";"OXICONAZOLE";"4.0";"429.13";"1";"6.12";"OXICONAZOLE";"Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL52440";"DEXTROMETHORPHAN";"4.0";"271.40";"0";"3.38";"DEXTROMETHORPHAN";"COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1351";"CARBOPLATIN";"4.0";"371.25";"None";"None";"CARBOPLATIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200656";"NATAMYCIN";"4.0";"665.73";"3";"0.12";"PIMARICIN";"C[C@@H]1C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@H]3O[C@@H]3/C=C/C(=O)O1)C[C@H](O)[C@H]2C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL435811";"";"None";"716.23";"2";"6.07";"11";"CCCCc1nn(-c2cc(NC(=O)CCOC)ccc2Cl)c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OC(C)(C)C)cc1F";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"12.21";"0.24";"2.67";"5.81";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL2108139";"POVIDONE";"4.0";"None";"None";"None";"POLYVINYLPYRROLIDONE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1016";"CANDESARTAN";"3.0";"440.46";"0";"4.03";"CANDESARTAN";"CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1024";"IFOSFAMIDE";"4.0";"261.09";"0";"1.88";"IFOSFAMIDE";"O=P1(NCCCl)OCCCN1CCCl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL508112";"BENZOTHIAZYL DISULFIDE";"None";"332.50";"1";"5.71";"BENZOTHIAZYL DISULFIDE";"c1ccc2sc(SSc3nc4ccccc4s3)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL311469";"2-ACETYLAMINOFLUORENE";"None";"223.27";"0";"3.22";"2-ACETYLAMINOFLUORENE";"CC(=O)Nc1ccc2c(c1)Cc1ccccc1-2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL578";"ENALAPRIL";"4.0";"376.45";"0";"1.60";"ENALAPRIL";"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL166143";"";"None";"427.43";"1";"5.35";"215";"O=C(O)c1ccccc1-c1ccc(CNc2nc(C(F)(F)F)nc3c2CCCC3)cc1";"IC50";"'='";"275.0";"nM";"6.56";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2208700";"Antagonist activity at angiotensin 2 receptor";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203023";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL276832";"HYDRALAZINE";"4.0";"160.18";"0";"0.92";"HYDRALAZINE";"NNc1nncc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL60889";"MOSAPRIDE";"3.0";"421.90";"0";"3.09";"MOSAPRIDE";"CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL18701";"RO-201724";"None";"278.35";"0";"2.10";"Ro-201724";"CCCCOc1cc(CC2CNC(=O)N2)ccc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL438";"SULFAMERAZINE";"4.0";"264.31";"0";"1.17";"SULFAMERAZINE";"Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1236282";"THIAMPHENICOL";"2.0";"356.23";"0";"0.40";"THIAMPHENICOL";"CS(=O)(=O)c1ccc([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL657";"DIPHENHYDRAMINE";"4.0";"255.36";"0";"3.35";"Diphenhydramine";"CN(C)CCOC(c1ccccc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL108545";"METHYL SALICYLATE";"4.0";"152.15";"0";"1.18";"METHYL SALICYLATE";"COC(=O)c1ccccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1321";"PROCARBAZINE";"4.0";"221.30";"0";"1.05";"PROCARBAZINE";"CNNCc1ccc(C(=O)NC(C)C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL163";"RITONAVIR";"4.0";"720.96";"2";"5.91";"RITONAVIR";"CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL92401";"IPRONIAZID";"4.0";"179.22";"0";"0.72";"IPRONIAZID";"CC(C)NNC(=O)c1ccncc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL762";"OXYMETAZOLINE";"4.0";"260.38";"0";"2.85";"OXYMETAZOLINE";"Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL748";"PRALIDOXIME CHLORIDE";"4.0";"172.62";"0";"0.32";"PRALIDOXIME CHLORIDE";"C[n+]1ccccc1/C=N/O.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL457299";"MACROGOL";"4.0";"62.07";"0";"-1.03";"ETHYLENE GLYCOL";"OCCO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL768";"ESMOLOL";"4.0";"295.38";"0";"1.53";"ESMOLOL";"COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL222863";"OUABAIN";"4.0";"584.66";"3";"-1.51";"OUABAIN";"C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1945010";"";"None";"591.71";"2";"6.70";"6i";"CCCc1nc2c(C)cc(C(=O)NCCc3cc(OC)ccc3OC)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"9.89";"0.18";"-0.85";"5.70";"0";"CHEMBL1949357";"Displacement of [125I]Sar1 Ile8-Ang 2 from angiotensin 2 AT2 receptor after 180 mins by gamma counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944634";"1";"Scientific Literature";"Eur J Med Chem";"2012";"None";"";"";""
"CHEMBL319244";"CAFFEIC ACID PHENETHYL ESTER";"None";"284.31";"0";"2.90";"CAFFEIC ACID PHENETHYL ESTER";"O=C(/C=C/c1ccc(O)c(O)c1)OCCc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1308";"FOMEPIZOLE";"4.0";"82.11";"0";"0.72";"4-METHYLPYRAZOLE";"Cc1cn[nH]c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL557555";"CIPROFIBRATE";"4.0";"289.16";"0";"3.59";"CIPROFIBRATE";"CC(C)(Oc1ccc(C2CC2(Cl)Cl)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL716";"QUETIAPINE";"4.0";"383.52";"0";"2.86";"QUETIAPINE";"OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL118";"CELECOXIB";"4.0";"381.38";"0";"3.51";"CELECOXIB";"Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL900";"ORPHENADRINE";"4.0";"269.39";"0";"3.66";"ORPHENADRINE";"Cc1ccccc1C(OCCN(C)C)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1727";"CEPHALEXIN ANHYDROUS";"4.0";"347.40";"0";"0.44";"CEPHALEXIN";"CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL7002";"CIGLITAZONE";"2.0";"333.45";"0";"3.93";"CIGLITAZONE";"CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL278172";"BENZOCAINE";"4.0";"165.19";"0";"1.45";"BENZOCAINE";"CCOC(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1612004";"";"None";"123.15";"0";"1.28";"O-ANISIDINE";"COc1ccccc1N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL527";"PIROXICAM";"4.0";"331.35";"0";"1.58";"PIROXICAM";"CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL446";"SULFAMETHAZINE";"4.0";"278.34";"0";"1.48";"SULFAMETHAZINE";"Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL742";"KETAMINE";"4.0";"237.73";"0";"2.90";"KETAMINE";"CNC1(c2ccccc2Cl)CCCCC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL508102";"CARBIMAZOLE";"4.0";"186.24";"0";"1.56";"CARBIMAZOLE";"CCOC(=O)n1ccn(C)c1=S";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL313005";"";"None";"616.81";"1";"4.83";"10a";"CCCCc1nc(SC)c(C(C)(O)C(=O)OCC)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)NCCC)cc1";"IC50";"'='";"3500.0";"nM";"5.46";"";"";"UO_0000065";"8.85";"0.18";"0.63";"3.91";"0";"CHEMBL643790";"In vitro binding affinity at Angiotensin II Type 2 receptor in rabbit uterus membrane by [125I]AII displacement.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"CHEMBL3638197";"Uterus";"None";"Membrane";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128070";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1995";"None";"";"";""
"CHEMBL115769";"";"None";"334.35";"0";"3.97";"RWJ-68354";"COc1cc(N)[nH]c2nc(-c3ccc(F)cc3)c(-c3ccncc3)c1-2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL84";"TOPOTECAN";"4.0";"421.45";"0";"1.85";"TOPOTECAN";"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909076";"";"None";"270.38";"0";"1.21";"S-(N-BENZYLTHIOCARBAMOYL)-L-CYSTEINE";"N[C@H](CSC(=S)NCc1ccccc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL95";"TACRINE";"4.0";"198.27";"0";"2.70";"TACRINE";"Nc1c2c(nc3ccccc13)CCCC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1679";"LEUCOVORIN";"4.0";"473.45";"1";"-0.73";"LEUCOVORIN";"Nc1nc(=O)c2c([nH]1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2C=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL838";"BENAZEPRIL";"4.0";"424.50";"0";"2.57";"BENAZEPRIL";"CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL89769";"";"None";"620.75";"2";"5.12";"26";"CCCCc1nc(SC)c(C(=O)C(=O)O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"11.95";"0.24";"2.30";"5.03";"0";"CHEMBL643790";"In vitro binding affinity at Angiotensin II Type 2 receptor in rabbit uterus membrane by [125I]AII displacement.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"CHEMBL3638197";"Uterus";"None";"Membrane";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128070";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1995";"None";"";"";""
"CHEMBL490";"PAROXETINE";"4.0";"329.37";"0";"3.33";"PAROXETINE";"Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1371937";"PANTHENOL";"3.0";"205.25";"0";"-1.14";"PANTHENOL";"CC(C)(CO)C(O)C(=O)NCCCO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL545";"ALCOHOL";"4.0";"46.07";"0";"0.00";"ETHANOL";"CCO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1902627";"CLORPRENALINE";"-1.0";"213.71";"0";"2.37";"CLORPRENALINE";"CC(C)NCC(O)c1ccccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1726";"NISOLDIPINE";"4.0";"388.42";"0";"3.20";"NISOLDIPINE";"COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL802";"MINOXIDIL";"4.0";"209.25";"0";"-0.13";"MINOXIDIL";"Nc1cc(N2CCCCC2)nc(N)[n+]1[O-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL181";"DIAZOXIDE";"4.0";"230.68";"0";"1.68";"DIAZOXIDE";"CC1=Nc2ccc(Cl)cc2S(=O)(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL44657";"ETOPOSIDE";"4.0";"588.56";"2";"1.34";"Etoposide";"COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL139835";"CYPROTERONE ACETATE";"4.0";"416.95";"0";"4.61";"CYPROTERONE ACETATE";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL104";"CLOTRIMAZOLE";"4.0";"344.85";"1";"5.38";"Clo";"Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL34139";"GENACONAZOLE";"None";"331.34";"0";"0.88";"GENACONAZOLE (RR(+) ISOMER)";"C[C@H]([C@](O)(Cn1cncn1)c1ccc(F)cc1F)S(C)(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL20883";"TEGAFUR";"4.0";"200.17";"0";"-0.02";"TEGAFUR";"O=c1[nH]c(=O)n(C2CCCO2)cc1F";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3545252";"DOCETAXEL";"4.0";"861.94";"2";"3.26";"DOCETAXEL";"CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O.O.O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL622";"ETODOLAC";"4.0";"287.36";"0";"3.38";"ETODOLAC";"CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"SULFADIAZINE";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL945";"AMILORIDE";"4.0";"229.63";"0";"-1.08";"AMILORIDE";"N=C(N)NC(=O)c1nc(Cl)c(N)nc1N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL441687";"GLYCYRRHIZIN";"2.0";"822.94";"3";"2.25";"GLYCYRRHIZIN";"CC1(C)[C@@H](O[C@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL496";"HEXACHLOROPHENE";"4.0";"406.91";"1";"6.61";"HEXACHLOROPHENE";"Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1480987";"CYCLANDELATE";"4.0";"276.38";"0";"3.48";"CYCLANDELATE";"CC1CC(OC(=O)C(O)c2ccccc2)CC(C)(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200545";"DIFLORASONE DIACETATE";"4.0";"494.53";"0";"2.99";"DIFLORASONE DIACETATE";"CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1198";"PRAMOXINE";"4.0";"293.41";"0";"2.97";"PRAMOXINE";"CCCCOc1ccc(OCCCN2CCOCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL493";"BROMOCRIPTINE";"4.0";"654.61";"1";"3.19";"BROMOCRIPTINE";"CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1370561";"AMINOPHYLLINE";"4.0";"420.43";"0";"-1.04";"AMINOPHYLLINE";"Cn1c(=O)c2[nH]cnc2n(C)c1=O.Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCN";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1460";"DIDANOSINE";"4.0";"236.23";"0";"-0.21";"DIDANOSINE";"O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL395110";"MEPAZINE";"4.0";"310.47";"0";"4.63";"MEPAZINE";"CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL253376";"BROMHEXINE";"4.0";"376.14";"0";"4.56";"BROMHEXINE";"CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL572";"NITROFURANTOIN";"4.0";"238.16";"0";"0.07";"NITROFURANTOIN";"O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL495778";"PENICILLIC ACID";"None";"170.16";"0";"0.34";"PENICILLIC ACID";"C=C(C)C1(O)OC(=O)C=C1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL42442";"OXFENDAZOLE";"2.0";"315.35";"0";"2.91";"OXFENDAZOLE";"COC(=O)Nc1nc2cc([S+]([O-])c3ccccc3)ccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL17157";"TERFENADINE";"4.0";"471.69";"1";"6.45";"TERFENADINE";"CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL306361";"";"None";"635.72";"2";"5.17";"7";"CCNC(=O)Nc1ccc2nc(CC)n(Cc3ccc(-c4ccccc4S(=O)(=O)NC(=O)OCCC4CC4)cc3F)c(=O)c2c1";"IC50";"'='";"9.8";"nM";"8.01";"";"";"UO_0000065";"12.60";"0.24";"2.84";"5.39";"0";"CHEMBL643789";"In vivo inhibitory concentration against AT2 receptor of human adrenal membrane";"B";"BAO_0000218";"organism-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150477";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL192";"SILDENAFIL";"4.0";"474.59";"0";"1.61";"SILDENAFIL";"CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200391";"TROMETHAMINE";"4.0";"121.14";"0";"-2.34";"TROMETHAMINE";"NC(CO)(CO)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL191";"LOSARTAN";"4.0";"422.92";"0";"4.27";"188";"CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2208700";"Antagonist activity at angiotensin 2 receptor";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203023";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL289614";"";"None";"576.76";"2";"6.74";"7, L-162782";"CCCCOC(=O)NS(=O)(=O)c1ccc(CC(C)C)cc1-c1ccc(Cn2c(CC)nc3c(C)cc(C)nc32)cc1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"15.87";"0.30";"2.41";"8.87";"1";"CHEMBL3396374";"Binding affinity to AT2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3392997";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";"";"";""
"CHEMBL1200679";"ZINC CHLORIDE";"4.0";"136.30";"None";"None";"ZINC CHLORIDE";"[Cl-].[Cl-].[Zn+2]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL160";"CYCLOSPORINE";"4.0";"1202.63";"None";"None";"CYCLOSPORIN A";"C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL290829";"";"None";"520.59";"2";"5.97";"L-159686";"O=C(O)[C@@H]1CN(C(=O)N(c2ccccc2)c2ccccc2)CCN1C(=O)N(c1ccccc1)c1ccccc1";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"16.95";"0.31";"2.85";"10.45";"0";"CHEMBL643594";"In vitro binding affinity of compound was measured against Angiotensin II receptor, type 2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127913";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL338433";"";"None";"749.78";"2";"6.44";"16";"CCCCc1nn(-c2cc(NC(=O)COCC)ccc2C(F)(F)F)c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OC(C)(C)C)cc1F";"IC50";"'='";"2.2";"nM";"8.66";"";"";"UO_0000065";"11.55";"0.23";"2.22";"5.75";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL16073";"PHENACETIN";"4.0";"179.22";"0";"2.04";"PHENACETIN";"CCOc1ccc(NC(C)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL156129";"";"None";"521.61";"2";"5.49";"6";"COc1ccc2c(c1OCCc1ccccc1)CC(C(=O)O)N(C(=O)C(c1ccccc1)c1ccccc1)C2";"IC50";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"15.95";"0.29";"2.83";"10.94";"0";"CHEMBL643791";"Inhibitory activity against angiotensin II type 2 (AT2) receptor in rabbit uterine membranes.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127723";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL70389";"";"None";"549.64";"1";"3.76";"12l";"CCc1nc(CN2CCN(c3ccccn3)CC2)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"11.46";"0.21";"2.54";"4.89";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL306489";"";"None";"597.12";"2";"5.40";"12e";"CCCc1nc(CN2CCN(c3ccccc3Cl)CC2)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"10.42";"0.20";"0.82";"5.36";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL290829";"";"None";"520.59";"2";"5.97";"L-159686";"O=C(O)[C@@H]1CN(C(=O)N(c2ccccc2)c2ccccc2)CCN1C(=O)N(c1ccccc1)c1ccccc1";"IC50";"'='";"0.89";"nM";"9.05";"";"";"UO_0000065";"17.39";"0.32";"3.08";"10.72";"0";"CHEMBL643791";"Inhibitory activity against angiotensin II type 2 (AT2) receptor in rabbit uterine membranes.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127723";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL64391";"ITRACONAZOLE";"4.0";"705.65";"3";"5.58";"ITRACONAZOLE";"CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL72819";"";"None";"678.82";"2";"5.09";"18b";"CCCc1nc(CN2CCN(c3ccccn3)CC2)c(C(=O)O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)c2ccccc2)cc1";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"9.28";"0.18";"1.21";"4.57";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL309365";"";"None";"652.80";"2";"6.36";"12o";"CCCc1nc(CN2CCN(c3ccccc3)C[C@H]2Cc2ccccc2)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"9.19";"0.17";"-0.36";"5.17";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL308703";"";"None";"563.67";"1";"4.15";"12j (XH148)";"CCCc1nc(CN2CCN(c3ccccn3)CC2)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"12.81";"0.23";"3.07";"5.60";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL302959";"";"None";"581.66";"1";"4.29";"12m";"CCCc1nc(CN2CCN(c3ccccn3)CC2)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1F";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"11.52";"0.21";"2.41";"5.20";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL178";"DAUNORUBICIN";"4.0";"527.53";"2";"1.03";"DAUNORUBICIN";"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL932";"DIPYRIDAMOLE";"4.0";"504.64";"2";"-0.02";"DIPYRIDAMOLE";"OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL633";"AMIODARONE";"4.0";"645.32";"2";"6.94";"AMIODARONE";"CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL195437";"4-OCTYLPHENOL";"None";"206.33";"0";"4.30";"4-OCTYLPHENOL";"CCCCCCCCc1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1650";"CORTISONE ACETATE";"4.0";"402.49";"0";"2.56";"CORTISONE ACETATE";"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1095699";"AZASERINE";"2.0";"173.13";"0";"-1.76";"AZASERINE";"[N-]=[N+]=CC(=O)OC[C@H](N)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL44814";"CARBON TETRACHLORIDE";"-1.0";"153.82";"0";"2.55";"CARBON TETRACHLORIDE";"ClC(Cl)(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1113";"AMOXAPINE";"4.0";"313.79";"0";"3.43";"AMOXAPINE";"Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL529";"AZITHROMYCIN";"4.0";"749.00";"2";"1.90";"AZITHROMYCIN";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL40583";"3-METHYLCHOLANTHRENE";"None";"268.36";"1";"5.55";"3-METHYLCHOLANTHRENE";"Cc1ccc2cc3c(ccc4ccccc43)c3c2c1CC3";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL476";"DACARBAZINE";"4.0";"182.19";"0";"0.07";"DTIC";"CN(C)/N=N/c1[nH]cnc1C(N)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL828";"PHENOTHIAZINE";"2.0";"199.28";"0";"3.89";"PHENOTHIAZINE";"c1ccc2c(c1)Nc1ccccc1S2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL844";"BRIMONIDINE";"4.0";"292.14";"0";"1.76";"BRIMONIDINE";"Brc1c(NC2=NCCN2)ccc2nccnc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3215298";"ABAMECTIN";"3.0";"1732.15";"None";"None";"ABAMECTIN";"CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL642";"ACEBUTOLOL";"4.0";"336.43";"0";"2.37";"38";"CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL49";"BUSPIRONE";"4.0";"385.51";"0";"2.09";"BUSPIRONE";"O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL534";"KETOTIFEN";"4.0";"309.43";"0";"4.01";"Ketotifen";"CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL822";"TERBINAFINE";"4.0";"291.44";"0";"4.88";"TERBINAFINE";"CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1945007";"";"None";"561.68";"2";"6.69";"6f";"CCCc1nc2c(C)cc(C(=O)NCCc3cccc(OC)c3)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1949357";"Displacement of [125I]Sar1 Ile8-Ang 2 from angiotensin 2 AT2 receptor after 180 mins by gamma counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944634";"1";"Scientific Literature";"Eur J Med Chem";"2012";"None";"";"";""
"CHEMBL1945008";"";"None";"561.68";"2";"6.69";"6g";"CCCc1nc2c(C)cc(C(=O)NCCc3ccc(OC)cc3)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"10.37";"0.19";"-0.87";"6.23";"0";"CHEMBL1949357";"Displacement of [125I]Sar1 Ile8-Ang 2 from angiotensin 2 AT2 receptor after 180 mins by gamma counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944634";"1";"Scientific Literature";"Eur J Med Chem";"2012";"None";"";"";""
"CHEMBL1945148";"";"None";"549.65";"2";"6.82";"6j";"CCCc1nc2c(C)cc(C(=O)NCCc3ccccc3F)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1949357";"Displacement of [125I]Sar1 Ile8-Ang 2 from angiotensin 2 AT2 receptor after 180 mins by gamma counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944634";"1";"Scientific Literature";"Eur J Med Chem";"2012";"None";"";"";""
"CHEMBL1483";"ALBENDAZOLE";"4.0";"265.34";"0";"3.24";"ALBENDAZOLE";"CCCSc1ccc2[nH]c(NC(=O)OC)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL72";"DESIPRAMINE";"4.0";"266.39";"0";"3.53";"DESIPRAMINE";"CNCCCN1c2ccccc2CCc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL70789";"";"None";"679.81";"2";"7.08";"40";"CCCc1nc(CC)c(C(=O)OCc2ccccc2OC)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"13.24";"0.26";"1.92";"7.15";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL306362";"";"None";"691.83";"2";"6.68";"2";"CCCCc1nc2ccc(NC(=O)N(C)C(C)C)cc2c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC2CC2)cc1F";"IC50";"'='";"7.8";"nM";"8.11";"";"";"UO_0000065";"11.72";"0.23";"1.43";"5.80";"0";"CHEMBL643789";"In vivo inhibitory concentration against AT2 receptor of human adrenal membrane";"B";"BAO_0000218";"organism-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150477";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL76821";"";"None";"663.77";"2";"6.07";"12";"CCc1nc2ccc(NC(=O)N(C)C(C)C)cc2c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCC=C(C)C)cc1F";"IC50";"'='";"9.3";"nM";"8.03";"";"";"UO_0000065";"12.10";"0.23";"1.96";"5.75";"0";"CHEMBL643789";"In vivo inhibitory concentration against AT2 receptor of human adrenal membrane";"B";"BAO_0000218";"organism-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150477";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL62193";"SULFADIMETHOXINE";"4.0";"310.34";"0";"0.88";"SULFADIMETHOXINE";"COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL475534";"NITRENDIPINE";"4.0";"360.37";"0";"2.57";"NITRENDIPINE";"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1544";"LIOTHYRONINE";"4.0";"650.98";"1";"3.95";"3,3',5-TRIIODO-L-THYRONINE";"N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL323506";"";"None";"714.26";"2";"7.01";"4l";"CCCCc1nn(-c2cc(NC(C)=O)ccc2Cl)c(=O)n1Cc1ccc(-c2cc(CCC)ccc2S(=O)(=O)NC(=O)OC(C)(C)C)cc1F";"IC50";"'='";"0.82";"nM";"9.09";"";"";"UO_0000065";"12.72";"0.25";"2.08";"6.43";"0";"CHEMBL876769";"Inhibitory concentration against cloned human AT1 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128028";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL36324";"";"None";"529.66";"2";"5.33";"14";"CCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)c2ccccc2)cc1";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"12.32";"0.23";"1.19";"6.80";"0";"CHEMBL643597";"The compound was tested for the ability to displace 50% of totally specifically bound [125I]- Ang II from Angiotensin II receptor, type 2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153253";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL331450";"";"None";"723.75";"2";"6.12";"36";"CCCNC(=O)c1ccc(C(F)(F)F)c(-n2nc(CCC)n(Cc3ccc(-c4ccccc4S(=O)(=O)NC(=O)c4ccccc4)cc3F)c2=O)c1";"IC50";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"12.12";"0.23";"2.65";"6.64";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL122";"ROFECOXIB";"4.0";"314.36";"0";"2.56";"ROFECOXIB";"CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL331507";"";"None";"735.76";"2";"6.05";"34";"CCCc1nn(-c2cc(NC(=O)COCC)ccc2C(F)(F)F)c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OC(C)(C)C)cc1F";"IC50";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"11.67";"0.23";"2.54";"5.70";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL85";"RISPERIDONE";"4.0";"410.49";"0";"3.59";"RISPERIDONE";"Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL865";"VALDECOXIB";"4.0";"314.37";"0";"2.96";"valdecoxib";"Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2106399";"KITASAMYCIN";"2.0";"785.97";"2";"2.44";"KITASAMYCIN";"CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL72249";"";"None";"610.72";"2";"6.88";"12";"CCCc1nc(CC)c(C(=O)OCc2cccc(C(=O)c3ccccc3)c2)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"9.82";"0.18";"-0.88";"5.19";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL2205685";"";"None";"495.46";"0";"4.75";"213";"O=c1c(O)c(Oc2ccccc2-c2ccc(CNc3nc(C(F)(F)F)nc4c3CCCC4)cc2)c1=O";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2208700";"Antagonist activity at angiotensin 2 receptor";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203023";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL388590";"BENZBROMARONE";"4.0";"424.09";"1";"5.46";"BENZBROMARONE";"CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1082";"AMOXICILLIN";"4.0";"365.41";"0";"0.02";"AMOXICILLIN";"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1447";"LINCOMYCIN";"4.0";"406.55";"0";"-0.86";"LINCOMYCIN";"CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1276308";"MIFEPRISTONE";"4.0";"429.60";"1";"5.41";"MIFEPRISTONE";"CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL311625";"";"None";"725.91";"2";"7.07";"49";"CCCc1nc(CC)c(C(=O)OCCC[S+]([O-])c2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"12.40";"0.25";"1.93";"6.44";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL304137";"";"None";"563.71";"2";"6.23";"11b";"CCCCN(Cc1ccccc1)Cc1nc(CCC)n(Cc2ccc(-c3ccccc3-c3nn[nH]n3)cc2)c1C(=O)O";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"12.50";"0.23";"0.82";"6.25";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL350220";"";"None";"462.50";"0";"4.33";"20";"COc1ccc(NC(=O)N2Cc3ccc(OC)c(OCc4ccccc4)c3CC2C(=O)O)cc1";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"12.88";"0.24";"1.63";"6.12";"0";"CHEMBL643791";"Inhibitory activity against angiotensin II type 2 (AT2) receptor in rabbit uterine membranes.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127723";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL597";"PHENTOLAMINE";"4.0";"281.36";"0";"2.84";"PHENTOLAMINE";"Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL58156";"";"None";"415.53";"0";"4.57";"122, L-159827";"CCc1nc2c(C)cc(C)nc2n1Cc1ccc(-c2ccsc2-c2nn[nH]n2)cc1";"IC50";"'='";"2.3";"nM";"8.64";"";"";"UO_0000065";"20.79";"0.39";"4.07";"10.14";"0";"CHEMBL1670671";"Binding affinity to angiotensin AT2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1667742";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1201139";"MEGESTROL ACETATE";"4.0";"384.52";"0";"4.58";"MEGESTROL ACETATE";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL28079";"ZAPRINAST";"2.0";"271.28";"0";"1.50";"ZAPRINAST";"CCCOc1ccccc1-c1nc2[nH]nnc2c(=O)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL338342";"";"None";"764.67";"2";"7.07";"28";"CCCc1nn(-c2cc(NC(=O)c3ccccc3)ccc2Br)c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OC(C)(C)C)cc1F";"IC50";"'='";"3.6";"nM";"8.44";"";"";"UO_0000065";"11.04";"0.23";"1.37";"5.97";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL436396";"";"None";"716.63";"2";"6.17";"29";"CCCc1nn(-c2cc(NC(=O)CC)ccc2Br)c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OC(C)(C)C)cc1F";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"12.35";"0.26";"2.68";"6.26";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL110691";"CHLORMADINONE ACETATE";"4.0";"404.93";"0";"4.75";"CHLORMADINONE ACETATE";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL61";"PODOFILOX";"4.0";"414.41";"0";"2.41";"PODOPHYLLOTOXIN";"COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1504";"TRIAMCINOLONE ACETONIDE";"4.0";"434.50";"0";"2.42";"TRIAMCINOLONE ACETONIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL70586";"SPIRADOLINE";"None";"425.40";"0";"4.56";"SPIRADOLINE";"CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@H]1CC[C@@]2(CCCO2)C[C@@H]1N1CCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL330302";"";"None";"620.80";"2";"6.04";"25";"CCCCc1nc(SC)c(C(C)C(=O)O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1";"IC50";"'='";"3800.0";"nM";"5.42";"";"";"UO_0000065";"8.73";"0.17";"-0.62";"4.16";"0";"CHEMBL643790";"In vitro binding affinity at Angiotensin II Type 2 receptor in rabbit uterus membrane by [125I]AII displacement.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"CHEMBL3638197";"Uterus";"None";"Membrane";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128070";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1995";"None";"";"";""
"CHEMBL267648";"PEFLOXACIN";"4.0";"333.36";"0";"1.61";"PEFLOXACIN";"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL877";"TRANEXAMIC ACID";"4.0";"157.21";"0";"0.84";"TRANEXAMIC ACID";"NC[C@H]1CC[C@H](C(=O)O)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200604";"TROPICAMIDE";"4.0";"284.36";"0";"2.21";"TROPICAMIDE";"CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL89052";"";"None";"634.78";"1";"4.92";"21i";"C=CC(O)(C(=O)O)c1c(SC)nc(CCC)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"13.08";"0.26";"3.38";"5.51";"0";"CHEMBL643790";"In vitro binding affinity at Angiotensin II Type 2 receptor in rabbit uterus membrane by [125I]AII displacement.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"CHEMBL3638197";"Uterus";"None";"Membrane";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128070";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1995";"None";"";"";""
"CHEMBL314827";"";"None";"650.82";"2";"5.39";"21d";"CCCc1nc(SC)c(C(O)(C(=O)O)C(C)C)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"13.77";"0.27";"3.57";"5.95";"0";"CHEMBL643790";"In vitro binding affinity at Angiotensin II Type 2 receptor in rabbit uterus membrane by [125I]AII displacement.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"CHEMBL3638197";"Uterus";"None";"Membrane";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128070";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1995";"None";"";"";""
"CHEMBL531";"PERGOLIDE";"4.0";"314.50";"0";"4.27";"PERGOLIDE";"CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL156165";"";"None";"576.48";"2";"6.75";"16";"COc1ccc2c(c1OCc1ccccc1)CC(C(=O)O)N(C(=O)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1)C2";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"12.93";"0.25";"0.71";"9.80";"0";"CHEMBL643791";"Inhibitory activity against angiotensin II type 2 (AT2) receptor in rabbit uterine membranes.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127723";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL84158";"TIAPRIDE";"3.0";"328.43";"0";"1.17";"TIAPRIDE";"CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL413925";"";"None";"1020.21";"None";"None";"5";"CNCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N1C[C@@H]2C[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)CSS2";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"7.76";"None";"None";"None";"0";"CHEMBL647843";"In vitro binding affinity at angiotensin II (type 2) receptor in rabbit uterus.";"B";"BAO_0000357";"single protein format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126724";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL508338";"THIMEROSAL";"4.0";"404.82";"None";"None";"THIMEROSAL";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200406";"DIMENHYDRINATE";"4.0";"469.97";"None";"None";"DIMENHYDRINATE";"CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1256017";"ARCAINE SULFATE";"None";"270.31";"1";"-1.27";"ARCAINE SULFATE";"N=C(N)NCCCCNC(=N)N.O=S(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1196";"PROPARACAINE";"4.0";"294.39";"0";"2.56";"PROPARACAINE";"CCCOc1ccc(C(=O)OCCN(CC)CC)cc1N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL313073";"";"None";"690.77";"2";"5.69";"11e";"CCCCc1nc(SC)c(C(O)(C(=O)O)C(F)(F)F)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1";"IC50";"'='";"9.1";"nM";"8.04";"";"";"UO_0000065";"11.64";"0.23";"2.35";"5.34";"0";"CHEMBL643790";"In vitro binding affinity at Angiotensin II Type 2 receptor in rabbit uterus membrane by [125I]AII displacement.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"CHEMBL3638197";"Uterus";"None";"Membrane";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128070";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1995";"None";"";"";""
"CHEMBL856";"PRIMIDONE";"4.0";"218.26";"0";"0.54";"PRIMIDONE";"CCC1(c2ccccc2)C(=O)NCNC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL286398";"PROPYLENE GLYCOL";"3.0";"76.10";"0";"-0.64";"PROPYLENE GLYCOL";"CC(O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1771";"CLOPIDOGREL";"4.0";"321.83";"0";"3.67";"CLOPIDOGREL";"COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2367892";"TEICOPLANIN";"None";"1767.46";"None";"None";"TEICOPLANIN";"CC(=O)N[C@@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O[C@@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]2NC(C)=O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@@H](CO)[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1162";"NORETHINDRONE";"4.0";"298.43";"0";"3.49";"NORETHINDRONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200748";"CARBIDOPA";"4.0";"244.25";"0";"-0.05";"S(-)-CARBIDOPA";"C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O.O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL37858";"SARAFLOXACIN";"-1.0";"385.37";"0";"2.38";"SARAFLOXACIN";"O=C(O)c1cn(-c2ccc(F)cc2)c2cc(N3CCNCC3)c(F)cc2c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL513";"CARMUSTINE";"4.0";"214.05";"0";"1.16";"CARMUSTINE";"O=NN(CCCl)C(=O)NCCCl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1055";"CHLORTHALIDONE";"4.0";"338.77";"0";"0.92";"CHLORTHALIDONE";"NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL338889";"";"None";"719.76";"2";"6.81";"38";"CCCCC(=O)Nc1ccc(C(F)(F)F)c(-n2nc(CC)n(Cc3ccc(-c4ccccc4S(=O)(=O)NC(=O)OC(C)(C)C)cc3F)c2=O)c1";"IC50";"'='";"3.6";"nM";"8.44";"";"";"UO_0000065";"11.73";"0.23";"1.63";"5.97";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL70161";"";"None";"705.85";"2";"7.53";"46";"CCCc1nc(CC)c(C(=O)OCCCC(=O)c2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"11.76";"0.23";"0.77";"6.21";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL308323";"";"None";"741.90";"2";"6.73";"50";"CCCc1nc(CC)c(C(=O)OCCCS(=O)(=O)c2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"11.73";"0.23";"1.97";"5.77";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL70770";"";"None";"517.59";"1";"4.45";"10b";"CCCc1nc(CNC(=O)OC(C)(C)C)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"4000.0";"nM";"5.40";"";"";"UO_0000065";"10.43";"0.19";"0.95";"3.65";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL583";"GREPAFLOXACIN";"4.0";"359.40";"0";"2.28";"GREPAFLOXACIN";"Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1006";"AMIFOSTINE";"4.0";"214.23";"0";"-0.25";"AMIFOSTINE";"NCCCNCCSP(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL14";"CARBACHOL";"4.0";"182.65";"0";"-0.21";"CARBACHOL";"C[N+](C)(C)CCOC(N)=O.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL139";"DICLOFENAC";"4.0";"296.15";"0";"4.36";"DICLOFENAC";"O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL290916";"EDARAVONE";"4.0";"174.20";"0";"1.80";"EDARAVONE";"CC1=NN(c2ccccc2)C(=O)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL177";"AMIKACIN";"4.0";"585.61";"3";"-8.42";"AMIKACIN";"NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL902";"FAMOTIDINE";"4.0";"337.46";"0";"-0.77";"FAMOTIDINE";"NC(N)=Nc1nc(CSCC/C(N)=N/S(N)(=O)=O)cs1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL19215";"METERGOLINE";"4.0";"403.53";"0";"4.06";"METERGOLINE";"CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL9";"NORFLOXACIN";"4.0";"319.34";"0";"1.27";"NORFLOXACIN";"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL504760";"CAMPHOR";"4.0";"152.24";"0";"2.40";"D-CAMPHOR";"CC1(C)[C@@H]2CC[C@@]1(C)C(=O)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL532";"ERYTHROMYCIN";"4.0";"733.94";"2";"1.79";"Erythromycin A";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL506";"PRIMAQUINE";"4.0";"259.35";"0";"2.78";"PRIMAQUINE";"COc1cc(NC(C)CCCN)c2ncccc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL164290";"N-NITROSODIETHYLAMINE";"None";"102.14";"0";"1.01";"N-NITROSODIETHYLAMINE";"CCN(CC)N=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1572";"NETILMICIN";"4.0";"475.59";"2";"-3.20";"NETILMICIN";"CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200585";"OXYMETHOLONE";"4.0";"332.48";"0";"4.40";"OXYMETHOLONE";"C[C@]12C/C(=C/O)C(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL891";"CLOXACILLIN";"4.0";"435.89";"0";"2.55";"CLOXACILLIN";"Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL9514";"NOCODAZOLE";"2.0";"301.33";"0";"3.03";"NOCODAZOLE";"COC(=O)Nc1nc2cc(C(=O)c3cccs3)ccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1560";"CAPTOPRIL";"4.0";"217.29";"0";"0.63";"CAPTOPRIL";"C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1373";"MODAFINIL";"4.0";"273.36";"0";"2.01";"MODAFINIL";"NC(=O)C[S+]([O-])C(c1ccccc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL330744";"";"None";"636.80";"2";"5.36";"30";"CCCCc1nc(SC)c(C(O)CC(=O)O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"10.87";"0.21";"1.56";"4.59";"0";"CHEMBL643790";"In vitro binding affinity at Angiotensin II Type 2 receptor in rabbit uterus membrane by [125I]AII displacement.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"CHEMBL3638197";"Uterus";"None";"Membrane";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128070";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1995";"None";"";"";""
"CHEMBL305017";"";"None";"782.94";"2";"8.22";"59";"CCCc1nc(CC)c(C(=O)OCCN(C(=O)c2ccccc2)c2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"11.11";"0.21";"0.48";"6.35";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL70801";"";"None";"590.69";"1";"4.39";"12a";"CCCc1nc(CN2CCN(C(=O)c3ccccc3)CC2)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL303426";"";"None";"577.65";"1";"3.79";"16";"CCCc1nc(C(=O)N2CCN(c3ccccn3)CC2)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"10.66";"0.20";"2.36";"4.22";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL307359";"";"None";"756.97";"2";"8.79";"63";"CCCc1nc(CC)c(C(=O)NCc2ccccc2Sc2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"11.26";"0.22";"-0.27";"7.14";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL588119";"SULOCTIDIL";"None";"337.57";"1";"5.56";"SULOCTIDIL";"CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1760";"TERBUTALINE";"4.0";"225.29";"0";"1.52";"TERBUTALINE";"CC(C)(C)NCC(O)c1cc(O)cc(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL179166";"SODIUM ORTHOVANAD";"None";"183.91";"None";"None";"SODIUM ORTHOVANADATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL94";"PHYSOSTIGMINE";"4.0";"275.35";"0";"1.77";"PHYSOSTIGMINE";"CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL21731";"MAPROTILINE";"4.0";"277.41";"0";"4.21";"MAPROTILINE";"CNCCCC12CCC(c3ccccc31)c1ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL15770";"SULINDAC";"4.0";"356.42";"0";"4.37";"SULINDAC";"CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc([S+](C)[O-])cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1790041";"RANITIDINE";"4.0";"314.41";"0";"1.46";"RANITIDINE";"CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL156455";"1,1-DICHLOROETHENE";"None";"96.94";"0";"1.94";"1,1-DICHLOROETHENE";"C=C(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201356";"METHYLERGONOVINE";"4.0";"339.44";"0";"1.92";"METHYLERGONOVINE";"CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL332909";"";"None";"723.75";"2";"6.72";"20";"CCCCc1nn(-c2cc(NC(=O)CC)ccc2C(F)(F)F)c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)c2ccccc2)cc1F";"IC50";"'='";"4.3";"nM";"8.37";"";"";"UO_0000065";"11.56";"0.22";"1.65";"6.33";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL122158";"";"None";"753.77";"2";"7.33";"33";"CCCc1nn(-c2cc(NC(=O)c3ccccc3)ccc2C(F)(F)F)c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OC(C)(C)C)cc1F";"IC50";"'='";"5.3";"nM";"8.28";"";"";"UO_0000065";"10.98";"0.21";"0.95";"5.85";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL744";"RILUZOLE";"4.0";"234.20";"0";"2.78";"RILUZOLE";"Nc1nc2ccc(OC(F)(F)F)cc2s1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL24322";"";"None";"550.67";"2";"5.51";"86";"CCCCc1nc2ccc(NC(=O)N(C)C(C)C)cc2c(=O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"4500.0";"nM";"5.35";"";"";"UO_0000065";"9.71";"0.18";"-0.16";"4.39";"0";"CHEMBL881769";"Inhibitory concentration against angiotensin II receptor, type 2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140446";"1";"Scientific Literature";"J Med Chem";"2005";"None";"";"";""
"CHEMBL505204";"";"None";"1522.76";"None";"None";"18";"CO/C(C)=C1/NC(=O)[C@H]([C@@H](C)O)NC(=O)c2csc(n2)-c2cc(OC)c(-c3nc(C(=O)NCCCN4CCN(C)CC4)cs3)nc2-c2csc(n2)[C@@H]2COC(=O)c3c4c5c(cccc5n3O)COC(=O)[C@@H](O[C@H]3C[C@](C)(O)[C@H](N(C)C)[C@H](C)O3)[C@@H](OC4)[C@H](NC(=O)c3csc1n3)c1nc(cs1)C(=O)N2";"IC50";"'='";"850.0";"nM";"6.07";"";"";"UO_0000065";"3.99";"None";"None";"None";"0";"CHEMBL996322";"Inhibition of AT2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136943";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL109";"VALPROIC ACID";"4.0";"144.21";"0";"2.29";"VALPROIC ACID";"CCCC(CCC)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL56448";"ANGIOTENSIN III";"None";"884.99";"3";"-2.43";"AIII";"CC(C)[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C";"IC50";"'='";"1.74";"nM";"8.76";"";"";"UO_0000065";"9.90";"0.19";"11.19";"2.31";"0";"CHEMBL647843";"In vitro binding affinity at angiotensin II (type 2) receptor in rabbit uterus.";"B";"BAO_0000357";"single protein format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126724";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL806";"FLUTAMIDE";"4.0";"276.21";"0";"3.21";"SID50105597";"CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200624";"ETHYNODIOL DIACETATE";"4.0";"384.52";"0";"4.43";"ETHYNODIOL DIACETATE";"C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C[C@@H](OC(C)=O)CC[C@@H]4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL117405";"";"None";"248.33";"0";"1.91";"(S)-(-)-PINDOLOL";"CC(C)NC[C@H](O)COc1cccc2[nH]ccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL506486";"";"None";"1508.73";"None";"None";"5";"CO/C(C)=C1/NC(=O)[C@H]([C@@H](C)O)NC(=O)c2csc(n2)-c2cc(O)c(-c3nc(C(=O)NCCCN4CCN(C)CC4)cs3)nc2-c2csc(n2)[C@@H]2COC(=O)c3c4c5c(cccc5n3O)COC(=O)[C@@H](O[C@H]3C[C@](C)(O)[C@H](N(C)C)[C@H](C)O3)[C@@H](OC4)[C@H](NC(=O)c3csc1n3)c1nc(cs1)C(=O)N2";"IC50";"'<'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL996322";"Inhibition of AT2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136943";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL499925";"";"None";"1522.72";"None";"None";"11";"CO/C(C)=C1/NC(=O)[C@H]([C@@H](C)O)NC(=O)c2csc(n2)-c2cc(O)c(-c3nc(C(=O)N4CCN(CC(=O)N(C)C)CC4)cs3)nc2-c2csc(n2)[C@@H]2COC(=O)c3c4c5c(cccc5n3O)COC(=O)[C@@H](O[C@H]3C[C@](C)(O)[C@H](N(C)C)[C@H](C)O3)[C@@H](OC4)[C@H](NC(=O)c3csc1n3)c1nc(cs1)C(=O)N2";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL996322";"Inhibition of AT2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136943";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL311160";"";"None";"687.77";"2";"6.16";"14";"CCc1ccc(C(=O)NS(=O)(=O)c2ccccc2-c2ccc(Cn3c(CC)nc4ccc(NC(=O)NC(C)C)cc4c3=O)c(F)c2)c(F)c1";"IC50";"'='";"3.1";"nM";"8.51";"";"";"UO_0000065";"12.37";"0.24";"2.35";"6.11";"0";"CHEMBL643789";"In vivo inhibitory concentration against AT2 receptor of human adrenal membrane";"B";"BAO_0000218";"organism-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150477";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL125542";"";"None";"524.63";"1";"4.81";"20";"CCCCc1ncc(/C=C2/C(=O)NC(=O)N2CCCC)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"789.0";"nM";"6.10";"";"";"UO_0000065";"11.63";"0.21";"1.29";"5.02";"0";"CHEMBL647846";"The compound was tested for binding affinity against Angiotensin II receptor, type 2 from rabbit uterus membrane by using [125I]AngII as radioligand";"B";"BAO_0000019";"assay format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128555";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL122380";"";"None";"770.63";"2";"6.74";"47";"CCCCC(=O)Nc1ccc(Br)c(-n2nc(CC)n(Cc3ccc(-c4ccccc4S(=O)(=O)NC(=O)c4cc(F)ccc4F)cc3F)c2=O)c1";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"11.45";"0.24";"2.08";"6.68";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL289614";"";"None";"576.76";"2";"6.74";"L-162782";"CCCCOC(=O)NS(=O)(=O)c1ccc(CC(C)C)cc1-c1ccc(Cn2c(CC)nc3c(C)cc(C)nc32)cc1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"15.87";"0.30";"2.41";"8.87";"0";"CHEMBL648580";"Binding affinity towards Angiotensin II receptor, type 2 was measured through displacement of [125I]-Ang II in pig uterus myometrial membranes";"B";"BAO_0000249";"cell membrane format";"Sus scrofa";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149104";"1";"Scientific Literature";"J Med Chem";"2004";"None";"";"";""
"CHEMBL70867";"";"None";"768.91";"2";"8.32";"56";"CCCc1nc(CC)c(C(=O)OCc2ccccc2C(=O)Nc2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"11.70";"0.22";"0.68";"6.18";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL433257";"HARRINGTONINE";"None";"531.60";"1";"2.19";"HARRINGTONINE";"COC(=O)C[C@](O)(CCC(C)(C)O)C(=O)O[C@@H]1C(OC)=C[C@]23CCCN2CCc2cc4c(cc2[C@H]13)OCO4";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL914";"FEXOFENADINE";"4.0";"501.67";"2";"5.51";"FEXOFENADINE";"CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL35";"FUROSEMIDE";"4.0";"330.75";"0";"1.89";"FUROSEMIDE";"NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL23";"DILTIAZEM";"4.0";"414.53";"0";"3.37";"DILTIAZEM";"COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL926";"DOBUTAMINE";"4.0";"301.39";"0";"2.96";"DOBUTAMINE";"CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL76525";"";"None";"544.70";"1";"4.76";"HR-720";"CCCCc1nc(SC)c(C(=O)O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)NCCC)cc1";"IC50";"'='";"920.0";"nM";"6.04";"";"";"UO_0000065";"11.08";"0.22";"1.28";"4.63";"0";"CHEMBL647844";"Inhibitory activity was evaluated against Angiotensin II receptor, type 2";"B";"BAO_0000357";"single protein format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129469";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL37161";"FENBENDAZOLE";"2.0";"299.36";"0";"3.89";"FENBENDAZOLE";"COC(=O)Nc1nc2cc(Sc3ccccc3)ccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL39959";"";"None";"562.74";"2";"6.49";"L-162389";"CCCCOC(=O)NS(=O)(=O)c1ccc(CCC)cc1-c1ccc(Cn2c(CC)nc3c(C)cc(C)nc32)cc1";"IC50";"'='";"6.1";"nM";"8.21";"";"";"UO_0000065";"14.60";"0.28";"1.72";"7.96";"0";"CHEMBL643595";"Inhibition of Angiotensin II receptor, type 2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129469";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL942";"BISACODYL";"4.0";"361.40";"0";"4.11";"BISACODYL";"CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL339722";"";"None";"716.23";"2";"6.07";"10";"CCCCc1nn(-c2cc(NC(=O)COCC)ccc2Cl)c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OC(C)(C)C)cc1F";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"12.46";"0.25";"2.85";"5.92";"0";"CHEMBL648579";"In vitro inhibitory activity against Angiotensin II receptor, type 2 in human adrenal membrane preparations. For this assay, only 0.02%BSA was present in the assay mixture.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL472";"GLYBURIDE";"4.0";"494.01";"0";"3.64";"GLYBURIDE";"COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL116";"AMPRENAVIR";"4.0";"505.64";"1";"2.40";"AMPRENAVIR";"CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL81977";"3-AMINOBENZAMIDE";"None";"136.15";"0";"0.37";"3-AMINOBENZAMIDE";"NC(=O)c1cccc(N)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1489";"AZACITIDINE";"4.0";"244.21";"0";"-3.17";"AZACITIDINE";"Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL307321";"";"None";"672.85";"2";"5.35";"18 (XM953)";"CCCCCC(=O)NS(=O)(=O)c1ccccc1-c1ccc(Cn2c(CCC)nc(CN3CCN(c4ccccn4)CC3)c2C(=O)O)cc1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"11.44";"0.22";"2.35";"5.59";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL564201";"6-AZAURIDINE";"None";"245.19";"0";"-3.46";"AZAURIDINE";"O=c1cnn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL234926";"ALLYL ALCOHOL";"None";"58.08";"0";"0.16";"ALLYL ALCOHOL";"C=CCO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL339672";"";"None";"724.64";"2";"7.01";"6b";"CCCCc1nn(-c2cc(NC(=O)CC)ccc2Cl)c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)c2ccccc2Cl)cc1F";"IC50";"'='";"3.1";"nM";"8.51";"";"";"UO_0000065";"11.74";"0.24";"1.50";"6.44";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL1159650";"CLOBETASOL PROPIONATE";"4.0";"466.98";"0";"4.10";"CLOBETASOL PROPIONATE";"CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL273542";"";"None";"750.65";"2";"6.68";"42";"CCc1nn(-c2cc(NC(=O)c3ccccc3)ccc2Br)c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OC(C)(C)C)cc1F";"IC50";"'='";"4.1";"nM";"8.39";"";"";"UO_0000065";"11.17";"0.23";"1.71";"5.93";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL122401";"";"None";"817.56";"2";"7.56";"32";"CCCCNC(=O)c1ccc(Br)c(-n2nc(CCC)n(Cc3ccc(-c4ccccc4S(=O)(=O)NC(=O)c4cc(Cl)ccc4Cl)cc3F)c2=O)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"10.64";"0.23";"1.14";"6.58";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL788";"IDOXURIDINE";"4.0";"354.10";"0";"-1.22";"IDOXURIDINE";"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909051";"";"None";"347.38";"0";"4.80";"4-(PHENYLMETHYL)-1-[2-(TRIFLUOROMETHYL)BENZOYL]-PIPERIDINE";"O=C(c1ccccc1C(F)(F)F)N1CCC(Cc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL296419";"ASTEMIZOLE";"4.0";"458.58";"1";"5.35";"astemizole";"COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL563";"FLURBIPROFEN";"4.0";"244.26";"0";"3.68";"FLURBIPROFEN";"CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1527608";"DOXOFYLLINE";"3.0";"266.26";"0";"-1.19";"DOXOFYLLINE";"Cn1c(=O)c2c(ncn2CC2OCCO2)n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL13341";"NIMETAZEPAM";"2.0";"295.30";"0";"2.41";"NIMETAZEPAM";"CN1C(=O)CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL288174";"";"None";"582.79";"2";"6.80";"1";"CCCCOC(=O)NS(=O)(=O)c1sc(CC(C)C)cc1-c1ccc(Cn2c(CC)nc3c(C)cc(C)nc32)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"14.93";"0.30";"1.90";"8.43";"1";"CHEMBL648581";"Inhibitory concentration against towards Angiotensin II receptor, type 2 was measured through displacement of [125I]-Ang II in pig uterus myometrial membranes";"B";"BAO_0000249";"cell membrane format";"Sus scrofa";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149104";"1";"Scientific Literature";"J Med Chem";"2004";"None";"";"";""
"CHEMBL1535";"HYDROXYCHLOROQUINE";"4.0";"335.88";"0";"3.78";"HYDROXYCHLOROQUINE";"CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL50588";"EMETINE";"2.0";"480.65";"0";"4.94";"EMETINE";"CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1536";"ERGOCALCIFEROL";"4.0";"396.66";"1";"7.64";"ERGOCALCIFEROL";"C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1501";"FLUOCINONIDE";"4.0";"494.53";"0";"2.94";"FLUOCINONIDE";"CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL376180";"AMINOPTERIN";"2.0";"440.42";"1";"0.24";"AMINOPTERIN";"Nc1nc(N)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL306473";"";"None";"647.82";"2";"7.06";"6";"CCCCN(Cc1ccccc1)C(=O)CCCOC(=O)c1c(CC)nc(CCC)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"10.07";"0.19";"-0.54";"5.49";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL288174";"";"None";"582.79";"2";"6.80";"L-162313";"CCCCOC(=O)NS(=O)(=O)c1sc(CC(C)C)cc1-c1ccc(Cn2c(CC)nc3c(C)cc(C)nc32)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"14.93";"0.30";"1.90";"8.43";"1";"CHEMBL832379";"Displacement of [125I]-Ang II from pig uterus membrane angiotensin II type 2 (AT2) receptor";"B";"BAO_0000019";"assay format";"Sus scrofa";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138699";"1";"Scientific Literature";"J Med Chem";"2004";"None";"";"";""
"CHEMBL339806";"";"None";"730.66";"2";"5.96";"45";"CCCCNC(=O)c1ccc(Br)c(-n2nc(CC)n(Cc3ccc(-c4ccccc4S(=O)(=O)NC(=O)OC(C)(C)C)cc3F)c2=O)c1";"IC50";"'='";"3.7";"nM";"8.43";"";"";"UO_0000065";"11.54";"0.25";"2.47";"5.96";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL313868";"";"None";"736.24";"2";"7.05";"4k";"CCCCc1nn(-c2cc(NC(C)=O)ccc2Cl)c(=O)n1Cc1ccc(-c2cc(CCC)ccc2S(=O)(=O)NC(=O)c2ccccc2F)cc1F";"IC50";"'='";"2.4";"nM";"8.62";"";"";"UO_0000065";"11.71";"0.23";"1.57";"6.52";"0";"CHEMBL649910";"In vitro inhibitory concentration against AT2 receptor from human adrenal tissues.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128028";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL339004";"";"None";"752.70";"2";"7.19";"7b";"CCCCNC(=O)c1ccc(Cl)c(-n2nc(CCCC)n(Cc3ccc(-c4ccccc4S(=O)(=O)NC(=O)c4ccccc4Cl)cc3F)c2=O)c1";"IC50";"'='";"3.7";"nM";"8.43";"";"";"UO_0000065";"11.20";"0.23";"1.24";"6.38";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL158";"AZTREONAM";"4.0";"435.44";"0";"-1.17";"AZTREONAM";"C[C@H]1[C@H](NC(=O)/C(=N\OC(C)(C)C(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4649901";"";"None";"1495.48";"None";"None";"BLEOMYCIN A2";"Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)[C@@H](C)O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL331455";"";"None";"705.73";"2";"6.42";"17";"CCCCc1nn(-c2cc(NC(=O)CC)ccc2C(F)(F)F)c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OC(C)C)cc1F";"IC50";"'='";"2.7";"nM";"8.57";"";"";"UO_0000065";"12.14";"0.24";"2.15";"6.06";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL122917";"";"None";"717.79";"2";"6.84";"19";"CCCCc1nn(-c2cc(NC(=O)CC)ccc2C(F)(F)F)c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)CC(C)(C)C)cc1F";"IC50";"'='";"4.3";"nM";"8.37";"";"";"UO_0000065";"11.66";"0.23";"1.53";"6.33";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL124771";"";"None";"730.66";"2";"6.56";"25";"CCCCc1nn(-c2cc(NC(=O)CC)ccc2Br)c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OC(C)(C)C)cc1F";"IC50";"'='";"2.3";"nM";"8.64";"";"";"UO_0000065";"11.82";"0.25";"2.08";"6.11";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL1103";"FURAZOLIDONE";"4.0";"225.16";"0";"0.97";"FURAZOLIDONE";"O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL275449";"";"None";"622.77";"1";"4.75";"21b";"CCCc1nc(SC)c(C(C)(O)C(=O)O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1";"IC50";"'='";"4.7";"nM";"8.33";"";"";"UO_0000065";"13.37";"0.26";"3.58";"5.53";"0";"CHEMBL643790";"In vitro binding affinity at Angiotensin II Type 2 receptor in rabbit uterus membrane by [125I]AII displacement.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"CHEMBL3638197";"Uterus";"None";"Membrane";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128070";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1995";"None";"";"";""
"CHEMBL1201195";"CEFMETAZOLE";"4.0";"471.55";"1";"-0.73";"CEFMETAZOLE";"CO[C@@]1(NC(=O)CSCC#N)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL442";"ERGOTAMINE";"4.0";"581.67";"1";"1.99";"ERGOTAMINE";"CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL415690";"BETADEX";"3.0";"1134.99";"None";"None";"BETA CYCLODEXTRIN";"OC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]1[C@H](O)[C@H]2O)O[C@@H]8CO)O[C@@H]7CO)O[C@@H]6CO)O[C@@H]5CO)O[C@@H]4CO)O[C@@H]3CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL407030";"";"None";"1281.13";"None";"None";"GAMMA-CYCLODEXTRIN";"OC[C@H]1OC2C3[C@@H](CO)OC(O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]9[C@H](O)[C@@H](O)C(OC1[C@H](O)[C@H]2O)O[C@@H]9CO)O[C@@H]8CO)O[C@@H]7CO)O[C@@H]6CO)O[C@@H]5CO)O[C@@H]4CO)[C@H](O)[C@H]3O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL6273";"FLEROXACIN";"2.0";"369.34";"0";"1.70";"FLEROXACIN";"CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(CCF)c3c2F)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL871";"ETIDRONIC ACID";"4.0";"206.03";"0";"-0.99";"ETIDRONATE";"CC(O)(P(=O)(O)O)P(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL321531";"";"None";"752.70";"2";"7.57";"4j";"CCCCc1nn(-c2cc(NC(C)=O)ccc2Cl)c(=O)n1Cc1ccc(-c2cc(CCC)ccc2S(=O)(=O)NC(=O)c2ccccc2Cl)cc1F";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"10.32";"0.21";"0.20";"5.88";"0";"CHEMBL649910";"In vitro inhibitory concentration against AT2 receptor from human adrenal tissues.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128028";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL1255901";"HUPERZINE A";"2.0";"242.32";"0";"2.00";"HUPERZINE A";"C/C=C1\[C@H]2C=C(C)C[C@@]1(N)c1ccc(=O)[nH]c1C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200993";"GALLAMINE TRIETHIODIDE";"4.0";"891.54";"2";"5.45";"GALLAMINE TRIETHIODIDE";"CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC.[I-].[I-].[I-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1297";"FENOPROFEN";"4.0";"242.27";"0";"3.67";"15";"CC(C(=O)O)c1cccc(Oc2ccccc2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1467";"ALLOPURINOL";"4.0";"136.11";"0";"0.06";"ALLOPURINOL";"Oc1ncnc2[nH]ncc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL45245";"";"None";"195.22";"0";"2.68";"6(5H)-PHENANTHRIDINONE";"O=c1[nH]c2ccccc2c2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL720";"BENZYL ALCOHOL";"4.0";"108.14";"0";"1.18";"BENZYL ALCOHOL";"OCc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3";"NICOTINE";"4.0";"162.24";"0";"1.85";"NICOTINE";"CN1CCC[C@H]1c1cccnc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1144";"PRAVASTATIN";"4.0";"424.53";"0";"2.44";"PRAVASTATIN";"CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL153479";"AMBROXOL";"3.0";"378.11";"0";"3.19";"AMBROXOL";"Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1430";"PENICILLAMINE";"4.0";"149.21";"0";"0.11";"PENICILLAMINE";"CC(C)(S)[C@@H](N)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1255837";"DIHYDROERGOCRISTINE MESYLATE";"None";"707.85";"1";"2.72";"DIHYDROERGOCRISTINE MESYLATE";"CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CS(=O)(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL107";"COLCHICINE";"4.0";"399.44";"0";"2.87";"SID170465011";"COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL160930";"";"None";"552.58";"2";"5.65";"14";"COC(=O)C1Cc2c(ccc(OC)c2Oc2ccc([N+](=O)[O-])cc2)CN1C(=O)C(c1ccccc1)c1ccccc1";"IC50";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"11.64";"0.21";"0.78";"5.94";"0";"CHEMBL643791";"Inhibitory activity against angiotensin II type 2 (AT2) receptor in rabbit uterine membranes.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127723";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL39959";"";"None";"562.74";"2";"6.49";"L-162389";"CCCCOC(=O)NS(=O)(=O)c1ccc(CCC)cc1-c1ccc(Cn2c(CC)nc3c(C)cc(C)nc32)cc1";"IC50";"'='";"4.2";"nM";"8.38";"";"";"UO_0000065";"14.89";"0.29";"1.89";"8.12";"0";"CHEMBL648580";"Binding affinity towards Angiotensin II receptor, type 2 was measured through displacement of [125I]-Ang II in pig uterus myometrial membranes";"B";"BAO_0000249";"cell membrane format";"Sus scrofa";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149104";"1";"Scientific Literature";"J Med Chem";"2004";"None";"";"";""
"CHEMBL389621";"HYDROCORTISONE";"4.0";"362.47";"0";"1.78";"HYDROCORTISONE";"C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL72099";"";"None";"727.86";"2";"8.62";"27";"CCCCOC(=O)NS(=O)(=O)c1ccccc1-c1ccc(Cn2c(CCC)nc(CC)c2C(=O)OCc2ccccc2Oc2ccccc2)c(F)c1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"11.71";"0.22";"-0.10";"6.77";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL38737";"THIOACETAMIDE";"None";"75.14";"0";"0.91";"THIOACETAMIDE";"CC(=N)S";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL242273";"SAFROLE";"-1.0";"162.19";"0";"2.14";"SAFROLE";"C=CCc1ccc2c(c1)OCO2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1747";"TOBRAMYCIN";"4.0";"467.52";"2";"-6.30";"TOBRAMYCIN";"NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL137";"METRONIDAZOLE";"4.0";"171.16";"0";"0.09";"METRONIDAZOLE";"Cc1ncc([N+](=O)[O-])n1CCO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1539";"SULFADOXINE";"4.0";"310.34";"0";"0.88";"SULFADOXINE";"COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL306435";"";"None";"699.81";"2";"6.89";"32";"CCCOC(=O)NS(=O)(=O)c1ccccc1-c1ccc(Cn2c(CCC)nc(CC)c2C(=O)OCc2ccccc2-c2cncnc2)c(F)c1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"11.43";"0.22";"1.11";"5.62";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL74514";"";"None";"753.89";"2";"8.49";"57";"CCCc1nc(CC)c(C(=O)OC(C(=O)c2ccccc2)c2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"11.31";"0.22";"0.03";"6.38";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL306923";"";"None";"582.71";"2";"7.32";"15";"CCCc1nc(CC)c(C(=O)OCc2ccc(-c3ccccc3)cc2)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"9.48";"0.17";"-1.80";"5.60";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL1619";"CLADRIBINE";"4.0";"285.69";"0";"-0.30";"CLADRIBINE";"Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL415073";"";"None";"679.81";"2";"6.68";"1";"CCCCOC(=O)NS(=O)(=O)c1ccccc1-c1ccc(Cn2c(CCCC)nc3ccc(NC(=O)N(C)C(C)C)cc3c2=O)c(F)c1";"IC50";"'='";"7.7";"nM";"8.11";"";"";"UO_0000065";"11.93";"0.23";"1.43";"5.81";"0";"CHEMBL643789";"In vivo inhibitory concentration against AT2 receptor of human adrenal membrane";"B";"BAO_0000218";"organism-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150477";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL54";"HALOPERIDOL";"4.0";"375.87";"0";"4.43";"HALOPERIDOL";"O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL89053";"";"None";"698.87";"2";"5.98";"21h";"CCCc1nc(SC)c(C(O)(Cc2ccccc2)C(=O)O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"12.82";"0.25";"2.98";"5.95";"0";"CHEMBL643790";"In vitro binding affinity at Angiotensin II Type 2 receptor in rabbit uterus membrane by [125I]AII displacement.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"CHEMBL3638197";"Uterus";"None";"Membrane";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128070";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1995";"None";"";"";""
"CHEMBL419073";"";"None";"772.97";"2";"7.81";"64";"CCCc1nc(CC)c(C(=O)NCc2ccccc2[S+]([O-])c2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"10.74";"0.21";"0.49";"5.83";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL121";"ROSIGLITAZONE";"4.0";"357.44";"0";"2.49";"rosiglitazone";"CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL264374";"BEZAFIBRATE";"4.0";"361.83";"0";"3.55";"BEZAFIBRATE";"CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1370";"BUDESONIDE";"4.0";"430.54";"0";"2.72";"BUDESONIDE";"CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL498847";"SECNIDAZOLE";"4.0";"185.18";"0";"0.48";"SECNIDAZOLE";"Cc1ncc([N+](=O)[O-])n1CC(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL21";"SULFANILAMIDE";"4.0";"172.21";"0";"-0.08";"3";"Nc1ccc(S(N)(=O)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL650";"METHYLPREDNISOLONE";"4.0";"374.48";"0";"1.80";"METHYLPREDNISOLONE";"C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)CO)[C@@]2(C)C=CC(=O)C=C12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1400945";"PREGNENOLONE CARBONITRILE ";"None";"341.50";"0";"4.26";"PREGNENOLONE-16ALPHA-CARBONITRILE";"CC(=O)[C@H]1[C@H](C#N)C[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL934";"METYRAPONE";"4.0";"226.28";"0";"2.64";"METYRAPONE";"CC(C)(C(=O)c1cccnc1)c1cccnc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL112";"ACETAMINOPHEN";"4.0";"151.16";"0";"1.35";"ACETAMINOPHEN";"CC(=O)Nc1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL569";"PROCAINE";"4.0";"236.31";"0";"1.77";"PROCAINE";"CCN(CC)CCOC(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL16068";"BROMOBENZENE";"None";"157.01";"0";"2.45";"BROMOBENZENE";"Brc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909050";"";"None";"293.41";"0";"4.09";"1-(2-METHYLBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE";"Cc1ccccc1C(=O)N1CCC(Cc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL49080";"CLENBUTEROL";"4.0";"277.19";"0";"3.00";"CLENBUTEROL";"CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL185";"FLUOROURACIL";"4.0";"130.08";"0";"-0.80";"5-FU";"O=c1[nH]cc(F)c(=O)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL263049";"MJ347-81F4 A";"None";"1437.57";"None";"None";"1";"C=C(NC(=O)c1csc(-c2nc3c(cc2O)-c2nc(cs2)C(=O)N[C@@H]([C@@H](C)O)C(=O)N/C(=C(\C)OC)c2nc(cs2)C(=O)N[C@@H]2c4nc(cs4)C(=O)N[C@@H](COC(=O)c4c5c6c(cccc6n4O)COC(=O)[C@@H](O[C@H]4C[C@](C)(O)[C@H](N(C)C)[C@H](C)O4)[C@H]2OC5)c2nc-3cs2)n1)C(N)=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL996322";"Inhibition of AT2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136943";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL63323";"NIFLUMIC ACID";"2.0";"282.22";"0";"3.54";"NIFLUMIC ACID";"O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL269732";"TACROLIMUS ANHYDROUS";"4.0";"804.03";"2";"4.64";"TACROLIMUS";"C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2105807";"MADURAMICIN";"2.0";"934.17";"2";"4.32";"MADURAMICIN";"CO[C@@H]1[C@@H](OC)[C@H](C)[C@@](O)(CC(=O)O)O[C@H]1[C@H](C)[C@H]1O[C@@]2(CC[C@@](C)([C@H]3CC[C@@](C)([C@@H]4O[C@@H]([C@H]5O[C@](C)(O)[C@H](C)C[C@@H]5C)C[C@@H]4O[C@@H]4C[C@H](OC)[C@@H](OC)[C@H](C)O4)O3)O2)C[C@H](O)[C@H]1C.N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1456";"MYCOPHENOLATE MOFETIL";"4.0";"433.50";"0";"2.52";"MYCOPHENOLATE MOFETIL";"COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL469";"KETOROLAC";"4.0";"255.27";"0";"2.29";"KETOROLAC";"O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL302102";"";"None";"611.75";"2";"7.08";"L-159689";"CCCCCN(C(=O)c1ccccc1)c1ccc2nc(CCC)n(Cc3ccc(-c4ccccc4-c4nn[nH]n4)cc3)c(=O)c2c1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"13.33";"0.24";"1.07";"7.44";"0";"CHEMBL643789";"In vivo inhibitory concentration against AT2 receptor of human adrenal membrane";"B";"BAO_0000218";"organism-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150477";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL338514";"";"None";"494.64";"1";"5.27";"48";"CCCCc1ncc(/C=C2/C(=O)N(CCCC)C(=O)N2CCCC)n1Cc1ccc(C(=O)OC)cc1";"IC50";"'='";"5870.0";"nM";"5.23";"";"";"UO_0000065";"10.58";"0.20";"-0.04";"6.17";"0";"CHEMBL647846";"The compound was tested for binding affinity against Angiotensin II receptor, type 2 from rabbit uterus membrane by using [125I]AngII as radioligand";"B";"BAO_0000019";"assay format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128555";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL357995";"BOPINDOLOL";"2.0";"380.49";"0";"4.47";"BOPINDOLOL";"Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1110";"ALOSETRON";"4.0";"294.36";"0";"2.41";"ALOSETRON";"Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL404520";"CHLORTETRACYCLINE";"4.0";"478.89";"1";"0.44";"CHLORTETRACYCLINE";"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1753";"CLINDAMYCIN";"4.0";"424.99";"0";"0.39";"CLINDAMYCIN";"CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL485259";"EUCALYPTOL";"3.0";"154.25";"0";"2.74";"EUCALYPTOL";"CC12CCC(CC1)C(C)(C)O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL348363";"";"None";"508.57";"2";"6.04";"22";"COc1ccc2c(c1OCc1ccccc1)CC(C(=O)O)N(C(=O)N(c1ccccc1)c1ccccc1)C2";"IC50";"'='";"5.8";"nM";"8.24";"";"";"UO_0000065";"16.20";"0.30";"2.20";"10.39";"0";"CHEMBL643791";"Inhibitory activity against angiotensin II type 2 (AT2) receptor in rabbit uterine membranes.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127723";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL691";"ETHINYL ESTRADIOL";"4.0";"296.41";"0";"3.61";"ETHINYLESTRADIOL";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL123292";"CYCLOHEXIMIDE";"2.0";"281.35";"0";"1.04";"CYCLOHEXIMIDE";"C[C@@H]1C[C@@H]([C@H](O)CC2CC(=O)NC(=O)C2)C(=O)[C@@H](C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL8";"CIPROFLOXACIN";"4.0";"331.35";"0";"1.58";"CIPROFLOXACIN";"O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL384467";"DEXAMETHASONE";"4.0";"392.47";"0";"1.90";"DEXAMETHASONE";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL339256";"";"None";"758.19";"2";"7.37";"22";"CCCCc1nn(-c2cc(NC(=O)CC)ccc2C(F)(F)F)c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)c2ccccc2Cl)cc1F";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"11.72";"0.23";"1.52";"6.72";"0";"CHEMBL648579";"In vitro inhibitory activity against Angiotensin II receptor, type 2 in human adrenal membrane preparations. For this assay, only 0.02%BSA was present in the assay mixture.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL72595";"";"None";"739.87";"2";"7.91";"21";"CCCc1nc(CC)c(C(=O)OCc2ccccc2C(=O)c2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCC(C)C)cc1F";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"12.16";"0.23";"1.09";"6.73";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL306340";"";"None";"692.85";"2";"6.91";"61";"CCCc1nc(CC)c(C(=O)NCCCOc2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"11.61";"0.22";"1.14";"6.26";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL70726";"";"None";"725.84";"2";"7.67";"20";"CCCOC(=O)NS(=O)(=O)c1ccccc1-c1ccc(Cn2c(CCC)nc(CC)c2C(=O)OCc2ccccc2C(=O)c2ccccc2)c(F)c1";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"12.12";"0.23";"1.13";"6.58";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL155836";"";"None";"507.59";"2";"5.44";"5";"COc1ccc2c(c1OCc1ccccc1)CC(C(=O)O)N(C(=O)C(c1ccccc1)c1ccccc1)C2";"IC50";"'='";"2.4";"nM";"8.62";"";"";"UO_0000065";"16.98";"0.31";"3.18";"11.33";"0";"CHEMBL643791";"Inhibitory activity against angiotensin II type 2 (AT2) receptor in rabbit uterine membranes.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127723";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL467872";"NOCATHIACIN ACID";"None";"1369.49";"None";"None";"2";"CO/C(C)=C1/NC(=O)[C@H]([C@@H](C)O)NC(=O)c2csc(n2)-c2cc(O)c(-c3nc(C(=O)O)cs3)nc2-c2csc(n2)[C@@H]2COC(=O)c3c4c5c(cccc5n3O)COC(=O)[C@@H](O[C@H]3C[C@](C)(O)[C@H](N(C)C)[C@H](C)O3)[C@@H](OC4)[C@H](NC(=O)c3csc1n3)c1nc(cs1)C(=O)N2";"IC50";"'='";"1120.0";"nM";"5.95";"";"";"UO_0000065";"4.35";"None";"None";"None";"0";"CHEMBL996322";"Inhibition of AT2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136943";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL502031";"";"None";"1508.69";"None";"None";"7";"CO/C(C)=C1/NC(=O)[C@H]([C@@H](C)O)NC(=O)c2csc(n2)-c2cc(O)c(-c3nc(C(=O)NCC(=O)N4CCN(C)CC4)cs3)nc2-c2csc(n2)[C@@H]2COC(=O)c3c4c5c(cccc5n3O)COC(=O)[C@@H](O[C@H]3C[C@](C)(O)[C@H](N(C)C)[C@H](C)O3)[C@@H](OC4)[C@H](NC(=O)c3csc1n3)c1nc(cs1)C(=O)N2";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL996322";"Inhibition of AT2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136943";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL70796";"";"None";"561.69";"2";"5.81";"12f";"CCCc1nc(CN2CCC(c3ccccc3)CC2)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"11.39";"0.21";"0.59";"5.67";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL339544";"";"None";"603.79";"2";"6.54";"37";"CCCCc1ncc(/C=C2/C(=O)N(CCCC)C(=O)N2Cc2csc(C)n2)n1Cc1ccc(C2(C(=O)O)CCCC2)cc1";"IC50";"'='";"549.0";"nM";"6.26";"";"";"UO_0000065";"10.37";"0.20";"-0.28";"5.76";"0";"CHEMBL647846";"The compound was tested for binding affinity against Angiotensin II receptor, type 2 from rabbit uterus membrane by using [125I]AngII as radioligand";"B";"BAO_0000019";"assay format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128555";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL424004";"";"None";"607.45";"1";"4.72";"2";"Cc1cc(Cn2cnc3c2C[C@@H](C(=O)O)N(C(=O)C(c2ccccc2)c2ccccc2)C3)cc(I)c1O";"IC50";"'='";"5.1";"nM";"8.29";"";"";"UO_0000065";"13.65";"0.31";"3.57";"8.67";"0";"CHEMBL643596";"The compound was evaluated for the inhibition of binding of [125I]-CGP 42112A to AT2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126478";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1993";"None";"";"";""
"CHEMBL408773";"";"None";"1020.21";"None";"None";"9";"CNCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N1C[C@H]2C[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)CSS2";"IC50";"'='";"6.1";"nM";"8.21";"";"";"UO_0000065";"8.05";"None";"None";"None";"0";"CHEMBL647843";"In vitro binding affinity at angiotensin II (type 2) receptor in rabbit uterus.";"B";"BAO_0000357";"single protein format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126724";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL259843";"";"None";"693.80";"2";"5.53";"4";"CCCc1nc2ccc(NC(=O)N3CCOCC3)cc2c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"3.3";"nM";"8.48";"";"";"UO_0000065";"12.22";"0.24";"2.95";"5.69";"0";"CHEMBL643789";"In vivo inhibitory concentration against AT2 receptor of human adrenal membrane";"B";"BAO_0000218";"organism-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150477";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL757";"NANDROLONE";"3.0";"274.40";"0";"3.49";"NANDROLONE";"C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL799";"CILOSTAZOL";"4.0";"369.47";"0";"3.46";"cilostazol";"O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1480";"FELODIPINE";"4.0";"384.26";"0";"3.96";"FELODIPINE";"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2221249";"COLISTIN";"4.0";"2296.97";"None";"None";"COLISTIN";"CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2252949";"(-)-CAMPHOR";"None";"152.24";"0";"2.40";"L-CAMPHOR";"CC1(C)[C@H]2CC[C@]1(C)C(=O)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL267894";"AMOBARBITAL";"4.0";"226.28";"0";"1.18";"AMOBARBITAL";"CCC1(CCC(C)C)C(=O)NC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL629";"AMITRIPTYLINE";"4.0";"277.41";"0";"4.17";"AMITRIPTYLINE";"CN(C)CCC=C1c2ccccc2CCc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL976";"PRAZIQUANTEL";"4.0";"312.41";"0";"2.53";"PRAZIQUANTEL";"O=C(C1CCCCC1)N1CC(=O)N2CCc3ccccc3C2C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909071";"";"None";"None";"None";"None";"NOVARTIS P-38 INHIBITOR";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1117";"IDARUBICIN";"4.0";"497.50";"0";"1.02";"IDARUBICIN";"CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL27";"PROPRANOLOL";"4.0";"259.35";"0";"2.58";"PROPRANOLOL";"CC(C)NCC(O)COc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1540";"PENCICLOVIR";"4.0";"253.26";"0";"-0.90";"PENCICLOVIR";"Nc1nc(O)c2ncn(CCC(CO)CO)c2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL26260";"BETA-NAPHTHOFLAVONE";"None";"272.30";"0";"4.61";"BETA-NAPHTHOFLAVONE";"O=c1cc(-c2ccccc2)oc2ccc3ccccc3c12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL608";"PROBUCOL";"4.0";"516.86";"2";"9.91";"PROBUCOL";"CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1626";"CLEMASTINE";"4.0";"343.90";"1";"5.10";"CLEMASTINE";"CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL289469";"GRANISETRON";"4.0";"312.42";"0";"2.32";"GRANISETRON";"CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL990";"BUTENAFINE";"4.0";"317.48";"1";"5.77";"BUTENAFINE";"CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL5314360";"ACONITINE";"-1.0";"645.75";"2";"0.65";"ACONITINE";"CCN1C[C@]2(COC)[C@H](O)C[C@H](OC)[C@@]34[C@@H]5C[C@@]6(O)[C@H](OC(=O)c7ccccc7)[C@@H]5[C@@](OC(C)=O)([C@@H]([C@H](OC)[C@H]23)[C@@H]14)[C@@H](O)[C@@H]6OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL182";"GANCICLOVIR";"4.0";"255.23";"0";"-1.97";"GANCICLOVIR";"Nc1nc2c(ncn2COC(CO)CO)c(=O)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1732";"DIHYDROERGOTAMINE";"4.0";"583.69";"1";"2.08";"DIHYDROERGOTAMINE";"CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1537";"AZLOCILLIN";"4.0";"461.50";"0";"0.09";"AZLOCILLIN";"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL290106";"BITHIONOL";"4.0";"356.06";"1";"5.86";"BITHIONOL";"Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1169";"AMINOSALICYLIC ACID";"4.0";"153.14";"0";"0.67";"AMINOSALICYLIC ACID";"Nc1ccc(C(=O)O)c(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL437002";"";"None";"297.37";"0";"3.92";"1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE";"O=C(c1ccccc1F)N1CCC(Cc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL701";"BACLOFEN";"4.0";"213.66";"0";"1.86";"BACLOFEN";"NCC(CC(=O)O)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2435829";"";"None";"457.53";"1";"5.89";"12";"CCCc1nc2c(C)cc(NC(=O)OC)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"IC50";"'='";"4366.0";"nM";"5.36";"";"";"UO_0000065";"11.71";"0.22";"-0.53";"5.74";"0";"CHEMBL2439560";"Displacement of [125I]-Sar1Ile8-angiotensin 2 from angiotensin 2 AT2 receptor (unknown origin) after 180 mins by gamma counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2434924";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";""
"CHEMBL2435831";"";"None";"483.61";"1";"6.24";"6b";"CCCCNC(=O)c1cc(C)c2nc(CCC)n(Cc3ccc(-c4ccccc4C(=O)O)cc3)c2c1";"IC50";"'='";"164.0";"nM";"6.79";"";"";"UO_0000065";"14.03";"0.26";"0.55";"8.06";"0";"CHEMBL2439560";"Displacement of [125I]-Sar1Ile8-angiotensin 2 from angiotensin 2 AT2 receptor (unknown origin) after 180 mins by gamma counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2434924";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";""
"CHEMBL2435833";"";"None";"495.62";"1";"6.34";"6d";"CCCc1nc2c(C)cc(C(=O)N3CCCCC3)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"14.88";"0.27";"1.04";"9.78";"0";"CHEMBL2439560";"Displacement of [125I]-Sar1Ile8-angiotensin 2 from angiotensin 2 AT2 receptor (unknown origin) after 180 mins by gamma counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2434924";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";""
"CHEMBL1947130";"";"None";"547.66";"2";"6.65";"6c";"CCCc1nc2c(C)cc(C(=O)NCc3cccc(OC)c3)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1949357";"Displacement of [125I]Sar1 Ile8-Ang 2 from angiotensin 2 AT2 receptor after 180 mins by gamma counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944634";"1";"Scientific Literature";"Eur J Med Chem";"2012";"None";"";"";""
"CHEMBL191";"LOSARTAN";"4.0";"422.92";"0";"4.27";"Losartan";"CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1949357";"Displacement of [125I]Sar1 Ile8-Ang 2 from angiotensin 2 AT2 receptor after 180 mins by gamma counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944634";"1";"Scientific Literature";"Eur J Med Chem";"2012";"None";"";"";""
"CHEMBL420";"GUANABENZ";"4.0";"231.09";"0";"1.81";"GUANABENZ";"N=C(N)N/N=C/c1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200600";"FLUOROMETHOLONE";"4.0";"376.47";"0";"2.92";"FLUOROMETHOLONE";"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL211501";"ANTIMYCIN A";"None";"548.63";"1";"3.48";"ANTIMYCIN A";"CCCCCC[C@H]1C(=O)O[C@H](C)[C@H](NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CC(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL127516";"BUTAMBEN";"4.0";"193.25";"0";"2.23";"BUTAMBEN";"CCCCOC(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL340978";"BENOXAPROFEN";"4.0";"301.73";"0";"4.34";"BENOXAPROFEN";"CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL661";"ALPRAZOLAM";"4.0";"308.77";"0";"3.58";"ALPRAZOLAM";"Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200623";"ETHYLESTRENOL";"4.0";"288.48";"1";"5.09";"ETHYLESTRENOL";"CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1542";"AZATHIOPRINE";"4.0";"277.27";"0";"1.15";"AZATHIOPRINE";"Cn1cnc([N+](=O)[O-])c1Sc1ncnc2[nH]cnc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL566534";"ARTEMETHER";"4.0";"298.38";"0";"2.84";"ARTEMETHER";"CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL803";"CYTARABINE";"4.0";"243.22";"0";"-2.56";"CYTARABINE";"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1568";"FLUDARABINE";"None";"285.24";"0";"-1.84";"FLUDARABINE";"Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL188921";"BUFLOMEDIL";"4.0";"307.39";"0";"2.77";"BUFLOMEDIL";"COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1751";"DIGOXIN";"4.0";"780.95";"3";"2.22";"Digoxin";"C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1054";"TRICHLORMETHIAZIDE";"4.0";"380.66";"0";"0.82";"TRICHLORMETHIAZIDE";"NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1712923";"IRSOGLADINE MALEATE";"1.0";"372.17";"0";"2.01";"IRSOGLADINE MALEATE";"Nc1nc(N)nc(-c2cc(Cl)ccc2Cl)n1.O=C(O)/C=C\C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL221753";"BENZETHONIUM CHLORIDE";"2.0";"448.09";"1";"6.07";"BENZETHONIUM CHLORIDE";"CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL136478";"SODIUM NITROPRUSSIDE";"4.0";"261.92";"None";"None";"SODIUM NITROPRUSSIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL56564";"TROPISETRON";"4.0";"284.36";"0";"2.95";"TROPISETRON";"CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)c1c[nH]c3ccccc13)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1444";"LETROZOLE";"4.0";"285.31";"0";"2.66";"LETROZOLE";"N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1490";"TRIHEXYPHENIDYL";"4.0";"301.47";"0";"4.33";"TRIHEXYPHENIDYL";"OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL221886";"SISOMICIN";"3.0";"447.53";"2";"-3.85";"SISOMICIN";"CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL310555";"OXYQUINOLINE";"-1.0";"145.16";"0";"1.94";"OXYQUINOLINE";"Oc1cccc2cccnc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1333512";"N,N'-DIPHENYL-P-PHENYLENEDIAMINE";"None";"260.34";"1";"5.17";"N,N'-DIPHENYL-P-PHENYLENEDIAMINE";"c1ccc(Nc2ccc(Nc3ccccc3)cc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL12948";"SEMUSTINE";"3.0";"247.73";"0";"2.50";"SEMUSTINE";"CC1CCC(NC(=O)N(CCCl)N=O)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL275742";"DEXPROPRANOLOL";"-1.0";"259.35";"0";"2.58";"R-(+)-PROPRANOLOL";"CC(C)NC[C@@H](O)COc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL19224";"PAPAVERINE";"4.0";"339.39";"0";"3.86";"PAPAVERINE";"COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL56337";"EPALRESTAT";"4.0";"319.41";"0";"2.92";"EPALRESTAT";"CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL403";"SULBACTAM";"4.0";"233.24";"0";"-0.79";"SULBACTAM";"CC1(C)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL27769";"STANOLONE";"2.0";"290.45";"0";"3.96";"STANOLONE";"C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL938";"SARALASIN";"4.0";"912.06";"3";"-2.30";"saralasin";"CNCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C";"IC50";"'='";"1.32";"nM";"8.88";"";"";"UO_0000065";"9.74";"0.19";"11.18";"2.50";"0";"CHEMBL647843";"In vitro binding affinity at angiotensin II (type 2) receptor in rabbit uterus.";"B";"BAO_0000357";"single protein format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126724";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL894";"BUPROPION";"4.0";"239.75";"0";"3.30";"BUPROPION";"CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1230813";"ALFADEX";"2.0";"972.85";"3";"-13.05";"ALPHA-CYCLODEXTRIN";"OC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]1[C@H](O)[C@H]2O)O[C@@H]7CO)O[C@@H]6CO)O[C@@H]5CO)O[C@@H]4CO)O[C@@H]3CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL128";"SUMATRIPTAN";"4.0";"295.41";"0";"1.32";"SUMATRIPTAN";"CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1630578";"TIRILAZAD";"3.0";"624.87";"2";"5.46";"TIRILAZAD";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@H]1C(=O)CN1CCN(c2cc(N3CCCC3)nc(N3CCCC3)n2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL384125";"";"None";"1020.21";"None";"None";"4";"CNCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H]1CSS[C@H]2C[C@@H](C(=O)N[C@@H](Cc3c[nH]cn3)C(=O)N3CCC[C@H]3C(=O)N[C@@H](Cc3ccccc3)C(=O)O)N(C2)C(=O)[C@H](Cc2ccc(O)cc2)NC1=O";"IC50";"'='";"7.4";"nM";"8.13";"";"";"UO_0000065";"7.97";"None";"None";"None";"0";"CHEMBL647843";"In vitro binding affinity at angiotensin II (type 2) receptor in rabbit uterus.";"B";"BAO_0000357";"single protein format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126724";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL170290";"";"None";"813.92";"3";"6.44";"7";"Cc1cc(Cn2cnc3c2C[C@@H](C(=O)O)N(C(=O)C(c2ccccc2)c2ccccc2)C3)ccc1NCCCCCCNC(=O)CCNc1ccc([N+](=O)[O-])c2nonc12";"IC50";"'='";"3.6";"nM";"8.44";"";"";"UO_0000065";"10.37";"0.19";"2.00";"4.01";"0";"CHEMBL643596";"The compound was evaluated for the inhibition of binding of [125I]-CGP 42112A to AT2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126478";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1993";"None";"";"";""
"CHEMBL70370";"";"None";"707.87";"2";"7.48";"37";"CCCc1nc(CC)c(C(=O)OCCCOCc2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"12.29";"0.24";"1.22";"6.91";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL303647";"";"None";"726.87";"2";"8.13";"33";"CCCc1nc(CC)c(C(=O)OCc2ccccc2-c2ccccn2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"11.73";"0.22";"0.39";"6.58";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL306186";"";"None";"613.81";"2";"6.66";"7";"CCCCN(CCCC)C(=O)CCCOC(=O)c1c(CC)nc(CCC)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"10.27";"0.19";"-0.36";"5.30";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL70868";"";"None";"791.00";"2";"8.48";"51";"CCCCN(Cc1ccccc1)C(=O)CCCOC(=O)c1c(CC)nc(CCC)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"10.49";"0.20";"-0.18";"6.06";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL238071";"VINDESINE";"4.0";"753.94";"1";"2.73";"VINDESINE";"CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(N)=O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1521";"ZALEPLON";"4.0";"305.34";"0";"2.64";"ZALEPLON";"CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL267044";"LEVOSULPIRIDE";"2.0";"341.43";"0";"0.56";"LEVOSULPIRIDE";"CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200559";"LACTIC ACID";"4.0";"90.08";"0";"-0.55";"LACTIC ACID";"CC(O)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL374478";"RIFAMPIN";"4.0";"822.95";"3";"4.34";"RIFAMPIN";"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1512";"FLUNISOLIDE";"4.0";"434.50";"0";"2.27";"FLUNISOLIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL282468";"CHOLINE CHLORIDE";"4.0";"139.63";"None";"None";"CHOLINE CHLORIDE";"C[N+](C)(C)CCO.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1073";"GLIPIZIDE";"4.0";"445.55";"0";"2.08";"GLIPIZIDE";"Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1046";"AMINOCAPROIC ACID";"4.0";"131.18";"0";"0.59";"AMINOCAPROIC ACID";"NCCCCCC(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL305647";"";"None";"701.80";"2";"6.55";"5";"CCCc1nc2ccc(NC(=O)NC(C)C)cc2c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)c2ccc(CC)cc2F)cc1F";"IC50";"'='";"4.4";"nM";"8.36";"";"";"UO_0000065";"11.91";"0.23";"1.81";"6.00";"0";"CHEMBL643789";"In vivo inhibitory concentration against AT2 receptor of human adrenal membrane";"B";"BAO_0000218";"organism-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150477";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL411657";"";"None";"2040.42";"None";"None";"6";"CNCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N1C[C@@H]2C[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)CSS[C@H]1C[C@@H](C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@H](C(=O)N[C@@H](Cc3c[nH]cn3)C(=O)N3CCC[C@H]3C(=O)N[C@@H](Cc3ccccc3)C(=O)O)CSS2)N(C(=O)[C@H](CCCN=C(N)N)NC(=O)CNC)C1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"3.73";"None";"None";"None";"0";"CHEMBL647843";"In vitro binding affinity at angiotensin II (type 2) receptor in rabbit uterus.";"B";"BAO_0000357";"single protein format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126724";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL406290";"";"None";"1034.24";"None";"None";"2";"CNCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H]1CCSS[C@H]2C[C@@H](C(=O)N[C@@H](Cc3c[nH]cn3)C(=O)N3CCC[C@H]3C(=O)N[C@@H](Cc3ccccc3)C(=O)O)N(C2)C(=O)[C@H](Cc2ccc(O)cc2)NC1=O";"IC50";"'='";"9.1";"nM";"8.04";"";"";"UO_0000065";"7.77";"None";"None";"None";"0";"CHEMBL647843";"In vitro binding affinity at angiotensin II (type 2) receptor in rabbit uterus.";"B";"BAO_0000357";"single protein format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126724";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL263452";"";"None";"683.81";"2";"6.37";"13";"CCc1ccc(C(=O)NS(=O)(=O)c2ccccc2-c2ccc(Cn3c(CC)nc4ccc(NC(=O)N(C)C(C)C)cc4c3=O)c(F)c2)cc1";"IC50";"'='";"8.9";"nM";"8.05";"";"";"UO_0000065";"11.77";"0.22";"1.68";"6.17";"0";"CHEMBL643789";"In vivo inhibitory concentration against AT2 receptor of human adrenal membrane";"B";"BAO_0000218";"organism-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150477";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL440063";"";"None";"1988.34";"None";"None";"0 (antiparallel)";"CNCC(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@@H]1CSSC[C@H](C(=O)N[C@H](Cc2c[nH]cn2)C(=O)N2CCC[C@@H]2C(=O)N[C@H](Cc2ccccc2)C(=O)O)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](NC(=O)[C@@H](CCCN=C(N)N)NC(=O)CNC)CSSC[C@H](C(=O)N[C@H](Cc2c[nH]cn2)C(=O)N2CCC[C@@H]2C(=O)N[C@H](Cc2ccccc2)C(=O)O)NC(=O)[C@@H](Cc2ccc(O)cc2)NC1=O";"IC50";"'='";"65.0";"nM";"7.19";"";"";"UO_0000065";"3.61";"None";"None";"None";"0";"CHEMBL647843";"In vitro binding affinity at angiotensin II (type 2) receptor in rabbit uterus.";"B";"BAO_0000357";"single protein format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126724";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL311484";"";"None";"645.69";"2";"5.21";"15";"CCNC(=O)Nc1ccc2nc(CC)n(Cc3ccc(-c4ccccc4S(=O)(=O)NC(=O)c4ccccc4F)cc3F)c(=O)c2c1";"IC50";"'='";"65.0";"nM";"7.19";"";"";"UO_0000065";"11.13";"0.21";"1.98";"5.16";"0";"CHEMBL643789";"In vivo inhibitory concentration against AT2 receptor of human adrenal membrane";"B";"BAO_0000218";"organism-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150477";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL70793";"";"None";"725.88";"2";"8.74";"34";"CCCc1nc(CC)c(C(=O)OCc2ccccc2-c2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"11.08";"0.21";"-0.69";"6.90";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL305369";"";"None";"701.83";"2";"8.63";"9";"CCCc1nc(CC)c(C(=O)OCc2cccc(C(=O)N(c3ccccc3)c3ccccc3)c2)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"9.29";"0.17";"-2.11";"5.49";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL964";"DISULFIRAM";"4.0";"296.55";"0";"3.62";"DISULFIRAM";"CCN(CC)C(=S)SSC(=S)N(CC)CC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1464";"WARFARIN";"4.0";"308.33";"0";"3.61";"WARFARIN";"CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201193";"LEVOBUPIVACAINE";"4.0";"288.44";"0";"3.90";"LEVOBUPIVACAINE";"CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL71172";"";"None";"739.87";"2";"8.06";"23";"CCCCOC(=O)NS(=O)(=O)c1ccccc1-c1ccc(Cn2c(CCC)nc(CC)c2C(=O)OCc2ccccc2C(=O)c2ccccc2)c(F)c1";"IC50";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"12.23";"0.23";"0.99";"6.77";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL75401";"";"None";"651.76";"2";"5.89";"20";"Cc1nc2ccc(NC(=O)N(C)C(C)C)cc2c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"12.5";"nM";"7.90";"";"";"UO_0000065";"12.13";"0.23";"2.01";"5.66";"0";"CHEMBL643789";"In vivo inhibitory concentration against AT2 receptor of human adrenal membrane";"B";"BAO_0000218";"organism-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150477";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL485549";"NIFURSOL";"2.0";"365.21";"0";"1.47";"NIFURSOL";"O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1503";"OMEPRAZOLE";"4.0";"345.42";"0";"2.90";"OMEPRAZOLE";"COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201151";"MESTRANOL";"4.0";"310.44";"0";"3.92";"MESTRANOL";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC)ccc4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1601669";"ALFACALCIDOL";"4.0";"400.65";"1";"6.59";"ALFACALCIDOL";"C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]23)C[C@@H](O)C[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL549";"CITALOPRAM";"4.0";"324.40";"0";"3.81";"CITALOPRAM";"CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL841";"LOPERAMIDE";"4.0";"477.05";"1";"5.09";"LOPERAMIDE";"CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1873703";"DIELDRIN";"2.0";"380.91";"0";"4.48";"DIELDRIN";"ClC1=C(Cl)[C@]2(Cl)[C@@H]3[C@@H]4C[C@@H]([C@H]5O[C@@H]45)[C@@H]3[C@@]1(Cl)C2(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL11359";"CISPLATIN";"4.0";"300.05";"None";"None";"CISPLATIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL516";"CYPROHEPTADINE";"4.0";"287.41";"0";"4.70";"CYPROHEPTADINE";"CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL196";"ASCORBIC ACID";"4.0";"176.12";"0";"-1.41";"ASCORBIC ACID";"O=C1O[C@H]([C@@H](O)CO)C(O)=C1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL728";"PROCHLORPERAZINE";"4.0";"373.95";"0";"4.58";"PROCHLORPERAZINE";"CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1630579";"MYRTECAINE";"2.0";"265.44";"0";"3.73";"MYRTECAINE";"CCN(CC)CCOCCC1=CCC2CC1C2(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL614";"PYRAZINAMIDE";"4.0";"123.11";"0";"-0.42";"PYRAZINAMIDE";"NC(=O)c1cnccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL191";"LOSARTAN";"4.0";"422.92";"0";"4.27";"Losartan";"CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL2439560";"Displacement of [125I]-Sar1Ile8-angiotensin 2 from angiotensin 2 AT2 receptor (unknown origin) after 180 mins by gamma counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2434924";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";""
"CHEMBL274447";"";"None";"398.89";"0";"4.78";"187";"CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2208700";"Antagonist activity at angiotensin 2 receptor";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203023";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL437";"SULFATHIAZOLE";"4.0";"255.32";"0";"1.53";"SULFATHIAZOLE";"Nc1ccc(S(=O)(=O)Nc2nccs2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2435819";"";"None";"540.66";"1";"4.77";"6g";"CCCc1nc2c(C)cc(C(=O)NCCN3CCOCC3)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2439560";"Displacement of [125I]-Sar1Ile8-angiotensin 2 from angiotensin 2 AT2 receptor (unknown origin) after 180 mins by gamma counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2434924";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";""
"CHEMBL302795";"TENOXICAM";"4.0";"337.38";"0";"1.64";"TENOXICAM";"CN1C(C(=O)Nc2ccccn2)=C(O)c2sccc2S1(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL715";"OLANZAPINE";"4.0";"312.44";"0";"3.44";"OLANZAPINE";"Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL559147";"Y-27632";"None";"247.34";"0";"2.17";"Y-27632";"C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL695";"TRIMETHADIONE";"4.0";"143.14";"0";"0.37";"TRIMETHADIONE";"CN1C(=O)OC(C)(C)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL80";"NALOXONE";"4.0";"327.38";"0";"1.30";"Naloxone";"C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL429023";"ROTENONE";"None";"394.42";"0";"3.70";"ROTENONE";"C=C(C)[C@H]1Cc2c(ccc3c2O[C@@H]2COc4cc(OC)c(OC)cc4[C@@H]2C3=O)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL65";"CAMPTOTHECIN";"-1.0";"348.36";"0";"2.08";"1, CPT";"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1255834";"BW-723C86";"None";"286.40";"0";"3.70";"BW-723C86";"CC(N)Cc1c[nH]c2ccc(OCc3cccs3)cc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL77675";"";"None";"211.27";"0";"3.15";"1,3-DIPHENYLGUANIDINE";"N=C(Nc1ccccc1)Nc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2435826";"";"None";"517.63";"2";"7.27";"11e";"CCCc1nc2c(C)cc(NC(=O)c3ccc(C)cc3)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2439560";"Displacement of [125I]-Sar1Ile8-angiotensin 2 from angiotensin 2 AT2 receptor (unknown origin) after 180 mins by gamma counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2434924";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";""
"CHEMBL2435818";"";"None";"531.66";"2";"6.68";"6f";"CCCc1nc2c(C)cc(C(=O)NCCc3ccccc3)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2439560";"Displacement of [125I]-Sar1Ile8-angiotensin 2 from angiotensin 2 AT2 receptor (unknown origin) after 180 mins by gamma counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2434924";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";""
"CHEMBL2435821";"";"None";"554.69";"2";"5.16";"6i";"CCCc1nc2c(C)cc(C(=O)NCCCN3CCOCC3)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"IC50";"'='";"718.0";"nM";"6.14";"";"";"UO_0000065";"11.08";"0.20";"0.98";"6.35";"0";"CHEMBL2439560";"Displacement of [125I]-Sar1Ile8-angiotensin 2 from angiotensin 2 AT2 receptor (unknown origin) after 180 mins by gamma counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2434924";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";""
"CHEMBL2435825";"";"None";"503.60";"2";"6.96";"11d";"CCCc1nc2c(C)cc(NC(=O)c3ccccc3)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"16.33";"0.30";"1.26";"9.76";"0";"CHEMBL2439560";"Displacement of [125I]-Sar1Ile8-angiotensin 2 from angiotensin 2 AT2 receptor (unknown origin) after 180 mins by gamma counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2434924";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";""
"CHEMBL81";"RALOXIFENE";"4.0";"473.59";"1";"6.08";"RALOXIFENE";"O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL417";"EPIRUBICIN";"4.0";"543.53";"3";"0.00";"EPIRUBICIN";"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL193482";"ESTRIOL";"4.0";"288.39";"0";"2.58";"ESTRIOL";"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909083";"ZIRCONIUM(IV) CHLORIDE";"None";"233.04";"None";"None";"ZIRCONIUM(IV) CHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1237174";"HYDRAZINE";"0.5";"32.05";"0";"-1.18";"HYDRAZINE";"NN";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1319362";"HOMATROPINE HYDROBROMIDE";"4.0";"356.26";"0";"1.89";"HOMATROPINE HYDROBROMIDE";"Br.CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(O)c1ccccc1)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL467";"HYDROXYUREA";"4.0";"76.05";"0";"-0.96";"Hydroxyurea";"NC(=O)NO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL93645";"ACECLOFENAC";"4.0";"354.19";"0";"3.91";"ACECLOFENAC";"O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL302102";"";"None";"611.75";"2";"7.08";"87";"CCCCCN(C(=O)c1ccccc1)c1ccc2nc(CCC)n(Cc3ccc(-c4ccccc4-c4nn[nH]n4)cc3)c(=O)c2c1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"14.97";"0.27";"2.07";"8.35";"0";"CHEMBL881769";"Inhibitory concentration against angiotensin II receptor, type 2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140446";"1";"Scientific Literature";"J Med Chem";"2005";"None";"";"";""
"CHEMBL190";"THEOPHYLLINE";"4.0";"180.17";"0";"-1.04";"THEOPHYLLINE";"Cn1c(=O)c2[nH]cnc2n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL159";"VINBLASTINE";"4.0";"810.99";"2";"3.99";"Vinblastine";"CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL153062";"4-NONYLPHENOL";"None";"220.36";"0";"4.69";"4-NONYLPHENOL";"CCCCCCCCCc1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1463";"FLUCYTOSINE";"4.0";"129.09";"0";"-0.51";"FLUCYTOSINE";"Nc1nc(=O)[nH]cc1F";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL509341";"";"None";"1453.65";"None";"None";"4";"CO/C(C)=C1/NC(=O)[C@H]([C@@H](C)O)NC(=O)c2csc(n2)-c2cc(O)c(-c3nc(C(=O)NCCCN(C)C)cs3)nc2-c2csc(n2)[C@@H]2COC(=O)c3c4c5c(cccc5n3O)COC(=O)[C@@H](O[C@H]3C[C@](C)(O)[C@H](N(C)C)[C@H](C)O3)[C@@H](OC4)[C@H](NC(=O)c3csc1n3)c1nc(cs1)C(=O)N2";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL996322";"Inhibition of AT2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136943";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL809";"SERTRALINE";"4.0";"306.24";"1";"5.18";"SERTRALINE";"CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1489254";"TRIACETIN";"2.0";"218.21";"0";"0.04";"TRIACETIN";"CC(=O)OCC(COC(C)=O)OC(C)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL698";"TETRACAINE";"4.0";"264.37";"0";"2.62";"TETRACAINE";"CCCCNc1ccc(C(=O)OCCN(C)C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL16";"PHENYTOIN";"4.0";"252.27";"0";"1.77";"PHENYTOIN";"O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1214185";"ROXITHROMYCIN";"4.0";"837.06";"2";"2.21";"ROXITHROMYCIN";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)/C(=N\OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL38";"TRETINOIN";"4.0";"300.44";"1";"5.60";"TRETINOIN";"CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL18797";"SULINDAC SULFIDE";"-1.0";"340.42";"1";"5.35";"SULINDAC SULFIDE";"CSc1ccc(/C=C2/C(C)=C(CC(=O)O)c3cc(F)ccc32)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL878";"METOLAZONE";"4.0";"365.84";"0";"2.71";"METOLAZONE";"Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL165572";"";"None";"530.49";"2";"5.91";"216";"O=S(=O)(Nc1ccccc1-c1ccc(CNc2nc(C(F)(F)F)nc3c2CCCC3)cc1)C(F)(F)F";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2208700";"Antagonist activity at angiotensin 2 receptor";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203023";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1068";"OXCARBAZEPINE";"4.0";"252.27";"0";"2.64";"OXCARBAZEPINE";"NC(=O)N1c2ccccc2CC(=O)c2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909072";"PIPAMAZINE";"4.0";"401.96";"0";"4.53";"PIPAMAZINE";"NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL461727";"AMYGDALIN";"None";"457.43";"2";"-3.11";"AMYGDALIN(D)";"N#C[C@H](O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL42710";"EUGENOL";"0.5";"164.20";"0";"2.13";"EUGENOL";"C=CCc1ccc(O)c(OC)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL95764";"GLYPHOSATE";"None";"169.07";"0";"-1.20";"GLYPHOSATE";"O=C(O)CNCP(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL191";"LOSARTAN";"4.0";"422.92";"0";"4.27";"Cozaar";"CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL3768051";"Binding affinity to type-2 angiotensin-2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763155";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL547";"ISOTRETINOIN";"4.0";"300.44";"1";"5.60";"ISOTRETINOIN";"CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1754";"DOXAPRAM";"4.0";"378.52";"0";"3.17";"DOXAPRAM";"CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL498";"CHLORPROPAMIDE";"4.0";"276.75";"0";"1.74";"CHLORPROPAMIDE";"CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL558551";"";"None";"258.23";"0";"0.09";"(+)-THALIDOMIDE";"O=C1CC[C@@H](N2C(=O)c3ccccc3C2=O)C(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL515914";"AZARIBINE";"4.0";"371.30";"1";"-1.74";"AZARIBINE";"CC(=O)OC[C@H]1O[C@@H](n2ncc(=O)[nH]c2=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL36994";"ANIRACETAM";"2.0";"219.24";"0";"1.46";"ANIRACETAM";"COc1ccc(C(=O)N2CCCC2=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL174";"AMPICILLIN";"4.0";"349.41";"0";"0.32";"SID482880";"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL307866";"";"None";"735.92";"2";"8.50";"42";"CCCc1nc(CC)c(C(=O)OCc2ccccc2OCCC(C)C)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"10.87";"0.21";"-0.50";"6.36";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL96314";"";"None";"729.20";"2";"7.97";"4g";"CCCCc1nn(-c2ccccc2C(F)(F)F)c(=O)n1Cc1ccc(-c2cc(CCC)ccc2S(=O)(=O)NC(=O)c2ccccc2Cl)cc1F";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"9.40";"0.19";"-1.12";"6.65";"0";"CHEMBL649910";"In vitro inhibitory concentration against AT2 receptor from human adrenal tissues.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128028";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL338434";"";"None";"747.81";"2";"7.59";"15";"CCCCC(=O)Nc1ccc(C(F)(F)F)c(-n2nc(CCCC)n(Cc3ccc(-c4ccccc4S(=O)(=O)NC(=O)OC(C)(C)C)cc3F)c2=O)c1";"IC50";"'='";"0.88";"nM";"9.06";"";"";"UO_0000065";"12.11";"0.24";"1.47";"6.40";"0";"CHEMBL648579";"In vitro inhibitory activity against Angiotensin II receptor, type 2 in human adrenal membrane preparations. For this assay, only 0.02%BSA was present in the assay mixture.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL1349";"VALACYCLOVIR";"4.0";"324.34";"0";"-0.80";"VALACYCLOVIR";"CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)nc(N)[nH]c21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL141";"LAMIVUDINE";"4.0";"229.26";"0";"-0.59";"LAMIVUDINE";"Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909065";"MADURAMICIN";"2.0";"917.14";"2";"4.32";"LYSERGOL";"CO[C@@H]1[C@@H](OC)[C@H](C)[C@@](O)(CC(=O)O)O[C@H]1[C@H](C)[C@H]1O[C@@]2(CC[C@@](C)([C@H]3CC[C@@](C)([C@@H]4O[C@@H]([C@H]5O[C@](C)(O)[C@H](C)C[C@@H]5C)C[C@@H]4O[C@@H]4C[C@H](OC)[C@@H](OC)[C@H](C)O4)O3)O2)C[C@H](O)[C@H]1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL86304";"MOCLOBEMIDE";"4.0";"268.74";"0";"1.40";"MOCLOBEMIDE";"O=C(NCCN1CCOCC1)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL408886";"";"None";"1034.24";"None";"None";"8";"CNCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N1C[C@@H]2C[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)CCSS2";"IC50";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"8.04";"None";"None";"None";"0";"CHEMBL647843";"In vitro binding affinity at angiotensin II (type 2) receptor in rabbit uterus.";"B";"BAO_0000357";"single protein format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126724";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL121872";"";"None";"744.68";"2";"6.35";"31";"CCCCNC(=O)c1ccc(Br)c(-n2nc(CCC)n(Cc3ccc(-c4ccccc4S(=O)(=O)NC(=O)OC(C)(C)C)cc3F)c2=O)c1";"IC50";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"11.55";"0.24";"2.25";"6.08";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL290286";"";"None";"447.53";"1";"5.52";"Du pont";"O=C(O)[C@@H]1Cc2cc(-c3ccccc3)ccc2CN1C(=O)C(c1ccccc1)c1ccccc1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"16.81";"0.30";"2.00";"13.06";"0";"CHEMBL647513";"In vitro binding affinity of compound was measured against angiotensin II (AT2) receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127913";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL127";"MEROPENEM";"4.0";"383.47";"0";"-0.31";"Meropenem";"C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL637";"VENLAFAXINE";"4.0";"277.41";"0";"3.04";"VENLAFAXINE";"COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL157101";"KETOCONAZOLE";"4.0";"531.44";"1";"4.21";"KETOCONAZOLE";"CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL429";"LABETALOL";"4.0";"328.41";"0";"2.14";"LABETALOL";"CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL157946";"";"None";"736.67";"1";"4.48";"PD-123319";"Cc1cc(Cn2cnc3c2C[C@@H](C(=O)O)N(C(=O)C(c2ccccc2)c2ccccc2)C3)ccc1N(C)C.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F";"IC50";"'='";"8.3";"nM";"8.08";"";"";"UO_0000065";"15.89";"0.29";"3.60";"10.27";"0";"CHEMBL643596";"The compound was evaluated for the inhibition of binding of [125I]-CGP 42112A to AT2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126478";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1993";"None";"";"";""
"CHEMBL414533";"";"None";"1020.21";"None";"None";"3";"CNCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H]1CSS[C@@H]2C[C@@H](C(=O)N[C@@H](Cc3c[nH]cn3)C(=O)N3CCC[C@H]3C(=O)N[C@@H](Cc3ccccc3)C(=O)O)N(C2)C(=O)[C@H](Cc2ccc(O)cc2)NC1=O";"IC50";"'='";"0.82";"nM";"9.09";"";"";"UO_0000065";"8.91";"None";"None";"None";"0";"CHEMBL647843";"In vitro binding affinity at angiotensin II (type 2) receptor in rabbit uterus.";"B";"BAO_0000357";"single protein format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126724";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL1411979";"METHAPYRILENE";"4.0";"261.39";"0";"2.71";"METHAPYRILENE";"CN(C)CCN(Cc1cccs1)c1ccccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4847398";"";"None";"1123.32";"None";"None";"9; SBL-AII-9";"CCCC[C@@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)N1Cc2[nH]c3ccccc3c2C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)[C@@H](C)CC)C1=O";"IC50";"'='";"70.29";"nM";"7.15";"";"";"UO_0000065";"6.37";"None";"None";"None";"0";"CHEMBL4812855";"Displacement of [125-I]-[Sar1, Ile8] from recombinant human AT2R transfected in human HEK293 cells incubated for 2 hrs by liquid scintillation counter analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811266";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"TIME = 2.0 hr";"BINDING AGENT";""
"CHEMBL502620";"ACLARUBICIN";"3.0";"811.88";"2";"3.16";"ACLARUBICIN";"CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(O)cccc2C3=O)[C@H]1C(=O)OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL504";"DIMETHYL SULFOXIDE";"4.0";"78.14";"0";"-0.01";"DIMETHYL SULFOXIDE";"C[S+](C)[O-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL30008";"FLUNARIZINE";"4.0";"404.50";"1";"5.39";"FLUNARIZINE";"Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL12131";"CLOSANTEL";"2.0";"663.08";"2";"7.12";"CLOSANTEL";"Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1123";"DICYCLOMINE";"4.0";"309.49";"0";"4.40";"DICYCLOMINE";"CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1598608";"AZASETRON";"2.0";"349.82";"0";"1.52";"AZASETRON";"CN1C(=O)COc2c(C(=O)NC3CN4CCC3CC4)cc(Cl)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL338027";"";"None";"730.66";"2";"6.56";"44";"CCCCC(=O)Nc1ccc(Br)c(-n2nc(CC)n(Cc3ccc(-c4ccccc4S(=O)(=O)NC(=O)OC(C)(C)C)cc3F)c2=O)c1";"IC50";"'='";"3.4";"nM";"8.47";"";"";"UO_0000065";"11.59";"0.25";"1.91";"5.99";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL277100";"TEMAFLOXACIN";"4.0";"417.39";"0";"2.90";"TEMAFLOXACIN";"CC1CN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)CCN1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL714";"ALBUTEROL";"4.0";"239.31";"0";"1.31";"SALBUTAMOL";"CC(C)(C)NCC(O)c1ccc(O)c(CO)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL309820";"";"None";"554.66";"1";"3.48";"12b";"CCCc1nc(CN2CCN(C(=O)C3CC3)CC2)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"6000.0";"nM";"5.22";"";"";"UO_0000065";"9.41";"0.17";"1.74";"3.92";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL427216";"GLICLAZIDE";"4.0";"323.42";"0";"1.63";"GLICLAZIDE";"Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL286134";"";"None";"543.69";"2";"5.72";"15";"CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)c2ccccc2)cc1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"12.87";"0.25";"1.28";"7.30";"0";"CHEMBL643597";"The compound was tested for the ability to displace 50% of totally specifically bound [125I]- Ang II from Angiotensin II receptor, type 2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153253";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL2391146";"ANGIOTENSIN";"3.0";"956.07";"3";"-2.72";"angiotensin";"CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(C)C";"IC50";"'='";"0.13";"nM";"9.89";"";"";"UO_0000065";"10.34";"0.20";"12.61";"2.43";"0";"CHEMBL2395772";"Binding affinity to human angiotensin AT2 receptor by radioligand displacement assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2390917";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";""
"CHEMBL325372";"METHYLPARABEN";"-1.0";"152.15";"0";"1.18";"METHYLPARABEN";"COC(=O)c1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL350875";"";"None";"522.60";"2";"5.33";"15";"COC(=O)C1Cc2c(ccc(OC)c2Oc2ccc(N)cc2)CN1C(=O)C(c1ccccc1)c1ccccc1";"IC50";"'='";"730.0";"nM";"6.14";"";"";"UO_0000065";"11.74";"0.21";"0.81";"6.74";"0";"CHEMBL643791";"Inhibitory activity against angiotensin II type 2 (AT2) receptor in rabbit uterine membranes.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127723";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL305238";"";"None";"706.84";"2";"6.90";"53";"CCCc1nc(CC)c(C(=O)OCCC(=O)Nc2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"12.06";"0.23";"1.62";"5.85";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL312301";"";"None";"789.95";"2";"7.90";"45";"CCCc1nc(CC)c(C(=O)OCc2ccccc2S(=O)(=O)c2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"10.51";"0.21";"0.40";"5.51";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL303427";"";"None";"792.97";"2";"8.56";"58";"CCCc1nc(CC)c(C(=O)OCCN(C(=O)OCCC(C)C)c2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"10.59";"0.20";"-0.16";"5.75";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL339256";"";"None";"758.19";"2";"7.37";"22";"CCCCc1nn(-c2cc(NC(=O)CC)ccc2C(F)(F)F)c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)c2ccccc2Cl)cc1F";"IC50";"'='";"3.5";"nM";"8.46";"";"";"UO_0000065";"11.15";"0.22";"1.09";"6.40";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL265790";"";"None";"934.22";"3";"5.84";"10";"Cc1cc(Cn2cnc3c2C[C@@H](C(=O)O)N(C(=O)C(c2ccccc2)c2ccccc2)C3)ccc1NCCCCCCNC(=O)[C@@H](N)CCCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"8.73";"0.17";"2.31";"3.83";"0";"CHEMBL643596";"The compound was evaluated for the inhibition of binding of [125I]-CGP 42112A to AT2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126478";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1993";"None";"";"";""
"CHEMBL340473";"";"None";"724.21";"2";"6.94";"9";"CCCCc1nn(-c2cc(NC(=O)c3ccco3)ccc2Cl)c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OC(C)(C)C)cc1F";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"10.63";"0.21";"0.76";"4.98";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL267354";"";"None";"1051.22";"None";"None";"CGP-42112A";"CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCNC(=O)[C@H](CCCN=C(N)N)NC(=O)OCc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1ccccc1)C(=O)O";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"7.53";"None";"None";"None";"0";"CHEMBL643595";"Inhibition of Angiotensin II receptor, type 2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129469";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL74476";"";"None";"661.82";"2";"6.54";"L-162393";"CCCCOC(=O)NS(=O)(=O)c1ccccc1-c1ccc(Cn2c(CCCC)nc3ccc(NC(=O)N(C)C(C)C)cc3c2=O)cc1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"10.91";"0.21";"0.68";"5.17";"0";"CHEMBL643789";"In vivo inhibitory concentration against AT2 receptor of human adrenal membrane";"B";"BAO_0000218";"organism-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150477";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL71286";"";"None";"703.86";"2";"8.16";"31";"CCCOC(=O)NS(=O)(=O)c1ccccc1-c1ccc(Cn2c(CCC)nc(CC)c2C(=O)OCc2ccccc2-c2ccsc2)c(F)c1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"10.94";"0.21";"-0.46";"6.60";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL409170";"";"None";"642.78";"1";"4.18";"18a";"CCCc1nc(CN2CCN(c3ccccn3)CC2)c(C(=O)O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)C2CC2)cc1";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"9.68";"0.18";"2.04";"4.52";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL923";"RISEDRONIC ACID";"4.0";"283.11";"0";"-0.37";"RISEDRONIC ACID";"O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL74236";"";"None";"731.91";"2";"8.80";"30";"CCCc1nc(CC)c(C(=O)OCc2ccccc2-c2ccsc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"10.52";"0.21";"-1.10";"6.60";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL959";"RIMANTADINE";"4.0";"179.31";"0";"2.55";"RIMANTADINE";"CC(N)C12CC3CC(CC(C3)C1)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL852";"MELPHALAN";"4.0";"305.21";"0";"1.93";"MELPHALAN";"N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL154";"NAPROXEN";"4.0";"230.26";"0";"3.04";"NAPROXEN";"COc1ccc2cc([C@H](C)C(=O)O)ccc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL307008";"";"None";"703.86";"2";"8.16";"29";"CCCOC(=O)NS(=O)(=O)c1ccccc1-c1ccc(Cn2c(CCC)nc(CC)c2C(=O)OCc2ccccc2-c2cccs2)c(F)c1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"12.11";"0.24";"0.36";"7.31";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL74113";"";"None";"625.73";"2";"6.20";"10f";"CCCc1nc(CN(Cc2ccccc2)C(=O)Cc2ccccc2)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"10.22";"0.19";"0.20";"4.93";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL384352";"";"None";"1034.24";"None";"None";"10";"CNCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N1C[C@H]2C[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)CCSS2";"IC50";"'='";"0.47";"nM";"9.33";"";"";"UO_0000065";"9.02";"None";"None";"None";"0";"CHEMBL647843";"In vitro binding affinity at angiotensin II (type 2) receptor in rabbit uterus.";"B";"BAO_0000357";"single protein format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126724";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL417584";"";"None";"980.14";"3";"-2.47";"c[Sar1,Cys3,5]";"NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H]1CSSC[C@H](C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N2CCC[C@@H]2C(=O)N[C@@H](Cc2ccccc2)C(=O)O)NC(=O)[C@@H](Cc2ccc(O)cc2)NC1=O";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"7.72";"0.15";"10.04";"2.04";"0";"CHEMBL647843";"In vitro binding affinity at angiotensin II (type 2) receptor in rabbit uterus.";"B";"BAO_0000357";"single protein format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126724";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL263714";"";"None";"600.78";"2";"6.20";"7";"CCCc1ccc2c(c1)-c1ccc(cc1)Cn1c(CCC)nc3ccc(cc3c1=O)NCCCCCCC(=O)NS2(=O)=O";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"12.68";"0.24";"1.42";"6.92";"0";"CHEMBL643595";"Inhibition of Angiotensin II receptor, type 2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129469";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL2435828";"";"None";"531.66";"2";"7.28";"11g";"CCCc1nc2c(C)cc(NC(=O)CCc3ccccc3)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"IC50";"'='";"149.0";"nM";"6.83";"";"";"UO_0000065";"12.84";"0.23";"-0.45";"8.11";"0";"CHEMBL2439560";"Displacement of [125I]-Sar1Ile8-angiotensin 2 from angiotensin 2 AT2 receptor (unknown origin) after 180 mins by gamma counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2434924";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";""
"CHEMBL423236";"";"None";"535.64";"2";"5.92";"13";"CCOC(=O)C1Cc2c(ccc(OC)c2OCc2ccccc2)CN1C(=O)C(c1ccccc1)c1ccccc1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"12.74";"0.23";"0.90";"10.49";"0";"CHEMBL643791";"Inhibitory activity against angiotensin II type 2 (AT2) receptor in rabbit uterine membranes.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127723";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL1065";"METHYSERGIDE";"None";"353.47";"0";"1.94";"METHYSERGIDE";"CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1077";"BROMFENAC";"4.0";"334.17";"0";"2.89";"bromfenac";"Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909079";"STANNOUS FLUORIDE";"4.0";"156.71";"None";"None";"STANNOUS FLUORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL27577";"SALICYLAMIDE";"2.0";"137.14";"0";"0.49";"SALICYLAMIDE";"NC(=O)c1ccccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL521606";"NADOLOL";"4.0";"309.41";"0";"0.63";"NADOLOL";"CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL43882";"TRICHLOROETHANE";"None";"133.41";"0";"2.03";"TRICHLOROETHANE";"ClCC(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL561";"LOMEFLOXACIN";"4.0";"351.35";"0";"1.80";"LOMEFLOXACIN";"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL54126";"NEOSTIGMINE BROMIDE";"4.0";"303.20";"0";"1.94";"NEOSTIGMINE BROMIDE";"CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL63998";"";"None";"530.67";"1";"4.37";"S0029";"CCCNC(=O)NS(=O)(=O)c1ccccc1-c1ccc(Cn2c(CCC)nc(SC)c2C(=O)O)cc1";"IC50";"'='";"775.0";"nM";"6.11";"";"";"UO_0000065";"11.52";"0.23";"1.74";"4.69";"0";"CHEMBL643595";"Inhibition of Angiotensin II receptor, type 2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129469";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL1628227";"DOXEPIN";"4.0";"279.38";"0";"3.96";"DOXEPIN";"CN(C)CCC=C1c2ccccc2COc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL71";"CHLORPROMAZINE";"4.0";"318.87";"0";"4.89";"Chloropromazine";"CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL165790";"IPRIFLAVONE";"2.0";"280.32";"0";"4.25";"IPRIFLAVONE";"CC(C)Oc1ccc2c(=O)c(-c3ccccc3)coc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL115";"INDINAVIR";"4.0";"613.80";"1";"2.87";"INDINAVIR";"CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1945006";"";"None";"577.68";"2";"6.66";"6e";"CCCc1nc2c(C)cc(C(=O)NCc3ccc(OC)c(OC)c3)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1949357";"Displacement of [125I]Sar1 Ile8-Ang 2 from angiotensin 2 AT2 receptor after 180 mins by gamma counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944634";"1";"Scientific Literature";"Eur J Med Chem";"2012";"None";"";"";""
"CHEMBL1945009";"";"None";"591.71";"2";"6.70";"6h";"CCCc1nc2c(C)cc(C(=O)NCCc3ccc(OC)c(OC)c3)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"10.01";"0.18";"-0.78";"5.77";"0";"CHEMBL1949357";"Displacement of [125I]Sar1 Ile8-Ang 2 from angiotensin 2 AT2 receptor after 180 mins by gamma counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944634";"1";"Scientific Literature";"Eur J Med Chem";"2012";"None";"";"";""
"CHEMBL1945149";"";"None";"549.65";"2";"6.82";"6k";"CCCc1nc2c(C)cc(C(=O)NCCc3ccc(F)cc3)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"10.71";"0.20";"-0.93";"6.99";"0";"CHEMBL1949357";"Displacement of [125I]Sar1 Ile8-Ang 2 from angiotensin 2 AT2 receptor after 180 mins by gamma counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944634";"1";"Scientific Literature";"Eur J Med Chem";"2012";"None";"";"";""
"CHEMBL938";"SARALASIN";"4.0";"912.06";"3";"-2.30";"Saralasin";"CNCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C";"IC50";"'='";"0.45";"nM";"9.35";"";"";"UO_0000065";"10.25";"0.20";"11.65";"2.63";"0";"CHEMBL953127";"Displacement of radiolabeled saralasin from human AT2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140203";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";""
"CHEMBL334255";"CETYLPYRIDINIUM BROMIDE";"None";"384.45";"1";"6.46";"CETYLPYRIDINIUM BROMIDE";"CCCCCCCCCCCCCCCC[n+]1ccccc1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1105";"6-METHOXY-2-NAPHTHYLACETIC ACID";"-1.0";"216.24";"0";"2.48";"6-METHOXY-2-NAPHTHYLACETIC ACID";"COc1ccc2cc(CC(=O)O)ccc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL90555";"VINCRISTINE";"4.0";"824.97";"2";"3.52";"VINCRISTINE";"CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL5315124";"LEVOFLOXACIN";"4.0";"740.76";"0";"1.54";"LEVOFLOXACIN";"C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL48449";"CANTHARIDIN";"4.0";"196.20";"0";"0.64";"CANTHARIDIN";"C[C@@]12C(=O)OC(=O)[C@]1(C)[C@H]1CC[C@@H]2O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL408";"TROGLITAZONE";"4.0";"441.55";"0";"4.37";"TROGLITAZONE";"Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL333224";"";"None";"716.63";"2";"6.30";"49";"CCCCC(=O)Nc1ccc(Br)c(-n2nc(C)n(Cc3ccc(-c4ccccc4S(=O)(=O)NC(=O)OC(C)(C)C)cc3F)c2=O)c1";"IC50";"'='";"2.1";"nM";"8.68";"";"";"UO_0000065";"12.11";"0.26";"2.38";"6.14";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL227934";"STRYCHNINE";"-1.0";"334.42";"0";"2.09";"STRYCHNINE";"O=C1C[C@@H]2OCC=C3CN4CC[C@]56c7ccccc7N1[C@H]5[C@H]2[C@H]3C[C@H]46";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL267744";"TICRYNAFEN";"4.0";"331.18";"0";"3.75";"TICRYNAFEN";"O=C(O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1947129";"";"None";"547.66";"2";"6.65";"6b";"CCCc1nc2c(C)cc(C(=O)NCc3ccccc3OC)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"10.88";"0.20";"-0.69";"6.38";"0";"CHEMBL1949357";"Displacement of [125I]Sar1 Ile8-Ang 2 from angiotensin 2 AT2 receptor after 180 mins by gamma counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944634";"1";"Scientific Literature";"Eur J Med Chem";"2012";"None";"";"";""
"CHEMBL41194";"PRATOSARTAN";"2.0";"426.52";"0";"4.64";"11c";"CCCc1nc2c(n1Cc1ccc(-c3ccccc3-c3nnn[nH]3)cc1)C(=O)CCCC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL648576";"Inhibitory concentration of compound to AT2 receptor of bovine cerebellum";"B";"BAO_0000221";"tissue-based format";"Bos taurus";"CHEMBL3638233";"Cerebellum";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149995";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1993";"None";"";"";""
"CHEMBL316021";"";"None";"636.80";"2";"5.14";"11b";"CCCCc1nc(SC)c(C(C)(O)C(=O)O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1";"IC50";"'='";"3.9";"nM";"8.41";"";"";"UO_0000065";"13.20";"0.26";"3.27";"5.58";"0";"CHEMBL643790";"In vitro binding affinity at Angiotensin II Type 2 receptor in rabbit uterus membrane by [125I]AII displacement.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"CHEMBL3638197";"Uterus";"None";"Membrane";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128070";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1995";"None";"";"";""
"CHEMBL81236";"";"None";"642.84";"2";"5.52";"11c";"CCCCc1nc(SC)c(C(C)(O)C(=O)O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)NCC2CCCCC2)cc1";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"13.57";"0.27";"3.20";"5.79";"0";"CHEMBL643790";"In vitro binding affinity at Angiotensin II Type 2 receptor in rabbit uterus membrane by [125I]AII displacement.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"CHEMBL3638197";"Uterus";"None";"Membrane";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128070";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1995";"None";"";"";""
"CHEMBL71220";"";"None";"753.89";"2";"8.30";"24";"CCCc1nc(CC)c(C(=O)OCc2cccc(C(=O)c3ccccc3)c2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"12.00";"0.23";"0.75";"6.77";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL408403";"ANGIOTENSIN II";"4.0";"1046.20";"None";"None";"AII";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O";"IC50";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"8.22";"None";"None";"None";"0";"CHEMBL647843";"In vitro binding affinity at angiotensin II (type 2) receptor in rabbit uterus.";"B";"BAO_0000357";"single protein format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126724";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL264450";"";"None";"1022.22";"None";"None";"c[Sar1,Hcy3,5]";"CNCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H]1CCSSCC[C@H](C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N2CCC[C@@H]2C(=O)N[C@@H](Cc2ccccc2)C(=O)O)NC(=O)[C@@H](Cc2ccc(O)cc2)NC1=O";"IC50";"'='";"80.0";"nM";"7.10";"";"";"UO_0000065";"6.94";"None";"None";"None";"0";"CHEMBL647843";"In vitro binding affinity at angiotensin II (type 2) receptor in rabbit uterus.";"B";"BAO_0000357";"single protein format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126724";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL273992";"";"None";"607.72";"2";"6.22";"10d";"CCCc1nc(CN(Cc2ccccc2)C(=O)OCC(C)C)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"800.0";"nM";"6.10";"";"";"UO_0000065";"10.03";"0.19";"-0.12";"4.38";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL89463";"";"None";"646.80";"2";"4.38";"28";"CCCCc1nc(SC)c(C(O)n2cnnn2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"12.52";"0.25";"3.72";"5.16";"0";"CHEMBL643790";"In vitro binding affinity at Angiotensin II Type 2 receptor in rabbit uterus membrane by [125I]AII displacement.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"CHEMBL3638197";"Uterus";"None";"Membrane";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128070";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1995";"None";"";"";""
"CHEMBL57";"NEVIRAPINE";"4.0";"266.30";"0";"2.65";"NEVIRAPINE";"Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL334300";"";"None";"668.22";"2";"6.31";"5a";"CCCCc1nn(-c2cc(NC(=O)CC)ccc2Cl)c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OC(C)(C)C)cc1";"IC50";"'='";"5.8";"nM";"8.24";"";"";"UO_0000065";"12.33";"0.24";"1.93";"5.83";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL1454";"LEVAMISOLE";"4.0";"204.30";"0";"2.15";"LEVAMISOLE";"c1ccc([C@H]2CN3CCSC3=N2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL306961";"";"None";"592.70";"1";"4.76";"12c";"CCCc1nc(CN2CCN(c3ccccc3OC)CC2)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"9.32";"0.17";"0.76";"4.41";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL506247";"TANNIC ACID";"4.0";"1701.21";"None";"None";"TANNIC ACID";"O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL685";"MEBENDAZOLE";"4.0";"295.30";"0";"2.97";"MEBENDAZOLE";"COC(=O)Nc1nc2cc(C(=O)c3ccccc3)ccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL421";"SULFASALAZINE";"4.0";"398.40";"0";"3.70";"SFZ";"O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL106";"FLUCONAZOLE";"4.0";"306.28";"0";"0.74";"FLUCONAZOLE";"OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL416";"METHOXSALEN";"4.0";"216.19";"0";"2.55";"METHOXSALEN";"COc1c2occc2cc2ccc(=O)oc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL980";"GUAIFENESIN";"4.0";"198.22";"0";"0.43";"GUAIFENESIN";"COc1ccccc1OCC(O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL833";"TICLOPIDINE";"4.0";"263.79";"0";"3.96";"TICLOPIDINE";"Clc1ccccc1CN1CCc2sccc2C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL248702";"DEXFENFLURAMINE";"4.0";"231.26";"0";"3.25";"DEXFENFLURAMINE";"CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909073";"PIPERILATE ETHOBROMIDE";"None";"448.40";"0";"3.49";"PIPERILATE ETHOBROMIDE";"CC[N+]1(CCOC(=O)C(O)(c2ccccc2)c2ccccc2)CCCCC1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL430792";"";"None";"720.86";"2";"7.29";"52";"CCCc1nc(CC)c(C(=O)OCCCC(=O)Nc2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"11.52";"0.22";"1.01";"5.70";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL70927";"DEFERIPRONE";"4.0";"139.15";"0";"0.40";"DEFERIPRONE";"Cc1c(O)c(=O)ccn1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3183075";"NIZATIDINE";"4.0";"331.47";"0";"1.32";"NIZATIDINE";"CNC(=C[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL406";"INDAPAMIDE";"4.0";"365.84";"0";"2.08";"INDAPAMIDE";"CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1487";"ATORVASTATIN";"4.0";"558.65";"2";"6.31";"ATORVASTATIN";"CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1069";"VALSARTAN";"4.0";"435.53";"0";"4.16";"VALSARTAN";"CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL711";"PHENINDIONE";"4.0";"222.24";"0";"2.85";"PHENINDIONE";"O=C1c2ccccc2C(=O)C1c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL422";"TRIFLUOPERAZINE";"4.0";"407.51";"0";"4.95";"TRIFLUOPERAZINE";"CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL585";"TRIAMTERENE";"4.0";"253.27";"0";"0.83";"TRIAMTERENE";"Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1172";"DESLORATADINE";"4.0";"310.83";"0";"4.02";"DESLORATADINE";"Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL339722";"";"None";"716.23";"2";"6.07";"10";"CCCCc1nn(-c2cc(NC(=O)COCC)ccc2Cl)c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OC(C)(C)C)cc1F";"IC50";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"12.01";"0.24";"2.53";"5.71";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL1371125";"BENZO[E]PYRENE";"None";"252.32";"1";"5.74";"BENZO[E]PYRENE";"c1ccc2c(c1)c1cccc3ccc4cccc2c4c31";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL514";"LOMUSTINE";"4.0";"233.70";"0";"2.25";"LOMUSTINE";"O=NN(CCCl)C(=O)NC1CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL308943";"";"None";"669.74";"2";"5.67";"10a";"CCCc1nc(CN(CC(=O)O)C(=O)C(c2ccccc2)c2ccccc2)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"7000.0";"nM";"5.16";"";"";"UO_0000065";"7.70";"0.14";"-0.52";"3.08";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL1087";"MEPIVACAINE";"4.0";"246.35";"0";"2.73";"MEPIVACAINE";"Cc1cccc(C)c1NC(=O)C1CCCCN1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL15245";"YOHIMBINE";"4.0";"354.45";"0";"2.65";"YOHIMBINE";"COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1070";"NABUMETONE";"4.0";"228.29";"0";"3.37";"NABUMETONE";"COc1ccc2cc(CCC(C)=O)ccc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL683";"CLOFIBRIC ACID";"2.0";"214.65";"0";"2.58";"CLOFIBRIC ACID";"CC(C)(Oc1ccc(Cl)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL156587";"";"None";"508.57";"2";"5.24";"9";"COc1ccc2c(c1Oc1ccc(N)cc1)CC(C(=O)O)N(C(=O)C(c1ccccc1)c1ccccc1)C2";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"14.55";"0.27";"2.16";"7.25";"0";"CHEMBL643791";"Inhibitory activity against angiotensin II type 2 (AT2) receptor in rabbit uterine membranes.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127723";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL1499";"CORTISONE";"3.0";"360.45";"0";"1.99";"CORTISONE";"C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL450895";"NYSTATIN";"4.0";"926.11";"3";"0.94";"Nystatin";"C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/CC/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL88";"CYCLOPHOSPHAMIDE ANHYDROUS";"4.0";"261.09";"0";"1.88";"CYCLOPHOSPHAMIDE";"O=P1(N(CCCl)CCCl)NCCCO1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL302964";"";"None";"707.87";"2";"7.73";"35";"CCCc1nc(CC)c(C(=O)OCCCCOc2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"12.29";"0.24";"0.97";"6.91";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL385433";"";"None";"1046.20";"None";"None";"Angiotensin-II";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O";"IC50";"'='";"0.08";"nM";"10.10";"";"";"UO_0000065";"9.65";"None";"None";"None";"0";"CHEMBL3779531";"Displacement of [125I]CGP42112A from human recombinant AT2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3774372";"1";"Scientific Literature";"Bioorg Med Chem";"2016";"CHEMBL3307715";"";"";""
"CHEMBL156324";"";"None";"356.38";"0";"2.47";"11";"COc1ccc2c(c1O)CC(C(=O)O)N(C(=O)N(C)c1ccccc1)C2";"IC50";"";"";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL643792";"Inhibitory activity against angiotensin II type 2 (AT2) receptor in rabbit uterine membranes at 10e-6 M; not active";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127723";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL73283";"";"None";"773.95";"2";"8.24";"44";"CCCc1nc(CC)c(C(=O)OCc2ccccc2[S+]([O-])c2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"11.24";"0.22";"0.46";"6.23";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL306922";"";"None";"607.72";"2";"6.37";"10c";"CCCc1nc(CN(Cc2ccccc2)C(=O)OC(C)(C)C)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"9.87";"0.18";"-0.37";"4.31";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL205596";"CHOLIC ACID";"4.0";"408.58";"0";"3.45";"CHOLIC ACID";"C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL428647";"PACLITAXEL";"4.0";"853.92";"2";"3.74";"SID418145";"CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3144487";"";"None";"1280.54";"None";"None";"AI";"CC[C@H](C)[C@H](NC(=O)[C@@H](NC[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)c1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)C(N)[C@H](CC(C)C)C(C)=O";"IC50";"'='";"116.0";"nM";"6.94";"";"";"UO_0000065";"5.42";"None";"None";"None";"0";"CHEMBL647843";"In vitro binding affinity at angiotensin II (type 2) receptor in rabbit uterus.";"B";"BAO_0000357";"single protein format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126724";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL1668008";"";"None";"474.95";"1";"5.19";"152-1";"CCCCc1nc(Cl)c2n1C(c1ccc(-c3ccccc3-c3nnn[nH]3)cc1)CC(C(=O)O)=C2";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"16.84";"0.32";"2.81";"7.30";"0";"CHEMBL1670671";"Binding affinity to angiotensin AT2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1667742";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL2435834";"";"None";"517.63";"2";"7.27";"6e";"CCCc1nc2c(C)cc(C(=O)Nc3ccc(C)cc3)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"IC50";"'='";"61.0";"nM";"7.21";"";"";"UO_0000065";"13.94";"0.25";"-0.06";"8.57";"0";"CHEMBL2439560";"Displacement of [125I]-Sar1Ile8-angiotensin 2 from angiotensin 2 AT2 receptor (unknown origin) after 180 mins by gamma counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2434924";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";""
"CHEMBL808";"ECONAZOLE";"4.0";"381.69";"1";"5.80";"ECONAZOLE";"Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909068";"";"None";"None";"None";"None";"MC 258717";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2392353";"ANGIOTENSIN-II";"None";"970.10";"3";"-2.33";"Angiotensin-II";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O";"IC50";"'='";"0.21";"nM";"9.68";"";"";"UO_0000065";"9.98";"0.19";"12.01";"2.38";"0";"CHEMBL2395706";"Binding affinity to human AT2 receptor by radioligand displacement assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2390830";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";""
"CHEMBL918";"PHENACEMIDE";"4.0";"178.19";"0";"0.42";"PHENACEMIDE";"NC(=O)NC(=O)Cc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL71639";"";"None";"709.91";"2";"8.05";"48";"CCCc1nc(CC)c(C(=O)OCCCSc2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"12.25";"0.24";"0.65";"7.46";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL311253";"";"None";"732.83";"2";"6.17";"38";"CCCc1nc(CC)c(C(=O)OCCN2C(=O)c3ccccc3C2=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"11.13";"0.21";"1.98";"5.30";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL70843";"";"None";"746.86";"2";"6.56";"39";"CCCc1nc(CC)c(C(=O)OCCCN2C(=O)c3ccccc3C2=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"11.41";"0.22";"1.96";"5.54";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL305239";"";"None";"695.87";"2";"8.09";"10";"CCCCN(Cc1ccccc1)C(=O)c1ccc(COC(=O)c2c(CC)nc(CCC)n2Cc2ccc(-c3ccccc3-c3nn[nH]n3)cc2)cc1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"9.63";"0.18";"-1.39";"5.63";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL940";"GABAPENTIN";"4.0";"171.24";"0";"1.37";"GABAPENTIN";"NCC1(CC(=O)O)CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL290214";"";"None";"640.81";"2";"7.14";"L-163491";"CCCCOC(=O)NS(=O)(=O)c1ccc(Cc2cccc(OC)c2)cc1-c1ccc(Cn2c(CC)nc3c(C)cc(C)nc32)cc1";"IC50";"'='";"101.0";"nM";"7.00";"";"";"UO_0000065";"10.92";"0.21";"-0.14";"6.22";"0";"CHEMBL643595";"Inhibition of Angiotensin II receptor, type 2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129469";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL444065";"";"None";"716.23";"2";"5.47";"12";"CCCCc1nn(-c2cc(C(=O)NCCOC)ccc2Cl)c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OC(C)(C)C)cc1F";"IC50";"'='";"4.1";"nM";"8.39";"";"";"UO_0000065";"11.71";"0.23";"2.92";"5.57";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL339113";"";"None";"719.76";"2";"6.81";"3b";"CCCCc1nn(-c2cc(NC(=O)CC)ccc2C(F)(F)F)c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OC(C)(C)C)cc1F";"IC50";"'='";"2.9";"nM";"8.54";"";"";"UO_0000065";"11.86";"0.23";"1.73";"6.04";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL541";"BENZOIC ACID";"4.0";"122.12";"0";"1.38";"Benzoic acid";"O=C(O)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL488025";"EXISULIND";"3.0";"372.42";"0";"4.03";"SULINDAC SULFONE";"CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc(S(C)(=O)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1167";"SPECTINOMYCIN";"4.0";"332.35";"0";"-2.93";"SPECTINOMYCIN";"CN[C@@H]1[C@H](O)[C@H](NC)[C@H]2O[C@@]3(O)C(=O)C[C@@H](C)O[C@H]3O[C@@H]2[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL571";"KETOPROFEN";"4.0";"254.29";"0";"3.11";"KETOPROFEN";"CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL155987";"";"None";"507.59";"2";"5.44";"12";"COc1cc2c(cc1OCc1ccccc1)CC(C(=O)O)N(C(=O)C(c1ccccc1)c1ccccc1)C2";"IC50";"'='";"59.0";"nM";"7.23";"";"";"UO_0000065";"14.24";"0.26";"1.79";"9.50";"0";"CHEMBL643791";"Inhibitory activity against angiotensin II type 2 (AT2) receptor in rabbit uterine membranes.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127723";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL154057";"";"None";"499.61";"1";"5.59";"18";"COc1ccc2c(c1OCc1ccccc1)CC(C(=O)O)N(C(=O)C(c1ccccc1)C1CCCC1)C2";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"17.93";"0.33";"3.37";"11.78";"0";"CHEMBL643791";"Inhibitory activity against angiotensin II type 2 (AT2) receptor in rabbit uterine membranes.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127723";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL156100";"";"None";"551.64";"2";"5.76";"7";"COc1ccc(COc2c(OC)ccc3c2CC(C(=O)O)N(C(=O)C(c2ccccc2)c2ccccc2)C3)cc1C";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"15.81";"0.29";"2.96";"10.22";"0";"CHEMBL643791";"Inhibitory activity against angiotensin II type 2 (AT2) receptor in rabbit uterine membranes.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127723";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL309165";"";"None";"564.65";"1";"3.54";"12i";"CCCc1nc(CN2CCN(c3ncccn3)CC2)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"80.0";"nM";"7.10";"";"";"UO_0000065";"12.57";"0.23";"3.56";"5.00";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL73369";"";"None";"649.76";"2";"6.82";"4";"CCCc1nc(CC)c(C(=O)OCC#CC(=O)N(c2ccccc2)c2ccccc2)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"9.58";"0.17";"-0.60";"5.23";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL71125";"";"None";"787.91";"2";"8.50";"19";"CCCc1nc(CC)c(C(=O)OCc2ccccc2C(=O)c2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCc2ccccc2)cc1F";"IC50";"'='";"0.69";"nM";"9.16";"";"";"UO_0000065";"11.63";"0.22";"0.66";"6.85";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL1909069";"";"None";"None";"None";"None";"MC 288769";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1431";"METFORMIN";"4.0";"129.17";"0";"-1.03";"METFORMIN";"CN(C)C(=N)NC(=N)N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL115021";"";"None";"416.49";"0";"3.99";"DMP-811";"CCCc1nc(CC)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL71069";"";"None";"722.86";"2";"7.16";"17a";"CCCc1nc(CN(Cc2ccccc2)C(=O)c2ccccc2)c(C(=O)O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCC(C)C)cc1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"9.68";"0.18";"-0.16";"4.73";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL308482";"";"None";"707.86";"2";"8.00";"41";"CCCCCCCOC(=O)NS(=O)(=O)c1ccccc1-c1ccc(Cn2c(CCC)nc(CC)c2C(=O)OCc2ccccc2OC)c(F)c1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"11.30";"0.22";"0.00";"6.36";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL452861";"(-)-PROPANOLOL ";"2.0";"259.35";"0";"2.58";"S-(-)-PROPRANOLOL";"CC(C)NC[C@H](O)COc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL897";"PROBENECID";"4.0";"285.37";"0";"2.20";"214";"CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL311350";"PIROMIDIC ACID";"2.0";"288.31";"0";"1.11";"PIROMIDIC ACID";"CCn1cc(C(=O)O)c(=O)c2cnc(N3CCCC3)nc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL898";"DIFLUNISAL";"4.0";"250.20";"0";"3.04";"DIFLUNISAL";"O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL309790";"";"None";"733.90";"2";"8.30";"26";"CCCc1nc(CC)c(C(=O)OCc2ccccc2C(=O)C(C)(C)C)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"11.61";"0.22";"0.22";"6.38";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL15511";"ENROFLOXACIN";"2.0";"359.40";"0";"2.32";"ENROFLOXACIN";"CCN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL73876";"";"None";"663.77";"2";"5.90";"9, (L-163579)";"CCc1nc2ccc(NC(=O)N(C)C(C)C)cc2c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC2CC2)cc1F";"IC50";"'='";"6.2";"nM";"8.21";"";"";"UO_0000065";"12.37";"0.24";"2.31";"5.88";"0";"CHEMBL643789";"In vivo inhibitory concentration against AT2 receptor of human adrenal membrane";"B";"BAO_0000218";"organism-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150477";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL787";"MONTELUKAST";"4.0";"586.20";"2";"8.95";"MONTELUKAST";"CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL101";"PHENYLBUTAZONE";"4.0";"308.38";"0";"3.79";"PHENYLBUTAZONE";"CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL702";"PIPERACILLIN";"4.0";"517.56";"1";"-0.24";"PIPERACILLIN";"CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3[C@@H]2SC(C)(C)[C@@H]3C(=O)O)c2ccccc2)C(=O)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL12089";"BERBERINE CHLORIDE";"1.0";"371.82";"0";"3.10";"BERBERINE CHLORIDE";"COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL29";"BENZYLPENICILLIN";"4.0";"334.40";"0";"0.86";"PENICILLIN G";"CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909067";"";"None";"None";"None";"None";"MC 258714";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201216";"DAPIPRAZOLE";"4.0";"325.46";"0";"2.29";"DAPIPRAZOLE";"Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL564";"PROMAZINE";"4.0";"284.43";"0";"4.24";"PROMAZINE";"CN(C)CCCN1c2ccccc2Sc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1592";"QUINAPRIL";"4.0";"438.52";"0";"2.57";"QUINAPRIL";"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201024";"METHSCOPOLAMINE BROMIDE";"None";"398.30";"0";"1.06";"METHSCOPOLAMINE BROMIDE";"C[N+]1(C)[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@H]1O[C@H]12.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL635";"PREDNISONE";"4.0";"358.43";"0";"1.77";"PREDNISONE";"C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL460291";"LACIDIPINE";"4.0";"455.55";"0";"4.40";"LACIDIPINE";"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1/C=C/C(=O)OC(C)(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL305956";"";"None";"621.69";"1";"4.87";"21";"Cc1nc2ccc(NC(=O)N(C)C)cc2c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC2CC2)cc1F";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"12.74";"0.25";"3.05";"5.67";"0";"CHEMBL643789";"In vivo inhibitory concentration against AT2 receptor of human adrenal membrane";"B";"BAO_0000218";"organism-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150477";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL1200709";"CROTAMITON";"4.0";"203.28";"0";"2.92";"CROTAMITON";"C/C=C/C(=O)N(CC)c1ccccc1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL567";"PERPHENAZINE";"4.0";"403.98";"0";"3.94";"PERPHENAZINE";"OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL43064";"CINNARIZINE";"4.0";"368.52";"1";"5.11";"CINNARIZINE";"C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL428";"TROVAFLOXACIN";"4.0";"416.36";"0";"1.89";"TROVAFLOXACIN";"N[C@@H]1[C@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL288705";"";"None";"401.47";"0";"4.89";"13";"CCCCc1nc2ccnc(O)c2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"19.18";"0.35";"2.81";"8.73";"0";"CHEMBL650859";"Inhibition of Angiotensin II induced contractions in rabbit aortic rings";"B";"BAO_0000221";"tissue-based format";"Oryctolagus cuniculus";"CHEMBL3638186";"Aorta";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127527";"1";"Scientific Literature";"J Med Chem";"1994";"None";"";"";""
"CHEMBL421478";"";"None";"699.24";"2";"7.47";"14";"CCCCC(=O)c1ccc(Cl)c(-n2nc(CCCC)n(Cc3ccc(-c4ccccc4S(=O)(=O)NC(=O)OC(C)(C)C)cc3F)c2=O)c1";"IC50";"'='";"7.5";"nM";"8.12";"";"";"UO_0000065";"11.62";"0.23";"0.65";"6.28";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL294512";"";"None";"573.69";"2";"5.50";"EXP-408";"CCCc1nc(CC)c(C(=O)OC)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"15.69";"0.31";"3.50";"7.72";"0";"CHEMBL643595";"Inhibition of Angiotensin II receptor, type 2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129469";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL268291";"DIMETHYLFORMAMIDE";"None";"73.10";"0";"-0.30";"N,N-DIMETHYLFORMAMIDE";"CN(C)C=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL341369";"";"None";"744.68";"2";"6.95";"30";"CCCCC(=O)Nc1ccc(Br)c(-n2nc(CCC)n(Cc3ccc(-c4ccccc4S(=O)(=O)NC(=O)OC(C)(C)C)cc3F)c2=O)c1";"IC50";"'='";"2.2";"nM";"8.66";"";"";"UO_0000065";"11.63";"0.25";"1.71";"6.12";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL121907";"";"None";"733.78";"2";"6.60";"35";"CCCCNC(=O)c1ccc(C(F)(F)F)c(-n2nc(CCC)n(Cc3ccc(-c4ccccc4S(=O)(=O)NC(=O)OC(C)(C)C)cc3F)c2=O)c1";"IC50";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"11.70";"0.23";"1.99";"6.07";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL995";"LOSARTAN POTASSIUM";"4.0";"461.01";"0";"4.27";"1 Losartan DuP-753";"CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[n-]2)cc1.[K+]";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"11.82";"0.23";"0.73";"5.40";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL372814";"";"None";"680.87";"2";"7.29";"89";"CCCc1cc(Cn2c(CC)nc3c(C)cc(C)nc32)ccc1OC(C(=O)NS(=O)(=O)c1ccc(C(C)C)cc1)c1ccc2c(c1)OCC2";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"11.01";"0.21";"0.20";"6.67";"0";"CHEMBL881769";"Inhibitory concentration against angiotensin II receptor, type 2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140446";"1";"Scientific Literature";"J Med Chem";"2005";"None";"";"";""
"CHEMBL517712";"ATROPINE";"4.0";"289.38";"0";"1.93";"ATROPINE";"CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201346";"BALSALAZIDE";"4.0";"357.32";"0";"2.71";"BALSALAZIDE";"O=C(O)CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)O)c2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL407";"FLUMAZENIL";"4.0";"303.29";"0";"1.77";"FLUMAZENIL";"CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL632";"BETAMETHASONE";"4.0";"392.47";"0";"1.90";"BETAMETHASONE";"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1282";"IMIQUIMOD";"4.0";"240.31";"0";"2.82";"IMIQUIMOD";"CC(C)Cn1cnc2c(N)nc3ccccc3c21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1455";"ALTRETAMINE";"4.0";"210.28";"0";"0.07";"ALTRETAMINE";"CN(C)c1nc(N(C)C)nc(N(C)C)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909049";"";"None";"309.41";"0";"3.79";"1-(2-METHOXYBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE";"COc1ccccc1C(=O)N1CCC(Cc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1230333";"";"None";"170.23";"0";"2.16";"4-(2-THIENYL)BUTYRIC ACID";"O=C(O)CCCc1cccs1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL157510";"";"None";"545.68";"2";"5.44";"PD-126055";"COc1ccc2c(c1OCc1ccccc1)C[C@@H](C(=O)[O-])N(C(=O)C(c1ccccc1)c1ccccc1)C2.[K+]";"IC50";"'='";"0.58";"nM";"9.24";"";"";"UO_0000065";"18.20";"0.33";"3.80";"12.14";"0";"CHEMBL643791";"Inhibitory activity against angiotensin II type 2 (AT2) receptor in rabbit uterine membranes.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127723";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL1108";"DROPERIDOL";"4.0";"379.44";"0";"3.68";"DROPERIDOL";"O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200633";"IVERMECTIN";"4.0";"1736.18";"None";"None";"IVERMECTIN";"CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1513";"IRBESARTAN";"4.0";"428.54";"0";"4.78";"IRBESARTAN";"CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL80370";"";"None";"582.79";"1";"4.76";"HR-720";"CCCCc1nc(SC)c(C(=O)[O-])n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)NCCC)cc1.[K+]";"IC50";"'='";"920.0";"nM";"6.04";"";"";"UO_0000065";"11.08";"0.22";"1.28";"4.63";"0";"CHEMBL643790";"In vitro binding affinity at Angiotensin II Type 2 receptor in rabbit uterus membrane by [125I]AII displacement.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"CHEMBL3638197";"Uterus";"None";"Membrane";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128070";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1995";"None";"";"";""
"CHEMBL315275";"";"None";"588.75";"1";"4.35";"11a";"CCCCc1nc(SC)c(C(C)(O)C(=O)O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)NCCC)cc1";"IC50";"'='";"8.2";"nM";"8.09";"";"";"UO_0000065";"13.73";"0.28";"3.74";"5.37";"0";"CHEMBL643790";"In vitro binding affinity at Angiotensin II Type 2 receptor in rabbit uterus membrane by [125I]AII displacement.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"CHEMBL3638197";"Uterus";"None";"Membrane";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128070";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1995";"None";"";"";""
"CHEMBL435";"HYDROCHLOROTHIAZIDE";"4.0";"297.75";"0";"-0.35";"HYDROCHLOROTHIAZIDE";"NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL954";"ENCLOMIPHENE";"3.0";"405.97";"1";"6.56";"CLOMIPHENE";"CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL741";"LAMOTRIGINE";"4.0";"256.10";"0";"2.01";"LAMOTRIGINE";"Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL499815";"ATRACTYLOSIDE";"None";"803.00";"2";"1.67";"ATRACTYLOSIDE";"C=C1[C@@H]2CCC3[C@@](CC[C@@H]4[C@H](C(=O)O)C[C@@H](O[C@@H]5O[C@H](CO)[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]5OC(=O)CC(C)C)C[C@@]34C)(C2)[C@@H]1O.[K+].[K+]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL567597";"ARTEMISININ";"4.0";"282.34";"0";"2.39";"Artemisinin";"C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@]32OO4";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL938";"SARALASIN";"4.0";"912.06";"3";"-2.30";"Saralasin";"CNCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C";"IC50";"'='";"0.53";"nM";"9.28";"";"";"UO_0000065";"10.17";"0.19";"11.58";"2.61";"0";"CHEMBL1663579";"Inhibition of human angiotensin II AT2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1649335";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL553025";"VINORELBINE";"4.0";"778.95";"2";"4.75";"VINORELBINE";"CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1687";"TUBOCURARINE CHLORIDE";"None";"645.20";"2";"6.70";"D-TUBOCURARINE CHLORIDE";"COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3N(C)CC2)CC[N+]1(C)C.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL500";"PINDOLOL";"4.0";"248.33";"0";"1.91";"PINDOLOL";"CC(C)NCC(O)COc1cccc2[nH]ccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL24";"ATENOLOL";"4.0";"266.34";"0";"0.45";"ATENOLOL";"CC(C)NCC(O)COc1ccc(CC(N)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1697694";"AFLATOXIN";"None";"312.28";"0";"2.28";"AFLATOXIN B1";"COc1cc2c(c3oc(=O)c4c(c13)CCC4=O)[C@@H]1C=CO[C@@H]1O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1567463";"CHOLINE ALFOSCERATE";"None";"257.22";"0";"-1.45";"CHOLINE ALFOSCERATE";"C[N+](C)(C)CCOP(=O)([O-])OC[C@H](O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL306043";"GOLD SODIUM THIOMALATE";"4.0";"346.11";"None";"None";"GOLD SODIUM THIOMALATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL631";"PROPAFENONE";"4.0";"341.45";"0";"3.24";"PROPAFENONE";"CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL55";"PENTAMIDINE";"4.0";"340.43";"0";"2.88";"PENTAMIDINE";"N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL372795";"STREPTOMYCIN";"4.0";"581.58";"3";"-8.16";"STREPTOMYCIN";"CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](N=C(N)N)[C@@H](O)[C@@H]3N=C(N)N)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL628";"PENTOXIFYLLINE";"4.0";"278.31";"0";"0.19";"PENTOXIFYLLINE";"CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL451";"CHLORDIAZEPOXIDE";"4.0";"299.76";"0";"2.95";"CHLORDIAZEPOXIDE";"CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL184618";"FRAMYCETIN";"3.0";"614.65";"3";"-8.90";"Neomycine";"NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL469912";"PUROMYCIN";"2.0";"471.52";"1";"-0.79";"GNF-Pf-2016";"COc1ccc(C[C@H](N)C(=O)N[C@H]2[C@@H](O)[C@H](n3cnc4c(N(C)C)ncnc43)O[C@@H]2CO)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL880";"FAMCICLOVIR";"4.0";"321.34";"0";"0.54";"FAMCICLOVIR";"CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL502896";"CETRAXATE HYDROCHLORIDE";"-1.0";"341.83";"0";"2.37";"CETRAXATE";"Cl.NC[C@H]1CC[C@H](C(=O)Oc2ccc(CCC(=O)O)cc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL452";"CLONAZEPAM";"4.0";"315.72";"0";"3.04";"CLONAZEPAM";"O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL998";"LORATADINE";"4.0";"382.89";"0";"4.89";"LORATADINE";"CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL727";"THIOGUANINE";"4.0";"167.20";"0";"0.60";"THIOGUANINE";"Nc1nc2[nH]cnc2c(=S)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL14053";"TRICHLOROACETIC ACID";"4.0";"163.39";"0";"1.44";"TRICHLOROACETIC ACID";"O=C(O)C(Cl)(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL79";"LIDOCAINE";"4.0";"234.34";"0";"2.58";"LIDOCAINE";"CCN(CC)CC(=O)Nc1c(C)cccc1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200693";"MANGANESE CHLORIDE ANHYDROUS";"4.0";"125.84";"None";"None";"MANGANESE (II) CHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL717";"MEDROXYPROGESTERONE ACETATE";"4.0";"386.53";"0";"4.66";"MEDROXYPROGESTERONE ACETATE";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL157946";"";"None";"736.67";"1";"4.48";"PD-123319";"Cc1cc(Cn2cnc3c2C[C@@H](C(=O)O)N(C(=O)C(c2ccccc2)c2ccccc2)C3)ccc1N(C)C.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"14.68";"0.27";"2.99";"9.49";"0";"CHEMBL832379";"Displacement of [125I]-Ang II from pig uterus membrane angiotensin II type 2 (AT2) receptor";"B";"BAO_0000019";"assay format";"Sus scrofa";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138699";"1";"Scientific Literature";"J Med Chem";"2004";"None";"";"";""
"CHEMBL58";"MITOXANTRONE";"4.0";"444.49";"1";"-0.14";"SID11111483";"O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL277474";"ANTIPYRINE";"4.0";"188.23";"0";"1.48";"ANTIPYRINE";"Cc1cc(=O)n(-c2ccccc2)n1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL481";"IRINOTECAN";"4.0";"586.69";"1";"4.09";"IRINOTECAN";"CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1660";"RIFAPENTINE";"4.0";"877.04";"4";"5.65";"RIFAPENTINE";"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL20";"ACETAZOLAMIDE";"4.0";"222.25";"0";"-0.86";"acetazolamide";"CC(=O)Nc1nnc(S(N)(=O)=O)s1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL459";"METHYLDOPA";"4.0";"211.22";"0";"0.44";"METHYLDOPA";"C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1020";"TOLMETIN";"4.0";"257.29";"0";"2.19";"TOLMETIN";"Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL86";"METOCLOPRAMIDE";"4.0";"299.80";"0";"2.00";"METOCLOPRAMIDE";"CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL6437";"MIANSERIN";"4.0";"264.37";"0";"3.08";"Mianserin";"CN1CCN2c3ccccc3Cc3ccccc3C2C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1766";"DESOXIMETASONE";"4.0";"376.47";"0";"2.78";"DESOXIMETASONE";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1208572";"SALINOMYCIN";"2.0";"751.01";"2";"6.19";"SALINOMYCIN";"CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)O)CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@@H](O)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1518";"PROPYLTHIOURACIL";"4.0";"170.24";"0";"1.38";"PROPYLTHIOURACIL";"CCCc1cc(=O)[nH]c(=S)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1554";"DACTINOMYCIN";"4.0";"1255.44";"None";"None";"DACTINOMYCIN";"Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL167911";"DICHLORVOS";"2.0";"220.98";"0";"2.68";"DICHLORVOS";"COP(=O)(OC)OC=C(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL521589";"BAMBUTEROL";"3.0";"367.45";"0";"2.23";"BAMBUTEROL";"CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(C(O)CNC(C)(C)C)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1908355";"TENIDAP";"2.0";"320.76";"0";"3.25";"TENIDAP";"NC(=O)N1C(=O)/C(=C(\O)c2cccs2)c2cc(Cl)ccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909070";"NAFENOPIN";"2.0";"310.39";"0";"4.40";"NAFENOPIN";"CC(C)(Oc1ccc(C2CCCc3ccccc32)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1009";"LEVODOPA";"4.0";"197.19";"0";"0.05";"LEVODOPA";"N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL509";"MECLOFENAMIC ACID";"4.0";"296.15";"0";"4.74";"MECLOFENAMIC ACID";"Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL773";"GLYCINE";"4.0";"75.07";"0";"-0.97";"GLYCINE";"NCC(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL511";"PYRILAMINE";"4.0";"285.39";"0";"2.66";"PYRILAMINE";"COc1ccc(CN(CCN(C)C)c2ccccn2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909057";"COPPER(II) OXIDE";"None";"79.55";"None";"None";"COPPER(II) OXIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL411";"DIETHYLSTILBESTROL";"4.0";"268.36";"0";"4.83";"DIETHYLSTILBESTROL";"CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL707";"DOXAZOSIN";"4.0";"451.48";"0";"1.72";"DOXAZOSIN";"COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL42";"CLOZAPINE";"4.0";"326.83";"0";"3.72";"clozapine";"CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1493";"FLAVOXATE";"4.0";"391.47";"0";"4.41";"FLAVOXATE";"Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL157548";"DANOFLOXACIN";"-1.0";"357.39";"0";"2.07";"DANOFLOXACIN";"CN1C[C@@H]2C[C@H]1CN2c1cc2c(cc1F)c(=O)c(C(=O)O)cn2C1CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL640";"PROCAINAMIDE";"4.0";"235.33";"0";"1.34";"PROCAINAMIDE";"CCN(CC)CCNC(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1908847";"SPARTEINE";"4.0";"234.39";"0";"2.35";"SPARTEINE";"C1CCN2C[C@@H]3C[C@@H](CN4CCCC[C@@H]34)[C@H]2C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL625";"THIABENDAZOLE";"4.0";"201.25";"0";"2.69";"THIABENDAZOLE";"c1ccc2[nH]c(-c3cscn3)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL595";"PIOGLITAZONE";"4.0";"356.45";"0";"3.16";"PIOGLITAZONE";"CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL434";"ISOPROTERENOL";"4.0";"211.26";"0";"1.13";"ISOPRENALINE";"CC(C)NCC(O)c1ccc(O)c(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1321154";"ROXARSONE";"None";"263.04";"None";"None";"ROXARSONE";"O=[N+]([O-])c1cc([As](=O)(O)O)ccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL348157";"";"None";"672.79";"2";"6.68";"L-162132";"CCCCCN(Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1)C(=O)N1CCN(C(=O)N(c2ccccc2)c2ccccc2)[C@H](C(=O)O)C1";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"10.03";"0.18";"0.06";"4.86";"0";"CHEMBL643595";"Inhibition of Angiotensin II receptor, type 2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129469";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL321531";"";"None";"752.70";"2";"7.57";"4j";"CCCCc1nn(-c2cc(NC(C)=O)ccc2Cl)c(=O)n1Cc1ccc(-c2cc(CCC)ccc2S(=O)(=O)NC(=O)c2ccccc2Cl)cc1F";"IC50";"'='";"0.48";"nM";"9.32";"";"";"UO_0000065";"12.38";"0.25";"1.75";"7.05";"0";"CHEMBL876769";"Inhibitory concentration against cloned human AT1 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128028";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL288174";"";"None";"582.79";"2";"6.80";"L-162313";"CCCCOC(=O)NS(=O)(=O)c1sc(CC(C)C)cc1-c1ccc(Cn2c(CC)nc3c(C)cc(C)nc32)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"14.93";"0.30";"1.90";"8.43";"0";"CHEMBL643595";"Inhibition of Angiotensin II receptor, type 2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129469";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL39996";"";"None";"561.73";"2";"5.28";"13";"CCCC1=NC2(CCSCC2)C(=O)N1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)c2ccccc2)cc1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"11.93";"0.23";"1.42";"6.98";"0";"CHEMBL643597";"The compound was tested for the ability to displace 50% of totally specifically bound [125I]- Ang II from Angiotensin II receptor, type 2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153253";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL1130";"DOXIFLURIDINE";"3.0";"246.19";"0";"-1.69";"DOXIFLURIDINE";"C[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)[C@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1405";"ESTRONE";"4.0";"270.37";"0";"3.82";"ESTRONE";"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL41543";"";"None";"238.29";"0";"3.00";"10,11-DIHYDRO-CARBAMAZEPINE";"NC(=O)N1c2ccccc2CCc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL917";"FLOXURIDINE";"4.0";"246.19";"0";"-1.68";"5-FLUORO-2'-DEOXYURIDINE";"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1403281";"ERGOCRYPTINE";"None";"575.71";"1";"2.43";"ALPHA-ERGOCRYPTINE";"CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL314506";"";"None";"692.90";"2";"6.70";"21f";"CCCCCCC(O)(C(=O)O)c1c(SC)nc(CCC)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"12.93";"0.25";"2.26";"5.95";"0";"CHEMBL643790";"In vitro binding affinity at Angiotensin II Type 2 receptor in rabbit uterus membrane by [125I]AII displacement.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"CHEMBL3638197";"Uterus";"None";"Membrane";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128070";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1995";"None";"";"";""
"CHEMBL3039597";"GENTAMICIN";"4.0";"1390.73";"None";"None";"Gentamicin";"CNC(C)[C@@H]1CC[C@@H](N)[C@@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H](N)C[C@@H]2N)O1.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](C(C)N)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL26";"SULPIRIDE";"4.0";"341.43";"0";"0.56";"SULPIRIDE";"CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL113";"CAFFEINE";"4.0";"194.19";"0";"-1.03";"CAFFEINE";"Cn1c(=O)c2c(ncn2C)n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL540445";"PARTHENOLIDE";"2.0";"248.32";"0";"2.76";"PARTHENOLIDE";"C=C1C(=O)O[C@H]2[C@H]1CC/C(C)=C/CC[C@@]1(C)O[C@@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1752";"DYPHYLLINE";"4.0";"254.25";"0";"-2.21";"DYPHYLLINE";"Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL535139";"";"None";"517.03";"0";"3.99";"PD-123177 (4)";"Cc1cc(Cn2cnc3c2CC(C(=O)O)N(C(=O)C(c2ccccc2)c2ccccc2)C3)ccc1N.Cl";"IC50";"'='";"66.0";"nM";"7.18";"";"";"UO_0000065";"14.94";"0.27";"3.19";"7.08";"0";"CHEMBL647512";"In vitro binding affinity against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1121863";"1";"Scientific Literature";"J Med Chem";"1981";"None";"";"";""
"CHEMBL86067";"";"None";"538.07";"2";"5.21";"189";"CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2C(=O)NS(=O)(=O)c2ccccc2)cc1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2208700";"Antagonist activity at angiotensin 2 receptor";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203023";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL165354";"";"None";"552.05";"2";"5.41";"190";"CCCCc1nc(Cl)c(C(=O)O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)c2ccccc2)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2208700";"Antagonist activity at angiotensin 2 receptor";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203023";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL526";"PROPOFOL";"4.0";"178.27";"0";"3.64";"PROPOFOL";"CC(C)c1cccc(C(C)C)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL765";"GUANETHIDINE";"4.0";"198.31";"0";"0.74";"GUANETHIDINE";"N=C(N)NCCN1CCCCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL44";"GENISTEIN";"2.0";"270.24";"0";"2.58";"GENISTEIN";"O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201012";"FLURANDRENOLIDE";"4.0";"436.52";"0";"2.50";"FLURANDRENOLIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3350037";"";"None";"1019.26";"None";"None";"OCTREOTIDE";"C[C@@H](O)[C@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL85728";"4,4'-METHYLENEDIANILINE";"None";"198.27";"0";"2.44";"4,4'-METHYLENEDIANILINE";"Nc1ccc(Cc2ccc(N)cc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL398440";"CHLOROXYLENOL";"4.0";"156.61";"0";"2.66";"CHLOROXYLENOL";"Cc1cc(O)cc(C)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1502";"PANTOPRAZOLE";"4.0";"383.38";"0";"2.88";"PANTOPRAZOLE";"COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[nH]2)c1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL584";"NELFINAVIR";"4.0";"567.80";"1";"4.75";"NELFINAVIR";"Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL866";"MYCOPHENOLIC ACID";"4.0";"320.34";"0";"2.73";"MYCOPHENOLIC ACID";"COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL295416";"PIRINIXIC ACID";"2.0";"323.81";"0";"3.67";"PIRINIXIC ACID";"Cc1cccc(Nc2cc(Cl)nc(SCC(=O)O)n2)c1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL723";"CARVEDILOL";"4.0";"406.48";"0";"3.74";"CARVEDILOL";"COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1395";"METHYLTESTOSTERONE";"4.0";"302.46";"0";"4.27";"17-METHYLTESTOSTERONE";"C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL291338";"3,3',4',5-TETRACHLOROSALICYLANILIDE";"4.0";"351.02";"1";"5.26";"3,3',4',5-TETRACHLOROSALICYLANILIDE";"O=C(Nc1ccc(Cl)c(Cl)c1)c1cc(Cl)cc(Cl)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL87285";"ANDROSTERONE";"None";"290.45";"0";"3.96";"ANDROSTERONE";"C[C@]12CC[C@@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL672";"FENOFIBRATE";"4.0";"360.84";"0";"4.68";"FENOFIBRATE";"CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1306";"TERCONAZOLE";"4.0";"532.47";"1";"4.46";"TERCONAZOLE";"CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL6";"INDOMETHACIN";"4.0";"357.79";"0";"3.93";"INDOMETHACIN";"COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL64";"ISONIAZID";"4.0";"137.14";"0";"-0.31";"ISONIAZID";"NNC(=O)c1ccncc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1668007";"";"None";"713.83";"2";"6.02";"138";"CCCCc1nc2ccn(CC(=O)N3CCCCC3)c(=O)c2n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCc2ccccc2)cc1F";"IC50";"'='";"3.5";"nM";"8.46";"";"";"UO_0000065";"11.85";"0.23";"2.44";"6.38";"0";"CHEMBL1670671";"Binding affinity to angiotensin AT2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1667742";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL44884";"ETHAMBUTOL";"4.0";"204.31";"0";"-0.29";"ETHAMBUTOL";"CC[C@@H](CO)NCCN[C@@H](CC)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL611";"TERAZOSIN";"4.0";"387.44";"0";"1.06";"TERAZOSIN";"COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL468";"THALIDOMIDE";"4.0";"258.23";"0";"0.09";"THALIDOMIDE";"O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL252556";"IDEBENONE";"4.0";"338.44";"0";"3.46";"IDEBENONE";"COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200862";"METYROSINE";"4.0";"195.22";"0";"0.74";"METYROSINE";"C[C@](N)(Cc1ccc(O)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2107797";"NORGESTREL";"4.0";"312.45";"0";"3.88";"NORGESTREL";"C#CC1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL316561";"PROGLUMIDE";"4.0";"334.42";"0";"2.30";"PROGLUMIDE";"CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1089";"PHENELZINE";"4.0";"136.20";"0";"0.69";"PHENELZINE";"NNCCc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2107687";"VALETHAMATE BROMIDE";"-1.0";"386.37";"0";"3.85";"VALETHAMATE BROMIDE";"CCC(C)C(C(=O)OCC[N+](C)(CC)CC)c1ccccc1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL155836";"";"None";"507.59";"2";"5.44";"5 (+)";"COc1ccc2c(c1OCc1ccccc1)CC(C(=O)O)N(C(=O)C(c1ccccc1)c1ccccc1)C2";"IC50";"'='";"0.84";"nM";"9.08";"";"";"UO_0000065";"17.88";"0.33";"3.64";"11.93";"0";"CHEMBL643791";"Inhibitory activity against angiotensin II type 2 (AT2) receptor in rabbit uterine membranes.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127723";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL4872735";"";"None";"1008.23";"None";"None";"10; SBL-AII-10";"CCCC[C@@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)N1Cc2[nH]c3ccccc3c2C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)[C@@H](C)CC)C1=O";"IC50";"'='";"24.44";"nM";"7.61";"";"";"UO_0000065";"7.55";"None";"None";"None";"0";"CHEMBL4812855";"Displacement of [125-I]-[Sar1, Ile8] from recombinant human AT2R transfected in human HEK293 cells incubated for 2 hrs by liquid scintillation counter analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811266";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"TIME = 2.0 hr";"BINDING AGENT";""
"CHEMBL5314404";"AJMALINE";"3.0";"326.44";"0";"1.55";"AJMALINE";"CC[C@H]1[C@@H]2C[C@H]3[C@@H]4N(C)c5ccccc5[C@]45C[C@@H]([C@@H]2[C@H]5O)N3[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL941";"IMATINIB";"4.0";"493.62";"0";"4.59";"IMATINIB";"Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL14060";"PHENOL";"4.0";"94.11";"0";"1.39";"PHENOL";"Oc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1668009";"";"None";"474.95";"1";"5.19";"152-2";"CCCCc1nc(Cl)c2n1C(c1ccc(-c3ccccc3-c3nnn[nH]3)cc1)CC=C2C(=O)O";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"15.37";"0.29";"2.11";"6.66";"0";"CHEMBL1670671";"Binding affinity to angiotensin AT2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1667742";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1140";"NIACINAMIDE";"4.0";"122.13";"0";"0.18";"NIACINAMIDE";"NC(=O)c1cccnc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1017";"TELMISARTAN";"4.0";"514.63";"2";"7.26";"Telmisartan";"CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"IC50";"'='";"0.33";"nM";"9.48";"";"";"UO_0000065";"18.42";"0.33";"2.22";"13.00";"0";"CHEMBL1949357";"Displacement of [125I]Sar1 Ile8-Ang 2 from angiotensin 2 AT2 receptor after 180 mins by gamma counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944634";"1";"Scientific Literature";"Eur J Med Chem";"2012";"None";"";"";""
"CHEMBL972";"SELEGILINE";"4.0";"187.29";"0";"2.18";"SELEGILINE";"C#CCN(C)[C@H](C)Cc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL282575";"ESTRADIOL BENZOATE";"4.0";"376.50";"1";"5.12";"BETA-ESTRADIOL 3-BENZOATE";"C[C@]12CC[C@@H]3c4ccc(OC(=O)c5ccccc5)cc4CC[C@H]3[C@@H]1CC[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL19019";"NALTREXONE";"4.0";"341.41";"0";"1.53";"NALTREXONE";"O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1384";"KANAMYCIN";"4.0";"484.50";"2";"-7.29";"kanamycin";"NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL184";"ACYCLOVIR";"4.0";"225.21";"0";"-1.33";"ACYCLOVIR";"Nc1nc2c(ncn2COCCO)c(=O)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL573";"NIACIN";"4.0";"123.11";"0";"0.78";"NIACIN";"O=C(O)c1cccnc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL445";"NORTRIPTYLINE";"4.0";"263.38";"0";"3.83";"NORTRIPTYLINE";"CNCCC=C1c2ccccc2CCc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1237";"LISINOPRIL ANHYDROUS";"4.0";"405.50";"0";"1.24";"LISINOPRIL";"NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909063";"LEAD(IV) ACETATE";"None";"443.38";"None";"None";"LEAD(IV) ACETATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL328480";"";"None";"644.78";"2";"4.53";"27";"CCCCc1nc(SC)c(C(=O)n2cnnn2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"11.41";"0.22";"2.83";"4.78";"0";"CHEMBL643790";"In vitro binding affinity at Angiotensin II Type 2 receptor in rabbit uterus membrane by [125I]AII displacement.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"CHEMBL3638197";"Uterus";"None";"Membrane";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128070";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1995";"None";"";"";""
"CHEMBL432378";"";"None";"664.85";"2";"5.92";"21e";"CCCCC(O)(C(=O)O)c1c(SC)nc(CCC)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1";"IC50";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"13.61";"0.27";"3.13";"6.01";"0";"CHEMBL643790";"In vitro binding affinity at Angiotensin II Type 2 receptor in rabbit uterus membrane by [125I]AII displacement.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"CHEMBL3638197";"Uterus";"None";"Membrane";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128070";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1995";"None";"";"";""
"CHEMBL499234";"";"None";"1451.64";"None";"None";"9";"CO/C(C)=C1/NC(=O)[C@H]([C@@H](C)O)NC(=O)c2csc(n2)-c2cc(O)c(-c3nc(C(=O)N4CCN(C)CC4)cs3)nc2-c2csc(n2)[C@@H]2COC(=O)c3c4c5c(cccc5n3O)COC(=O)[C@@H](O[C@H]3C[C@](C)(O)[C@H](N(C)C)[C@H](C)O3)[C@@H](OC4)[C@H](NC(=O)c3csc1n3)c1nc(cs1)C(=O)N2";"IC50";"'='";"102.0";"nM";"6.99";"";"";"UO_0000065";"4.82";"None";"None";"None";"0";"CHEMBL996322";"Inhibition of AT2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136943";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL88446";"";"None";"684.84";"2";"5.78";"21g";"CCCc1nc(SC)c(C(O)(C(=O)O)c2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1";"IC50";"'='";"2.1";"nM";"8.68";"";"";"UO_0000065";"12.67";"0.25";"2.90";"5.76";"0";"CHEMBL643790";"In vitro binding affinity at Angiotensin II Type 2 receptor in rabbit uterus membrane by [125I]AII displacement.";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"CHEMBL3638197";"Uterus";"None";"Membrane";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128070";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1995";"None";"";"";""
"CHEMBL7568";"QUINACRINE";"2.0";"399.97";"1";"5.97";"QUINACRINE";"CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1261";"CITRIC ACID";"4.0";"192.12";"0";"-1.25";"CITRIC ACID";"O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL562";"GRISEOFULVIN";"4.0";"352.77";"0";"2.81";"GRISEOFULVIN";"COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2435824";"";"None";"469.59";"1";"6.45";"11c";"CCCC(=O)Nc1cc(C)c2nc(CCC)n(Cc3ccc(-c4ccccc4C(=O)O)cc3)c2c1";"IC50";"'='";"53.0";"nM";"7.28";"";"";"UO_0000065";"15.49";"0.28";"0.83";"8.64";"0";"CHEMBL2439560";"Displacement of [125I]-Sar1Ile8-angiotensin 2 from angiotensin 2 AT2 receptor (unknown origin) after 180 mins by gamma counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2434924";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";""
"CHEMBL69721";"";"None";"693.84";"2";"7.34";"36";"CCCc1nc(CC)c(C(=O)OCCCOc2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"12.54";"0.24";"1.36";"6.91";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL462547";"URETHANE";"4.0";"89.09";"0";"0.10";"URETHANE";"CCOC(N)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL772";"RESERPINE";"4.0";"608.69";"1";"4.17";"RESERPINE";"COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL105";"MITOMYCIN";"4.0";"334.33";"0";"-1.65";"MITOMYCIN C";"CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL648";"CYCLIZINE";"4.0";"266.39";"0";"3.02";"CYCLIZINE";"CN1CCN(C(c2ccccc2)c2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL141343";"";"None";"520.72";"1";"4.21";"U-78517F";"Cc1c(C)c2c(c(C)c1O)CCC(C)(CN1CCN(c3cc(N4CCCC4)nc(N4CCCC4)n3)CC1)O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL6966";"VERAPAMIL";"4.0";"454.61";"1";"5.09";"VERAPAMIL";"COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL219916";"DOMPERIDONE";"4.0";"425.92";"0";"3.35";"DOMPERIDONE";"O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL479";"THIORIDAZINE";"4.0";"370.59";"1";"5.89";"THIORIDAZINE";"CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL332576";"";"None";"691.70";"2";"6.03";"18";"CCCCc1nn(-c2cc(NC(=O)CC)ccc2C(F)(F)F)c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCC)cc1F";"IC50";"'='";"4.6";"nM";"8.34";"";"";"UO_0000065";"12.05";"0.24";"2.31";"5.90";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL270299";"BAY-11-7085";"None";"249.34";"0";"2.80";"BAY-117085";"CC(C)(C)c1ccc(S(=O)(=O)/C=C/C#N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1231530";"BETAMIPRON";"2.0";"193.20";"0";"0.89";"BETAMIPRON";"O=C(O)CCNC(=O)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL862";"GUANFACINE";"4.0";"246.10";"0";"1.55";"GUANFACINE";"N=C(N)NC(=O)Cc1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200431";"GADOPENTETATE DIMEGLUMINE";"4.0";"742.79";"None";"None";"GADOPENTETATE DIMEGLUMINE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1454946";"FLUBENDAZOLE";"2.0";"313.29";"0";"3.11";"FLUBENDAZOLE";"COC(=O)Nc1nc2cc(C(=O)c3ccc(F)cc3)ccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1614641";"FLUNOXAPROFEN";"2.0";"285.27";"0";"3.82";"FLUNOXAPROFEN";"C[C@H](C(=O)O)c1ccc2oc(-c3ccc(F)cc3)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL157946";"";"None";"736.67";"1";"4.48";"PD-123319";"Cc1cc(Cn2cnc3c2C[C@@H](C(=O)O)N(C(=O)C(c2ccccc2)c2ccccc2)C3)ccc1N(C)C.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F";"IC50";"'='";"6.9";"nM";"8.16";"";"";"UO_0000065";"16.05";"0.29";"3.68";"10.37";"1";"CHEMBL647513";"In vitro binding affinity of compound was measured against angiotensin II (AT2) receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127913";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL2205685";"";"None";"495.46";"0";"4.75";"76";"O=c1c(O)c(Oc2ccccc2-c2ccc(CNc3nc(C(F)(F)F)nc4c3CCCC4)cc2)c1=O";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"15.38";"0.29";"2.87";"7.51";"0";"CHEMBL5215025";"Inhibition of Angiotensin 2 binding to Angiotensin 2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214881";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL565";"CLOFIBRATE";"4.0";"242.70";"0";"3.06";"CLOFIBRATE";"CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL457";"GEMFIBROZIL";"4.0";"250.34";"0";"3.57";"GEMFIBROZIL";"Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL175";"DEXIBUPROFEN";"4.0";"206.28";"0";"3.07";"DEXIBUPROFEN";"CC(C)Cc1ccc([C@H](C)C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1381098";"1-NAPHTHYLISOTHIOCYANATE";"None";"185.25";"0";"3.57";"1-NAPHTHYL ISOTHIOCYANATE";"S=C=Nc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL488";"AMINOGLUTETHIMIDE";"4.0";"232.28";"0";"1.35";"AMINOGLUTETHIMIDE";"CCC1(c2ccc(N)cc2)CCC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL47";"ALPHA-TOCOPHEROL";"None";"430.72";"1";"8.84";"ALPHA-TOCOPHEROL";"Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL413965";"FELBINAC";"4.0";"212.25";"0";"2.98";"FELBINAC";"O=C(O)Cc1ccc(-c2ccccc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1481";"GLIMEPIRIDE";"4.0";"490.63";"0";"3.07";"GLIMEPIRIDE";"CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL338687";"";"None";"716.63";"2";"6.17";"46";"CCCCC(=O)Nc1ccc(Br)c(-n2nc(CC)n(Cc3ccc(-c4ccccc4S(=O)(=O)NC(=O)OC(C)C)cc3F)c2=O)c1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"12.50";"0.27";"2.79";"6.34";"0";"CHEMBL648578";"In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128554";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL4873899";"";"None";"969.15";"3";"1.14";"12; SBL-AII-12";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N1Cc2cc(O)ccc2C[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O";"IC50";"'='";"118.8";"nM";"6.92";"";"";"UO_0000065";"7.15";"0.14";"5.79";"2.15";"0";"CHEMBL4812855";"Displacement of [125-I]-[Sar1, Ile8] from recombinant human AT2R transfected in human HEK293 cells incubated for 2 hrs by liquid scintillation counter analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811266";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"TIME = 2.0 hr";"BINDING AGENT";""
"CHEMBL321313";"";"None";"686.21";"2";"6.23";"4m";"CCCCc1nn(-c2cc(NC(C)=O)ccc2Cl)c(=O)n1Cc1ccc(-c2cc(CCC)ccc2S(=O)(=O)NC(=O)OCC)cc1F";"IC50";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"12.51";"0.25";"2.36";"6.07";"0";"CHEMBL649910";"In vitro inhibitory concentration against AT2 receptor from human adrenal tissues.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128028";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL292277";"";"None";"480.57";"0";"3.99";"PD-123177";"Cc1cc(Cn2cnc3c2C[C@@H](C(=O)O)N(C(=O)C(c2ccccc2)c2ccccc2)C3)ccc1N";"IC50";"'='";"66.0";"nM";"7.18";"";"";"UO_0000065";"14.94";"0.27";"3.19";"7.08";"0";"CHEMBL643595";"Inhibition of Angiotensin II receptor, type 2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129469";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL24441";"BETAHISTINE";"4.0";"136.20";"0";"0.84";"BETAHISTINE";"CNCCc1ccccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1168";"RAMIPRIL";"4.0";"416.52";"0";"2.38";"RAMIPRIL";"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1393";"SPIRONOLACTONE";"4.0";"416.58";"0";"4.85";"SPIRONOLACTONE";"CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200558";"BACITRACIN";"4.0";"1422.72";"None";"None";"Bacitracin";"CC[C@H](C)[C@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC)CS1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL25";"ASPIRIN";"4.0";"180.16";"0";"1.31";"aspirin";"CC(=O)Oc1ccccc1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909062";"LEAD (II) ACETATE";"None";"325.29";"None";"None";"LEAD (II) ACETATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1149";"LEVOCARNITINE";"4.0";"161.20";"0";"-1.81";"LEVOCARNITINE";"C[N+](C)(C)C[C@H](O)CC(=O)[O-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL5272027";"";"None";"949.00";"None";"None";"7; LCZ696";"CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[n-]2)cc1)[C@H](C(=O)[O-])C(C)C.CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)CCC(=O)[O-].O.O.[Na+].[Na+].[Na+]";"IC50";"'='";"1.05";"nM";"8.98";"";"";"UO_0000065";"10.60";"None";"None";"None";"0";"CHEMBL5233432";"Inhibition of angiotensin 2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233209";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";""
"CHEMBL12";"DIAZEPAM";"4.0";"284.75";"0";"3.15";"DIAZEPAM";"CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1729";"CISAPRIDE";"4.0";"465.95";"0";"3.36";"CISAPRIDE";"COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200629";"VECURONIUM BROMIDE";"4.0";"637.74";"2";"5.97";"VECURONIUM BROMIDE";"CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1386";"TRANSPLATIN";"3.0";"300.05";"None";"None";"TRANS-PLATINUM(II)DIAMMINE DICHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1651906";"STREPTOZOCIN";"4.0";"265.22";"0";"-2.89";"12";"CN(N=O)C(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL323506";"";"None";"714.26";"2";"7.01";"4l";"CCCCc1nn(-c2cc(NC(C)=O)ccc2Cl)c(=O)n1Cc1ccc(-c2cc(CCC)ccc2S(=O)(=O)NC(=O)OC(C)(C)C)cc1F";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"11.09";"0.22";"0.91";"5.60";"0";"CHEMBL649910";"In vitro inhibitory concentration against AT2 receptor from human adrenal tissues.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128028";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL75435";"DEXKETOPROFEN";"4.0";"254.29";"0";"3.11";"DEXKETOPROFEN";"C[C@H](C(=O)O)c1cccc(C(=O)c2ccccc2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL45";"MELATONIN";"4.0";"232.28";"0";"1.86";"MELATONIN";"COc1ccc2[nH]cc(CCNC(C)=O)c2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL14192";"BENZYLIMIDAZOLE";"None";"158.20";"0";"1.93";"1-BENZYLIMIDAZOLE";"c1ccc(Cn2ccnc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL36715";"PIRACETAM";"4.0";"142.16";"0";"-0.91";"PIRACETAM";"NC(=O)CN1CCCC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL870";"ALENDRONIC ACID";"4.0";"249.10";"1";"-1.27";"ALENDRONIC ACID";"NCCCC(O)(P(=O)(O)O)P(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL76904";"TYRPHOSTIN 23";"None";"186.17";"0";"1.53";"TYRPHOSTIN A23";"N#CC(C#N)=Cc1ccc(O)c(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL24944";"TRIBROMSALAN";"4.0";"449.92";"0";"4.93";"TRIBROMSALAN";"O=C(Nc1ccc(Br)cc1)c1cc(Br)cc(Br)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL134342";"THIOCTIC ACID";"None";"206.33";"0";"2.79";"THIOCTIC ACID";"O=C(O)CCCC[C@@H]1CCSS1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL689";"MANNITOL";"4.0";"182.17";"1";"-3.59";"MANNITOL";"OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL203266";"TRIMETAZIDINE";"4.0";"266.34";"0";"1.12";"TRIMETAZIDINE";"COc1ccc(CN2CCNCC2)c(OC)c1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1221";"SULCONAZOLE";"4.0";"397.76";"1";"6.52";"SULCONAZOLE";"Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL408885";"";"None";"994.17";"3";"-2.08";"c[Sar1,Cys3,Hcy5]";"NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H]1CSSCC[C@H](C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N2CCC[C@@H]2C(=O)N[C@@H](Cc2ccccc2)C(=O)O)NC(=O)[C@@H](Cc2ccc(O)cc2)NC1=O";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"7.60";"0.15";"9.63";"2.03";"0";"CHEMBL647843";"In vitro binding affinity at angiotensin II (type 2) receptor in rabbit uterus.";"B";"BAO_0000357";"single protein format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126724";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL385283";"";"None";"1034.24";"None";"None";"1";"CNCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H]1CCSS[C@@H]2C[C@@H](C(=O)N[C@@H](Cc3c[nH]cn3)C(=O)N3CCC[C@H]3C(=O)N[C@@H](Cc3ccccc3)C(=O)O)N(C2)C(=O)[C@H](Cc2ccc(O)cc2)NC1=O";"IC50";"'='";"0.65";"nM";"9.19";"";"";"UO_0000065";"8.88";"None";"None";"None";"0";"CHEMBL647843";"In vitro binding affinity at angiotensin II (type 2) receptor in rabbit uterus.";"B";"BAO_0000357";"single protein format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126724";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL70638";"";"None";"680.81";"2";"5.91";"12d";"CCCc1nc(CN2CCN(C(=O)C(c3ccccc3)c3ccccc3)CC2)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"8.81";"0.16";"0.09";"4.51";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL1643";"RIBAVIRIN";"4.0";"244.21";"0";"-3.01";"RIBAVIRIN";"NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909078";"SODIUM ARSENITE";"None";"129.91";"None";"None";"SODIUM ARSENITE";"O=[As][O-].[Na+]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL311386";"";"None";"665.79";"2";"5.16";"11";"CCc1nc2ccc(NC(=O)N(C)C(C)C)cc2c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)COCC(C)C)cc1F";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"11.95";"0.23";"2.80";"5.70";"0";"CHEMBL643789";"In vivo inhibitory concentration against AT2 receptor of human adrenal membrane";"B";"BAO_0000218";"organism-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150477";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL293492";"CINNAMALDEHYDE";"-1.0";"132.16";"0";"1.90";"CINNAMALDEHYDE";"O=C/C=C/c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL74069";"";"None";"731.91";"2";"8.80";"28";"CCCc1nc(CC)c(C(=O)OCc2ccccc2-c2cccs2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"11.64";"0.23";"-0.28";"7.31";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL47244";"PICROTOXININ";"None";"292.29";"0";"-0.06";"COCCULIN";"C=C(C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]1(O)C[C@H]3O[C@]34C(=O)O[C@H]2[C@]14C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL510139";"CITRININ";"None";"250.25";"0";"1.72";"CITRININ";"CC1=C2C(=CO[C@H](C)[C@H]2C)C(O)=C(C(=O)O)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL306761";"";"None";"757.95";"2";"9.22";"43";"CCCc1nc(CC)c(C(=O)OCc2ccccc2Sc2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"11.48";"0.22";"-0.52";"7.46";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL1385840";"ERGOCORNINE";"None";"561.68";"1";"2.04";"ERGOCORNINE";"CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL989";"FLUOCINOLONE ACETONIDE";"4.0";"452.49";"0";"2.37";"FLUOCINOLONE ACETONIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL515";"CHLORAMBUCIL";"4.0";"304.22";"0";"3.38";"CHLORAMBUCIL";"O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL130";"CHLORAMPHENICOL";"4.0";"323.13";"0";"0.91";"CHLORAMPHENICOL";"O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL888";"GEMCITABINE";"4.0";"263.20";"0";"-1.29";"GEMCITABINE";"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL826";"ENOXACIN";"4.0";"320.32";"0";"0.66";"ENOXACIN";"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1366";"AURANOFIN";"4.0";"678.49";"None";"None";"AURANOFIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1479";"DANAZOL";"4.0";"337.46";"0";"4.22";"DANAZOL";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1399";"ANASTROZOLE";"4.0";"293.37";"0";"2.93";"ANASTROZOLE";"CC(C)(C#N)c1cc(Cn2cncn2)cc(C(C)(C)C#N)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL31184";"BENZO[DEF]CHRYSENE";"0.5";"252.32";"1";"5.74";"BENZO[A]PYRENE";"c1ccc2c(c1)cc1ccc3cccc4ccc2c1c34";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL134";"CLONIDINE";"4.0";"230.10";"0";"2.36";"CLONIDINE";"Clc1cccc(Cl)c1NC1=NCCN1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200528";"CHROMIC CHLORIDE";"4.0";"158.36";"None";"None";"CHROMIUM(III) CHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1231107";"CYROMAZINE";"2.0";"166.19";"0";"-0.39";"CYROMAZINE";"Nc1nc(N)nc(NC2CC2)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2220427";"ERYTHROMYCIN PROPIONATE";"4.0";"790.00";"2";"2.75";"ERYTHROMYCIN PROPIONATE";"CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL241694";"ETHISTERONE";"3.0";"312.45";"0";"3.88";"ETHISTERONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL456";"ETHACRYNIC ACID";"4.0";"303.14";"0";"3.61";"ETHACRYNIC ACID";"C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201469";"GRAMICIDIN";"4.0";"None";"None";"None";"GRAMICIDIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL434063";"";"None";"495.58";"0";"4.94";"GW-1929";"CN(CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(=O)O)cc1)c1ccccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1466";"DICUMAROL";"4.0";"336.30";"0";"2.90";"DICUMAROL";"O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL74442";"";"None";"665.79";"2";"6.15";"10";"CCc1nc2ccc(NC(=O)N(C)C(C)C)cc2c(=O)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"9.2";"nM";"8.04";"";"";"UO_0000065";"12.07";"0.23";"1.89";"5.75";"0";"CHEMBL643789";"In vivo inhibitory concentration against AT2 receptor of human adrenal membrane";"B";"BAO_0000218";"organism-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150477";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL443325";"";"None";"2040.42";"None";"None";"7";"CNCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N1C[C@@H]2C[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)CSSC[C@H](C(=O)N[C@H](Cc1c[nH]cn1)C(=O)N1CCC[C@@H]1C(=O)N[C@H](Cc1ccccc1)C(=O)O)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@H]1C[C@H](CN1C(=O)[C@@H](CCCN=C(N)N)NC(=O)CNC)SS2";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"3.74";"None";"None";"None";"0";"CHEMBL647843";"In vitro binding affinity at angiotensin II (type 2) receptor in rabbit uterus.";"B";"BAO_0000357";"single protein format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126724";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL302760";"";"None";"611.71";"2";"5.88";"10e";"CCCc1nc(CNC(=O)C(c2ccccc2)c2ccccc2)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"10.17";"0.18";"0.34";"4.49";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL306924";"";"None";"582.71";"2";"7.32";"14";"CCCc1nc(CC)c(C(=O)OCc2ccccc2-c2ccccc2)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"9.78";"0.18";"-1.62";"5.78";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL2220442";"FLUVASTATIN";"4.0";"411.47";"0";"4.63";"Fluvastatin";"CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2";"PRAZOSIN";"4.0";"383.41";"0";"1.78";"PRAZOSIN";"COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201146";"NORETHINDRONE ACETATE";"4.0";"340.46";"0";"4.06";"NORETHINDRONE ACETATE";"C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL414804";"OXALIPLATIN";"4.0";"395.27";"None";"None";"OXALIPLATIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1289";"HALOPROGIN";"4.0";"361.39";"0";"4.42";"HALOPROGIN";"Clc1cc(Cl)c(OCC#CI)cc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201203";"BENZTROPINE";"4.0";"307.44";"0";"4.42";"BENZTROPINE";"CN1[C@@H]2CC[C@H]1C[C@@H](OC(c1ccccc1)c1ccccc1)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4850726";"";"None";"1067.21";"None";"None";"7; SBL-AII-7";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@H]1Cc2c([nH]c3ccccc23)CN(CC(=O)N[C@@H](Cc2ccccc2)C(=O)O)C1=O";"IC50";"'='";"45.74";"nM";"7.34";"";"";"UO_0000065";"6.88";"None";"None";"None";"0";"CHEMBL4812855";"Displacement of [125-I]-[Sar1, Ile8] from recombinant human AT2R transfected in human HEK293 cells incubated for 2 hrs by liquid scintillation counter analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811266";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"TIME = 2.0 hr";"BINDING AGENT";""
"CHEMBL290214";"";"None";"640.81";"2";"7.14";"L-163491";"CCCCOC(=O)NS(=O)(=O)c1ccc(Cc2cccc(OC)c2)cc1-c1ccc(Cn2c(CC)nc3c(C)cc(C)nc32)cc1";"IC50";"'='";"101.0";"nM";"7.00";"";"";"UO_0000065";"10.92";"0.21";"-0.14";"6.22";"1";"CHEMBL832379";"Displacement of [125I]-Ang II from pig uterus membrane angiotensin II type 2 (AT2) receptor";"B";"BAO_0000019";"assay format";"Sus scrofa";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138699";"1";"Scientific Literature";"J Med Chem";"2004";"None";"";"";""
"CHEMBL309081";"";"None";"701.83";"2";"8.63";"8";"CCCc1nc(CC)c(C(=O)OCc2ccc(C(=O)N(c3ccccc3)c3ccccc3)cc2)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"9.55";"0.17";"-1.93";"5.63";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL254219";"DIGITOXIN";"4.0";"764.95";"2";"3.25";"DIGITOXIN";"C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL53463";"DOXORUBICIN";"4.0";"543.53";"3";"0.00";"Doxo (I)";"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL119443";"ERGONOVINE";"4.0";"325.41";"0";"1.53";"ERGONOVINE";"C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1062";"HYDROXYPROGESTERONE";"2.0";"330.47";"0";"3.84";"HYDROXYPROGESTERONE";"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201010";"FLUDROCORTISONE ACETATE";"4.0";"422.49";"0";"2.44";"FLUDROCORTISONE ACETATE";"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL74573";"";"None";"753.89";"2";"8.30";"22";"CCCc1nc(CC)c(C(=O)OCc2ccccc2C(=O)c2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"12.14";"0.23";"0.85";"6.85";"0";"CHEMBL647510";"Binding affinity for angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150518";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL307756";"";"None";"562.68";"1";"4.75";"12h (XH669)";"CCCc1nc(CN2CCN(c3ccccc3)CC2)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"12.98";"0.24";"2.55";"6.29";"0";"CHEMBL647511";"In vitro binding affinity of compound against angiotensin II AT-2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1994";"None";"";"";""
"CHEMBL83668";"TOLNAFTATE";"4.0";"307.42";"0";"4.95";"TOLNAFTATE";"Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1064";"SIMVASTATIN";"4.0";"418.57";"0";"4.59";"SIMVASTATIN";"CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1515611";"BROMISOVALUM";"2.0";"223.07";"0";"0.60";"BROMISOVALUM";"CC(C)C(Br)C(=O)NC(N)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909080";"STRONTIUM CHLORIDE HEXAHYDRATE";"None";"266.62";"None";"None";"STRONTIUM CHLORIDE HEXAHYDRATE";"O.O.O.O.O.O.[Cl-].[Cl-].[Sr+2]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1220";"TINIDAZOLE";"4.0";"247.28";"0";"0.53";"TINIDAZOLE";"CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL135";"ESTRADIOL";"4.0";"272.39";"0";"3.61";"BETA-ESTRADIOL";"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL558";"MEXILETINE";"4.0";"179.26";"0";"2.03";"MEXILETINE";"Cc1cccc(C)c1OCC(C)N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL10";"SB-203580";"None";"377.44";"0";"4.68";"SB-203580";"C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL40381";"";"None";"449.94";"1";"5.60";"20";"CCCc1nc2c(C)ccnc2n1Cc1ccc(OC(C(=O)O)c2ccccc2Cl)cc1";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"17.02";"0.33";"2.06";"9.91";"0";"CHEMBL647845";"Tested in vitro for Angiotensin II receptor, type 2 binding affinity using rabbit aorta binding assay";"B";"BAO_0000221";"tissue-based format";"Oryctolagus cuniculus";"CHEMBL3638186";"Aorta";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128037";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1995";"None";"";"";""
"CHEMBL1909048";"";"None";"313.83";"0";"4.43";"1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE";"O=C(c1ccccc1Cl)N1CCC(Cc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL32749";"FERULATE";"-1.0";"194.19";"0";"1.50";"ferulic acid";"COc1cc(/C=C/C(=O)O)ccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL64894";"GENTIAN VIOLET";"4.0";"407.99";"0";"4.46";"GENTIAN VIOLET";"CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL6466";"COUMARIN";"4.0";"146.14";"0";"1.79";"COUMARIN";"O=c1ccc2ccccc2o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1194";"PRILOCAINE";"4.0";"220.32";"0";"2.32";"PRILOCAINE";"CCCNC(C)C(=O)Nc1ccccc1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4";"OFLOXACIN";"4.0";"361.37";"0";"1.54";"OFLOXACIN";"CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1515";"METHIMAZOLE";"4.0";"114.17";"0";"0.71";"METHIMAZOLE";"Cn1ccnc1S";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL119385";"NEFLAMAPIMOD";"2.0";"436.27";"1";"5.49";"SID103905630";"O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL3559671";"POLYVINYL ALCOHOL";"4.0";"None";"None";"None";"POLYVINYL ALCOHOL";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL599";"MELOXICAM";"4.0";"351.41";"0";"1.95";"MELOXICAM";"Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1413";"CICLOPIROX";"4.0";"207.27";"0";"2.44";"CICLOPIROX";"Cc1cc(C2CCCCC2)n(O)c(=O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL577294";"2-HYDROXYPROPYL-BETA-CYCLODEXTRIN";"3.0";"1541.55";"None";"None";"2-HYDROXYPROPYL-BETA-CYCLODEXTRIN";"CC(O)COC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]1[C@H](O)[C@H]2O)O[C@@H]8COCC(C)O)O[C@@H]7COCC(C)O)O[C@@H]6COCC(C)O)O[C@@H]5COCC(C)O)O[C@@H]4COCC(C)O)O[C@@H]3COCC(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1902981";"EPERISONE";"3.0";"259.39";"0";"3.55";"EPERISONE";"CCc1ccc(C(=O)C(C)CN2CCCCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1200396";"BUPIVACAINE HYDROCHLORIDE";"4.0";"324.90";"0";"3.90";"BUPIVACAINE HYDROCHLORIDE";"CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C.Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1491";"AMLODIPINE";"4.0";"408.88";"0";"2.27";"AMLODIPINE";"CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL832";"SULFINPYRAZONE";"4.0";"404.49";"0";"3.80";"SULFINPYRAZONE";"O=C1C(CC[S+]([O-])c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL444633";"RIFABUTIN";"4.0";"847.02";"2";"4.62";"RIFABUTIN";"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL114";"SAQUINAVIR";"4.0";"670.86";"1";"3.09";"SAQUINAVIR";"CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1741";"CLARITHROMYCIN";"4.0";"747.96";"2";"2.44";"CLARITHROMYCIN";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL189";"MILRINONE";"4.0";"211.22";"0";"1.62";"MILRINONE";"Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL960";"LEFLUNOMIDE";"4.0";"270.21";"0";"3.25";"LEFLUNOMIDE";"Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL273348";"TOSUFLOXACIN";"2.0";"404.35";"0";"2.04";"TOSUFLOXACIN";"NC1CCN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1433";"DOXYCYCLINE ANHYDROUS";"4.0";"444.44";"1";"-0.35";"DOXYCYCLINE";"C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL503";"LOVASTATIN";"4.0";"404.55";"0";"4.20";"LOVASTATIN";"CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL480";"LANSOPRAZOLE";"4.0";"369.37";"0";"3.52";"LANSOPRAZOLE";"Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4861538";"";"None";"952.13";"2";"1.04";"8; SBL-AII-8";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@H]1Cc2c([nH]c3ccccc23)CN(CC(=O)N[C@@H](Cc2ccccc2)C(=O)O)C1=O";"IC50";"'='";"106.6";"nM";"6.97";"";"";"UO_0000065";"7.32";"0.14";"5.93";"2.13";"0";"CHEMBL4812855";"Displacement of [125-I]-[Sar1, Ile8] from recombinant human AT2R transfected in human HEK293 cells incubated for 2 hrs by liquid scintillation counter analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811266";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"TIME = 2.0 hr";"BINDING AGENT";""
"CHEMBL1237044";"TRAMADOL";"4.0";"263.38";"0";"2.63";"TRAMADOL";"COc1cccc(C2(O)CCCCC2CN(C)C)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1221512";"";"None";"559.80";"1";"1.75";"L-744832";"CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL404";"TAZOBACTAM";"4.0";"300.30";"0";"-1.52";"tazo";"C[C@]1(Cn2ccnn2)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL443";"SULFAMETHOXAZOLE";"4.0";"253.28";"0";"1.37";"SULFAMETHOXAZOLE";"Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL83";"TAMOXIFEN";"4.0";"371.52";"1";"6.00";"tamoxifen";"CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4873167";"";"None";"1084.24";"None";"None";"13; SBL-AII-13";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N1Cc2ccc(O)cc2C[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O";"IC50";"'='";"59.28";"nM";"7.23";"";"";"UO_0000065";"6.67";"None";"None";"None";"0";"CHEMBL4812855";"Displacement of [125-I]-[Sar1, Ile8] from recombinant human AT2R transfected in human HEK293 cells incubated for 2 hrs by liquid scintillation counter analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811266";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"TIME = 2.0 hr";"BINDING AGENT";""
"CHEMBL4854474";"";"None";"969.15";"3";"1.14";"14; SBL-AII-14";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N1Cc2ccc(O)cc2C[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O";"IC50";"'='";"315.4";"nM";"6.50";"";"";"UO_0000065";"6.71";"0.13";"5.36";"2.01";"0";"CHEMBL4812855";"Displacement of [125-I]-[Sar1, Ile8] from recombinant human AT2R transfected in human HEK293 cells incubated for 2 hrs by liquid scintillation counter analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811266";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"TIME = 2.0 hr";"BINDING AGENT";""
"CHEMBL30327";"2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN";"None";"321.97";"1";"6.20";"2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN";"Clc1cc2c(cc1Cl)Oc1cc(Cl)c(Cl)cc1O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL46";"ONDANSETRON";"4.0";"293.37";"0";"3.13";"SID170464701";"Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1109";"SULFAPHENAZOLE";"4.0";"314.37";"0";"2.26";"SULFAPHENAZOLE";"Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1762";"TOCAINIDE";"4.0";"192.26";"0";"1.59";"TOCAINIDE";"Cc1cccc(C)c1NC(=O)C(C)N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201631";"INSULIN HUMAN";"4.0";"None";"None";"None";"INSULIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1191";"SULFAMETHIZOLE";"4.0";"270.34";"0";"1.23";"SULFAMETHIZOLE";"Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL2079587";"STANOZOLOL";"4.0";"328.50";"0";"4.12";"STANOZOLOL";"C[C@]12Cc3c[nH]nc3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL471";"SOTALOL";"4.0";"272.37";"0";"1.09";"SOTALOL";"CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL129";"ZIDOVUDINE";"4.0";"267.24";"0";"-0.20";"ZIDOVUDINE";"Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL447";"SECOBARBITAL";"4.0";"238.29";"0";"1.35";"SECOBARBITAL";"C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL75880";"PERHEXILINE";"4.0";"277.50";"1";"5.30";"PERHEXILINE";"C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL424";"SALICYLIC ACID";"4.0";"138.12";"0";"1.09";"SALICYLIC ACID";"O=C(O)c1ccccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1909054";"CARBOXYMETHYLCELLULOSE";"None";"None";"None";"None";"CARBOXYMETHYLCELLULOSE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1371";"CHLORZOXAZONE";"4.0";"169.57";"0";"1.77";"CHLORZOXAZONE";"O=c1[nH]c2cc(Cl)ccc2o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1177";"PEMOLINE";"4.0";"176.18";"0";"0.60";"PEMOLINE";"NC1=NC(=O)C(c2ccccc2)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL402794";"BIS(2-ETHYLHEXYL)PHTHALATE";"None";"390.56";"1";"6.43";"BIS(2-ETHYLHEXYL)PHTHALATE";"CCCC[C@@H](CC)COC(=O)c1ccccc1C(=O)OC[C@@H](CC)CCCC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL499";"TIMOLOL";"4.0";"316.43";"0";"0.50";"TIMOLOL";"CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1076211";"TOLPERISONE";"3.0";"245.37";"0";"3.30";"TOLPERISONE";"Cc1ccc(C(=O)C(C)CN2CCCCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1476898";"CADMIUM ACETATE";"None";"230.50";"None";"None";"CADMIUM ACETATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL726";"FLUPHENAZINE";"4.0";"437.53";"0";"4.31";"FLUPHENAZINE";"OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1586";"BECLOMETHASONE";"2.0";"408.92";"0";"2.17";"BECLOMETHASONE";"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL12856";"INAMRINONE";"4.0";"187.20";"0";"1.02";"AMRINONE";"Nc1cc(-c2ccncc2)c[nH]c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL252557";"GLYCOLIC ACID";"2.0";"76.05";"0";"-0.94";"GLYCOLIC ACID";"O=C(O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL660";"AMANTADINE";"4.0";"151.25";"0";"1.91";"AMANTADINE";"NC12CC3CC(CC(C3)C1)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1201353";"DEXCHLORPHENIRAMINE";"4.0";"274.80";"0";"3.82";"DEXCHLORPHENIRAMINE";"CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1517";"OXYTETRACYCLINE";"4.0";"460.44";"1";"-1.24";"SID855768";"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL40";"PHENOBARBITAL";"4.0";"232.24";"0";"0.70";"PHENOBARBITAL";"CCC1(c2ccccc2)C(=O)NC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL426123";"";"None";"258.23";"0";"0.09";"(-)-THALIDOMIDE";"O=C1CC[C@H](N2C(=O)c3ccccc3C2=O)C(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL415324";"TRANILAST";"3.0";"327.34";"0";"3.05";"TRANILAST";"COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1243";"SULFABENZAMIDE";"4.0";"276.32";"0";"1.39";"SULFABENZAMIDE";"Nc1ccc(S(=O)(=O)NC(=O)c2ccccc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL245416";"L-MIMOSINE";"None";"198.18";"0";"-1.03";"L-MIMOSINE";"N[C@@H](Cn1ccc(=O)c(O)c1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL13";"METOPROLOL";"4.0";"267.37";"0";"1.61";"22";"COCCc1ccc(OCC(O)CNC(C)C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL580";"LORAZEPAM";"4.0";"321.16";"0";"3.10";"LORAZEPAM";"O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL54440";"MEVASTATIN";"2.0";"390.52";"0";"3.95";"MEVASTATIN";"CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL108";"CARBAMAZEPINE";"4.0";"236.27";"0";"3.39";"CARBAMAZEPINE";"NC(=O)N1c2ccccc2C=Cc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL696";"ETHOSUXIMIDE";"4.0";"141.17";"0";"0.45";"ETHOSUXIMIDE";"CCC1(C)CC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL313493";"METHANESULFONIC ACID METHYL ESTER";"None";"110.13";"0";"-0.41";"METHYL METHANESULFONATE";"COS(C)(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1388";"MONOBENZONE";"4.0";"200.24";"0";"2.97";"MONOBENZONE";"Oc1ccc(OCc2ccccc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL305660";"EBASTINE";"4.0";"469.67";"1";"7.22";"EBASTINE";"CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL817";"TOLAZAMIDE";"4.0";"311.41";"0";"1.77";"TOLAZAMIDE";"Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL44618";"CHLOROFORM";"4.0";"119.38";"0";"1.99";"CHLOROFORM";"ClC(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL600325";"PROSCILLARIDIN";"4.0";"530.66";"1";"3.01";"PROSCILLARIDIN";"C[C@@H]1O[C@@H](O[C@@H]2C=C3CC[C@@H]4[C@H](CC[C@]5(C)[C@@H](c6ccc(=O)oc6)CC[C@]45O)[C@@]3(C)CC2)[C@H](O)[C@H](O)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL1428";"NIMODIPINE";"4.0";"418.45";"0";"2.97";"NIMODIPINE";"COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL4875696";"";"None";"1084.24";"None";"None";"11; SBL-AII-11";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N1Cc2cc(O)ccc2C[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O";"IC50";"'='";"89.22";"nM";"7.05";"";"";"UO_0000065";"6.50";"None";"None";"None";"0";"CHEMBL4812855";"Displacement of [125-I]-[Sar1, Ile8] from recombinant human AT2R transfected in human HEK293 cells incubated for 2 hrs by liquid scintillation counter analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811266";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"TIME = 2.0 hr";"BINDING AGENT";""
"CHEMBL1071";"OXAPROZIN";"4.0";"293.32";"0";"4.03";"OXAPROZIN";"O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";""
"CHEMBL408403";"ANGIOTENSIN II";"4.0";"1046.20";"None";"None";"5; Ang II";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O";"IC50";"'='";"0.617";"nM";"9.21";"";"";"UO_0000065";"8.80";"None";"None";"None";"0";"CHEMBL4812855";"Displacement of [125-I]-[Sar1, Ile8] from recombinant human AT2R transfected in human HEK293 cells incubated for 2 hrs by liquid scintillation counter analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811266";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"TIME = 2.0 hr";"BINDING AGENT";""
"CHEMBL4852514";"";"None";"1072.23";"None";"None";"6";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"7.83";"None";"None";"None";"0";"CHEMBL4812855";"Displacement of [125-I]-[Sar1, Ile8] from recombinant human AT2R transfected in human HEK293 cells incubated for 2 hrs by liquid scintillation counter analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811266";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"TIME = 2.0 hr";"BINDING AGENT";""
"CHEMBL39959";"";"None";"562.74";"2";"6.49";"4; L-162,389";"CCCCOC(=O)NS(=O)(=O)c1ccc(CCC)cc1-c1ccc(Cn2c(CC)nc3c(C)cc(C)nc32)cc1";"IC50";"'='";"4.2";"nM";"8.38";"";"";"UO_0000065";"14.89";"0.29";"1.89";"8.12";"1";"CHEMBL3768051";"Binding affinity to type-2 angiotensin-2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763155";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL34124";"OLODANRIGAN";"2.0";"507.59";"2";"5.44";"25; EMA-401";"COc1ccc2c(c1OCc1ccccc1)C[C@@H](C(=O)O)N(C(=O)C(c1ccccc1)c1ccccc1)C2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4358381";"Inhibition of human AT2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354850";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL39959";"";"None";"562.74";"2";"6.49";"8, L-162389";"CCCCOC(=O)NS(=O)(=O)c1ccc(CCC)cc1-c1ccc(Cn2c(CC)nc3c(C)cc(C)nc32)cc1";"IC50";"'='";"4.2";"nM";"8.38";"";"";"UO_0000065";"14.89";"0.29";"1.89";"8.12";"1";"CHEMBL3396374";"Binding affinity to AT2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3392997";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";"";"";""
"CHEMBL5219534";"";"None";"477.48";"1";"5.83";"88";"O=c1c(O)c(-c2ccccc2-c2ccc(CNc3cc(C(F)(F)F)cc4c3CCCC4)cc2)c1=O";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"15.92";"0.30";"1.77";"11.45";"0";"CHEMBL5215025";"Inhibition of Angiotensin 2 binding to Angiotensin 2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214881";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL288174";"";"None";"582.79";"2";"6.80";"3; L-162,313";"CCCCOC(=O)NS(=O)(=O)c1sc(CC(C)C)cc1-c1ccc(Cn2c(CC)nc3c(C)cc(C)nc32)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"14.93";"0.30";"1.90";"8.43";"1";"CHEMBL5148370";"Displacement of [125-I]-[Sar1, Ile8]-angiotensin II from AT2R (unknown origin) by radioligand binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143706";"1";"Scientific Literature";"Bioorg Med Chem";"2022";"None";"";"AGONIST";""
